STOCK TITAN

Boxlight: $31.7M short-term debt, going-concern doubt

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Boxlight Corporation (BOXL) reported third-quarter 2026 revenue of $30.063 million, compared with $29.337 million a year earlier; gross profit was $11.154 million versus $8.535 million, and net loss narrowed to $1.018 million from $6.184 million. For the first nine months of 2026, revenue was $78.423 million versus $82.612 million, gross profit was $31.007 million versus $27.368 million, and net loss was $7.034 million versus $14.146 million. Net cash used in operating activities was $8.664 million, compared with $3.217 million.

As of September 30, 2026, cash and equivalents were $6.289 million, working capital was $1.1 million, and short-term debt was $31.735 million. Management concluded substantial doubt existed about Boxlight’s ability to continue as a going concern within one year after issuance, citing uncertainty around amending or refinancing debt and having sufficient liquidity. Boxlight was not in compliance with borrowing-base and Minimum Consolidated Adjusted EBITDA covenants. A November 10, 2026 waiver covered specified defaults subject to continued compliance; the Post-Default Rate remains applicable until the Loan Parties achieve compliance with Credit Agreement requirements.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 4 points

How the balance works

Positive

  • Moderate pointThird-quarter gross profit rose to $11.154 million from $8.535 million.
  • Moderate pointThird-quarter net loss narrowed to $1.018 million from $6.184 million.
  • Minor pointNine-month gross profit rose to $31.007 million from $27.368 million.
  • Minor pointNine-month net loss narrowed to $7.034 million from $14.146 million.

Negative

  • Major pointManagement concluded substantial doubt existed as of September 30, 2026.
  • Major pointCovenant noncompliance: borrowing base and Minimum Consolidated Adjusted EBITDA, September 30, 2026.
  • Moderate pointNine-month revenue declined to $78.423 million from $82.612 million.
  • Moderate pointOperating cash use rose to $8.664 million from $3.217 million for nine months.

Filing Explained

By September 30, 844,556 Class A shares were outstanding, while 11.8 million shares from preferred-stock conversion remained potential, not issued.

The 10-Q reports outstanding Class A shares rising from 228,335 at December 31, 2025 to 844,556 at September 30, 2026, reducing existing holders’ percentage ownership absent offsetting changes.

The filing labels one component an at-the-market program, an arrangement for gradual issuer share sales into the market, and records 338,616 shares issued through it in the nine-month equity rollforward.

The same rollforward lists 167,290 shares issued on related-party debt conversion; the Series D preferred financing is reported at $4,709 thousand.

The filing also identifies 11.8 million shares from assumed conversion of Series A, D, and E preferred stock as potentially dilutive, but excludes them from diluted loss per share because they would be anti-dilutive.

Third-quarter revenue $30.063 million Three months ended September 30, 2026; $29.337 million in 2025.
Nine-month revenue $78.423 million Nine months ended September 30, 2026; $82.612 million in 2025.
Third-quarter net loss $1.018 million Three months ended September 30, 2026; $6.184 million in 2025.
Nine-month net loss $7.034 million Nine months ended September 30, 2026; $14.146 million in 2025.
Third-quarter gross profit $11.154 million Three months ended September 30, 2026; $8.535 million in 2025.
Net cash used in operating activities $8.664 million Nine months ended September 30, 2026; $3.217 million in 2025.
Cash and cash equivalents $6.289 million As of September 30, 2026.
Short-term debt $31.735 million As of September 30, 2026.
going concern financial
"substantial doubt exists as to its ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
Minimum Consolidated Adjusted EBITDA financial
"Minimum Consolidated Adjusted EBITDA covenant"
borrowing base financial
"borrowing base covenant"
A borrowing base is the amount a lender will allow a company to borrow based on the value of assets the company offers as security, typically things like accounts receivable and inventory. It matters to investors because it sets a practical ceiling on short-term financing and influences a company’s liquidity and risk: if the borrowing base falls, the company may lose access to cash or be forced to sell assets, which can affect operations and share value.
remaining performance obligations financial
"aggregate amount of the contractual transaction prices allocated to remaining performance obligations"
Remaining performance obligations are the work a company still needs to complete for its customers, like finishing a service or delivering a product. It’s important because it shows how much future income the company has coming in from current agreements, giving a clearer picture of its ongoing business.
embedded derivative liability financial
"Recognition of embedded derivative liability"
product financing arrangement financial
"accounted for as a product financing arrangement under ASC 470-40"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were BOXL’s revenue and net loss in the third quarter of 2026?

Revenue was $30.063 million, compared with $29.337 million in the third quarter of 2025. Net loss was $1.018 million, versus $6.184 million a year earlier.

What did BOXL’s November 2026 debt waiver cover?

On November 10, 2026, lenders granted a limited waiver for specified defaults, including borrowing-base and financial-covenant noncompliance. The waiver was conditioned on continued compliance with its terms; a failure would constitute an immediate event of default and render the waiver null and void. The Post-Default Rate remained applicable pending compliance with Credit Agreement requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001624512 Boxlight Corp false --12-31 Q3 2026 1 1 1 1 1 3 5 5 1.75 1.75 2023 2024 2025 2026 2022 2023 2024 2025 2026 6 5.5 4 5 4 3 86 1 5 false false false false Eliminations and adjustments represent net sales between the Americas, EMEA and Rest of World segments. Sales between these segments are generally valued at market. The Company does not expect to pay a dividend in the foreseeable future. The historical trading volatility was based on historical fluctuations in stock price for Boxlight. The significant expense categories and amounts align with the segment-level information that is regularly provided to the Chief Operating Decision Maker. The risk-free interest rate was determined using the applicable (six month)Treasury Bill as of the measurement date. Other Segment items for each reportable segment includes: Research and development - consists primarily of personnel related costs, prototype and sample costs, design costs, and global product certifications mostly for wireless certifications. Other Expense - consists of interest expense associated with our debt financing arrangements, the effects of changes in the fair value of derivative liabilities and warrants. The historical trading volatility was based on historical fluctuations in stock price for Boxlight. The risk-free interest rate was determined using the applicable (six month) Treasury Bill as of the measurement date. Other Segment items for each reportable segment includes: Research and development - consists primarily of personnel related costs, prototype and sample costs, design costs, and global product certifications mostly for wireless certifications. Other Expense - consists of interest expense associated with our debt financing arrangements, the effects of changes in the fair value of derivative liabilities and warrants. 1,012 1,055 0.0001 0.0001 250,000 250,000 167,972 167,972 167,972 167,972 0.0001 0.0001 1,586,620 1,586,620 1,586,620 1,586,620 1,586,620 1,586,620 0.0001 0.0001 937,500 937,500 661,748 0 661,748 0 0.0001 0.0001 106,250 106,250 106,250 0 106,250 0 0.0001 0.0001 55,000,000 55,000,000 844,556 228,335 844,556 228,335 00016245122026-01-012026-09-30 xbrli:shares 00016245122026-11-16 thunderdome:item iso4217:USD 00016245122026-07-012026-09-30 00016245122025-07-012025-09-30 00016245122025-01-012025-09-30 iso4217:USDxbrli:shares 00016245122026-09-30 00016245122025-12-31 0001624512us-gaap:NonrelatedPartyMember2026-09-30 0001624512us-gaap:NonrelatedPartyMember2025-12-31 0001624512us-gaap:RelatedPartyMember2026-09-30 0001624512us-gaap:RelatedPartyMember2025-12-31 0001624512us-gaap:SeriesAPreferredStockMember2026-09-30 0001624512us-gaap:SeriesAPreferredStockMember2025-12-31 0001624512us-gaap:SeriesBPreferredStockMember2026-09-30 0001624512us-gaap:SeriesBPreferredStockMember2025-12-31 0001624512us-gaap:SeriesDPreferredStockMember2026-09-30 0001624512us-gaap:SeriesDPreferredStockMember2025-12-31 0001624512us-gaap:SeriesEPreferredStockMember2026-09-30 0001624512us-gaap:SeriesEPreferredStockMember2025-12-31 0001624512us-gaap:CommonClassAMember2026-09-30 0001624512us-gaap:CommonClassAMember2025-12-31 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001624512us-gaap:CommonStockMember2026-06-30 0001624512us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-30 0001624512us-gaap:RetainedEarningsMember2026-06-30 00016245122026-06-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512us-gaap:CommonStockMember2026-07-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-30 0001624512us-gaap:RetainedEarningsMember2026-07-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:CommonStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512boxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:CommonStockMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:RetainedEarningsMember2026-07-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:CommonStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512boxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:CommonStockMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:RetainedEarningsMember2026-07-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2026-07-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001624512us-gaap:CommonStockMember2026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMember2026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-30 0001624512us-gaap:RetainedEarningsMember2026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001624512us-gaap:CommonStockMember2025-12-31 0001624512us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-31 0001624512us-gaap:RetainedEarningsMember2025-12-31 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512us-gaap:CommonStockMember2026-01-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-30 0001624512us-gaap:RetainedEarningsMember2026-01-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:CommonStockMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512boxl:IssuanceOfSeriesDConvertiblePreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001624512boxl:ConversionsOfSeriesDPreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:CommonStockMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512boxl:IssuanceOfSeriesEConvertiblePreferredStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:CommonStockMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:AtmProgramMember2026-01-012026-09-30 0001624512boxl:AtmProgramMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:SeriesEPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2026-01-012026-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-06-30 0001624512us-gaap:CommonStockMember2025-06-30 0001624512us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-30 0001624512us-gaap:RetainedEarningsMember2025-06-30 00016245122025-06-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:CommonStockMember2025-07-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:RetainedEarningsMember2025-07-012025-09-30 0001624512boxl:PrefundedWarrantsMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:CommonStockMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:RetainedEarningsMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMember2025-07-012025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001624512us-gaap:CommonStockMember2025-07-012025-09-30 0001624512us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-30 0001624512us-gaap:RetainedEarningsMember2025-07-012025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:September2025PrivatePlacementMember2025-07-012025-09-30 0001624512us-gaap:CommonStockMemberboxl:September2025PrivatePlacementMember2025-07-012025-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:September2025PrivatePlacementMember2025-07-012025-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:September2025PrivatePlacementMember2025-07-012025-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:September2025PrivatePlacementMember2025-07-012025-09-30 0001624512boxl:September2025PrivatePlacementMember2025-07-012025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-09-30 0001624512us-gaap:CommonStockMember2025-09-30 0001624512us-gaap:AdditionalPaidInCapitalMember2025-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-30 0001624512us-gaap:RetainedEarningsMember2025-09-30 00016245122025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2024-12-31 0001624512us-gaap:CommonStockMember2024-12-31 0001624512us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-31 0001624512us-gaap:RetainedEarningsMember2024-12-31 00016245122024-12-31 0001624512srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2024-12-31 0001624512srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:CommonStockMember2024-12-31 0001624512srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2024-12-31 0001624512srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-31 0001624512srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2024-12-31 0001624512srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2024-12-31 0001624512boxl:PrefundedWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:CommonStockMember2025-01-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-30 0001624512boxl:PrefundedWarrantsMemberus-gaap:RetainedEarningsMember2025-01-012025-09-30 0001624512boxl:PrefundedWarrantsMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:CommonStockMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMemberus-gaap:RetainedEarningsMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMember2025-01-012025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001624512us-gaap:CommonStockMember2025-01-012025-09-30 0001624512us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-30 0001624512us-gaap:RetainedEarningsMember2025-01-012025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:February2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:CommonStockMemberboxl:February2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:February2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:February2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:February2025PrivatePlacementMember2025-01-012025-09-30 0001624512boxl:February2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMemberboxl:September2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:CommonStockMemberboxl:September2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:AdditionalPaidInCapitalMemberboxl:September2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:AccumulatedOtherComprehensiveIncomeMemberboxl:September2025PrivatePlacementMember2025-01-012025-09-30 0001624512us-gaap:RetainedEarningsMemberboxl:September2025PrivatePlacementMember2025-01-012025-09-30 0001624512boxl:September2025PrivatePlacementMember2025-01-012025-09-30 0001624512boxl:CommonStockAndPrefundedWarrantsMember2026-01-012026-09-30 0001624512boxl:CommonStockAndPrefundedWarrantsMember2025-01-012025-09-30 0001624512boxl:IssuanceOfSeriesDConvertiblePreferredStockMember2025-01-012025-09-30 0001624512boxl:IssuanceOfSeriesEConvertiblePreferredStockMember2025-01-012025-09-30 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2025-01-012025-09-30 xbrli:pure 0001624512boxl:ReverseStockSplitMember2026-06-172026-06-17 0001624512srt:ScenarioPreviouslyReportedMember2025-01-012025-09-30 0001624512srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-01-012025-09-30 0001624512us-gaap:RelatedPartyMembersrt:ScenarioPreviouslyReportedMember2025-01-012025-12-31 0001624512us-gaap:RelatedPartyMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-01-012025-12-31 0001624512us-gaap:RelatedPartyMember2025-01-012025-12-31 0001624512srt:ScenarioPreviouslyReportedMember2025-07-012025-09-30 0001624512srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-07-012025-09-30 0001624512us-gaap:ProductMembersrt:ScenarioPreviouslyReportedMember2025-07-012025-09-30 0001624512us-gaap:ServiceMembersrt:ScenarioPreviouslyReportedMember2025-07-012025-09-30 0001624512us-gaap:ProductMembersrt:ScenarioPreviouslyReportedMember2025-01-012025-09-30 0001624512us-gaap:ServiceMembersrt:ScenarioPreviouslyReportedMember2025-01-012025-09-30 0001624512us-gaap:ProductMember2025-07-012025-09-30 0001624512us-gaap:ServiceMember2025-07-012025-09-30 0001624512us-gaap:ProductMember2025-01-012025-09-30 0001624512us-gaap:ServiceMember2025-01-012025-09-30 0001624512us-gaap:ProductMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-07-012025-09-30 0001624512us-gaap:ProductMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-01-012025-09-30 0001624512us-gaap:ServiceMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-07-012025-09-30 0001624512us-gaap:ServiceMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2025-01-012025-09-30 0001624512boxl:CommonWarrantsMember2025-01-012025-09-30 0001624512us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2026-09-30 0001624512us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2026-09-30 0001624512us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2026-09-30 0001624512us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001624512boxl:WarrantLiabilitiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512boxl:WarrantLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512boxl:WarrantLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512boxl:WarrantLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2025-12-31 0001624512us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2025-12-31 0001624512us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2025-12-31 0001624512us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RelatedPartyMember2025-12-31 0001624512us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:RelatedPartyMember2026-06-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-06-30 0001624512boxl:DeferredCompensationLiabilityMember2026-06-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:RelatedPartyMember2026-07-012026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-07-012026-09-30 0001624512boxl:DeferredCompensationLiabilityMember2026-07-012026-09-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:RelatedPartyMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-09-30 0001624512boxl:DeferredCompensationLiabilityMember2026-09-30 0001624512boxl:WarrantLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-31 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:RelatedPartyMember2025-12-31 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-31 0001624512boxl:DeferredCompensationLiabilityMember2025-12-31 0001624512boxl:WarrantLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-01-012026-09-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:RelatedPartyMember2026-01-012026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-01-012026-09-30 0001624512boxl:DeferredCompensationLiabilityMember2026-01-012026-09-30 0001624512boxl:WarrantLiabilitiesMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-09-30 0001624512boxl:CommonWarrantsMemberboxl:WarrantLiabilitiesMember2025-06-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:NonrelatedPartyMember2025-06-30 0001624512boxl:DeferredCompensationLiabilityMember2025-06-30 0001624512boxl:CommonWarrantsMemberboxl:WarrantLiabilitiesMember2025-07-012025-09-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:NonrelatedPartyMember2025-07-012025-09-30 0001624512boxl:DeferredCompensationLiabilityMember2025-07-012025-09-30 0001624512boxl:CommonWarrantsMemberboxl:WarrantLiabilitiesMember2025-09-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:NonrelatedPartyMember2025-09-30 0001624512boxl:DeferredCompensationLiabilityMember2025-09-30 0001624512boxl:CommonWarrantsMemberboxl:WarrantLiabilitiesMember2024-12-31 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:NonrelatedPartyMember2024-12-31 0001624512boxl:DeferredCompensationLiabilityMember2024-12-31 0001624512boxl:CommonWarrantsMemberboxl:WarrantLiabilitiesMember2025-01-012025-09-30 0001624512us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:NonrelatedPartyMember2025-01-012025-09-30 0001624512boxl:DeferredCompensationLiabilityMember2025-01-012025-09-30 0001624512us-gaap:EmployeeStockOptionMember2026-01-012026-09-30 0001624512us-gaap:RestrictedStockMember2026-01-012026-09-30 0001624512us-gaap:WarrantMember2026-01-012026-09-30 0001624512us-gaap:PreferredStockMember2026-01-012026-09-30 0001624512us-gaap:EmployeeStockOptionMember2025-01-012025-09-30 0001624512us-gaap:WarrantMember2025-01-012025-09-30 0001624512us-gaap:PreferredStockMember2025-01-012025-09-30 utr:M 0001624512boxl:InteractiveDevicesHardwareMaintenanceServiceMembersrt:MinimumMember2026-01-012026-09-30 0001624512boxl:InteractiveDevicesHardwareMaintenanceServiceMembersrt:MaximumMember2026-01-012026-09-30 0001624512boxl:NoninteractiveDevicesHardwareMaintenanceServiceMember2026-01-012026-09-30 utr:D 0001624512srt:MinimumMember2026-01-012026-09-30 0001624512srt:MaximumMember2026-01-012026-09-30 00016245122026-10-012026-09-30 utr:Y 00016245122027-10-012026-09-30 00016245122028-10-012026-09-30 00016245122029-10-012026-09-30 00016245122030-10-012026-09-30 0001624512us-gaap:ProductMember2026-07-012026-09-30 0001624512us-gaap:ProductMember2026-01-012026-09-30 0001624512us-gaap:ServiceMember2026-07-012026-09-30 0001624512us-gaap:ServiceMember2026-01-012026-09-30 0001624512srt:MaximumMember2026-09-30 0001624512boxl:VendorsMember2026-09-30 0001624512us-gaap:PatentsMembersrt:MinimumMember2026-09-30 0001624512us-gaap:PatentsMembersrt:MaximumMember2026-09-30 0001624512us-gaap:PatentsMember2026-09-30 0001624512us-gaap:PatentsMember2025-12-31 0001624512us-gaap:CustomerRelationshipsMembersrt:MinimumMember2026-09-30 0001624512us-gaap:CustomerRelationshipsMembersrt:MaximumMember2026-09-30 0001624512us-gaap:CustomerRelationshipsMember2026-09-30 0001624512us-gaap:CustomerRelationshipsMember2025-12-31 0001624512us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MinimumMember2026-09-30 0001624512us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MaximumMember2026-09-30 0001624512us-gaap:TechnologyBasedIntangibleAssetsMember2026-09-30 0001624512us-gaap:TechnologyBasedIntangibleAssetsMember2025-12-31 0001624512us-gaap:NoncompeteAgreementsMember2026-09-30 0001624512us-gaap:NoncompeteAgreementsMember2025-12-31 0001624512us-gaap:TradeNamesMembersrt:MinimumMember2026-09-30 0001624512us-gaap:TradeNamesMembersrt:MaximumMember2026-09-30 0001624512us-gaap:TradeNamesMember2026-09-30 0001624512us-gaap:TradeNamesMember2025-12-31 00016245122025-01-012025-12-31 0001624512boxl:CreditAgreementMember2025-03-24 0001624512boxl:CreditAgreementMember2025-03-242025-03-24 0001624512boxl:CreditAgreementMember2025-08-132025-08-13 0001624512boxl:CreditAgreementMember2025-12-022025-12-02 0001624512boxl:CreditAgreementMember2025-12-02 0001624512boxl:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMember2025-12-022025-12-02 0001624512boxl:CreditAgreementMemberboxl:ReferenceRateMember2025-12-022025-12-02 0001624512boxl:CreditAgreementMember2025-08-13 0001624512boxl:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMember2025-12-182025-12-18 0001624512boxl:CreditAgreementMemberboxl:ReferenceRateMember2025-12-182025-12-18 0001624512boxl:CreditAgreementMember2025-12-182025-12-18 0001624512boxl:CreditAgreementMember2025-01-012025-12-17 0001624512boxl:CreditAgreementMember2025-12-18 0001624512boxl:CreditAgreementMember2025-12-31 0001624512boxl:CreditAgreementMember2026-01-31 0001624512boxl:CreditAgreementMember2026-02-28 0001624512boxl:CreditAgreementMember2026-03-31 0001624512boxl:CreditAgreementMember2025-04-012025-05-31 0001624512boxl:CreditAgreementMember2025-03-31 0001624512boxl:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMember2025-08-132025-08-13 0001624512boxl:CreditAgreementMemberboxl:ReferenceRateMember2025-08-132025-08-13 0001624512boxl:CreditAgreementMember2026-08-31 0001624512boxl:CreditAgreementMember2026-08-012026-08-31 0001624512boxl:CreditAgreementMemberus-gaap:SubsequentEventMember2026-10-012026-10-31 0001624512boxl:CreditAgreementMemberus-gaap:CommonClassAMember2022-01-012022-01-31 0001624512boxl:WarrantsMemberboxl:CreditAgreementMember2022-01-31 0001624512boxl:CreditAgreementMemberboxl:SeriesBAndSeriesCConvertiblePreferredStockMember2022-01-31 0001624512boxl:WarrantsMemberboxl:CreditAgreementMember2022-01-012022-01-31 0001624512boxl:CreditAgreementMember2022-01-012022-01-31 0001624512boxl:CreditAgreementMember2022-01-31 0001624512boxl:WarrantsMemberboxl:CreditAgreementMember2022-03-31 0001624512boxl:WhitehawkWarrantsMember2022-07-22 0001624512boxl:WhitehawkWarrantsMember2025-02-19 0001624512boxl:WhitehawkWarrantsMember2025-09-23 0001624512boxl:ConversionOfDebtIntoClassACommonStockMember2026-04-012026-04-01 0001624512boxl:ConversionOfDebtIntoClassACommonStockMember2026-04-01 0001624512boxl:WhitehawkWarrantsMember2026-04-01 0001624512boxl:WhitehawkWarrantsMember2026-08-05 0001624512boxl:ConversionOfDebtIntoClassACommonStockMember2026-08-172026-08-19 0001624512boxl:ConversionOfDebtIntoClassACommonStockMember2026-08-19 0001624512boxl:WhitehawkWarrantsMember2026-08-19 0001624512boxl:WhitehawkWarrantsMember2026-09-30 0001624512us-gaap:MeasurementInputSharePriceMember2026-09-30 0001624512us-gaap:MeasurementInputExercisePriceMember2026-09-30 0001624512us-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-30 0001624512us-gaap:MeasurementInputExpectedTermMember2026-09-30 0001624512us-gaap:MeasurementInputPriceVolatilityMember2026-09-30 0001624512us-gaap:MeasurementInputExpectedDividendRateMember2026-09-30 0001624512us-gaap:MeasurementInputSharePriceMember2025-12-31 0001624512us-gaap:MeasurementInputExercisePriceMember2025-12-31 0001624512us-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-31 0001624512us-gaap:MeasurementInputExpectedTermMember2025-12-31 0001624512us-gaap:MeasurementInputPriceVolatilityMember2025-12-31 0001624512us-gaap:MeasurementInputExpectedDividendRateMember2025-12-31 0001624512boxl:SeriesDDerivativeLiabilitiesMemberboxl:FairValueOfEmbeddedDerivativeLiabilityMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberboxl:ExpectedPayoffUponConversionMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberboxl:CalibratedProbabilityExchangeCapLiftedMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberboxl:CalibratedProbabilityDownsideInvestorMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberboxl:CalibratedDiscountRateMembersrt:MinimumMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMemberboxl:CalibratedDiscountRateMembersrt:MaximumMember2026-09-30 0001624512boxl:SeriesDDerivativeLiabilitiesMember2026-01-012026-09-30 0001624512us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMember2026-01-012026-09-30 0001624512us-gaap:ForeignCountryMemberus-gaap:HerMajestysRevenueAndCustomsHMRCMember2026-01-012026-09-30 0001624512us-gaap:SeriesCPreferredStockMember2026-09-30 0001624512us-gaap:SeriesAPreferredStockMember2017-11-302017-11-30 0001624512us-gaap:SeriesBPreferredStockMember2020-09-252020-09-25 0001624512us-gaap:SeriesCPreferredStockMember2020-09-252020-09-25 0001624512us-gaap:SeriesBPreferredStockMember2020-09-25 0001624512us-gaap:CommonClassAMember2020-09-25 0001624512us-gaap:SeriesCPreferredStockMember2020-09-25 0001624512boxl:ConversionOfSeriesCPreferredStockIntoClassACommonStockMember2025-10-012025-10-01 0001624512us-gaap:CommonClassAMember2025-10-01 0001624512boxl:ReverseStockSplitMember2026-06-222026-06-22 0001624512us-gaap:SeriesBPreferredStockMembersrt:ScenarioForecastMember2027-10-022027-10-02 0001624512us-gaap:SeriesBPreferredStockMembersrt:ScenarioForecastMember2028-10-022028-10-02 0001624512us-gaap:SeriesBPreferredStockMembersrt:ScenarioForecastMember2029-10-022029-10-02 0001624512us-gaap:SeriesBPreferredStockMembersrt:ScenarioForecastMember2030-10-022030-10-02 0001624512us-gaap:SeriesDPreferredStockMember2026-08-05 0001624512us-gaap:SeriesDPreferredStockMember2026-08-052026-08-05 0001624512us-gaap:SeriesDPreferredStockMembersrt:ScenarioForecastMember2026-11-152026-12-31 0001624512srt:MaximumMemberus-gaap:SeriesDPreferredStockMember2026-08-05 0001624512us-gaap:SeriesDPreferredStockMember2026-01-012026-09-30 0001624512boxl:EquityLineOfCreditMember2026-08-05 0001624512srt:MaximumMemberboxl:EquityLineOfCreditMember2026-08-05 0001624512boxl:PrefundedWarrantsMember2026-08-05 0001624512boxl:PrefundedWarrantsMembersrt:MaximumMember2026-08-05 0001624512boxl:EquityLineOfCreditMember2026-08-052026-08-05 0001624512us-gaap:SeriesEPreferredStockMember2026-09-302026-09-30 0001624512srt:MinimumMemberus-gaap:SeriesEPreferredStockMember2026-09-30 0001624512boxl:ReverseStockSplitMember2026-06-012026-06-30 0001624512us-gaap:CommonClassAMember2026-06-30 0001624512us-gaap:CommonClassBMember2026-09-30 0001624512us-gaap:CommonClassAMember2026-07-22 0001624512us-gaap:CommonClassAMember2026-07-23 0001624512us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2025-02-192025-02-19 0001624512boxl:PrefundedWarrantsMemberus-gaap:PrivatePlacementMember2025-02-19 0001624512boxl:CommonWarrantsMemberus-gaap:PrivatePlacementMember2025-02-19 0001624512boxl:SharesAndWarrantSharesMemberus-gaap:PrivatePlacementMember2025-02-19 0001624512boxl:PrefundedWarrantsAndCommonWarrantsMemberus-gaap:PrivatePlacementMember2025-02-19 0001624512us-gaap:PrivatePlacementMember2025-02-192025-02-19 0001624512boxl:CommonWarrantsMemberus-gaap:PrivatePlacementMember2025-02-192025-02-19 0001624512us-gaap:CommonClassAMemberboxl:RegisteredDirectOfferingMember2025-09-232025-09-23 0001624512us-gaap:CommonClassAMemberboxl:RegisteredDirectOfferingMember2025-09-23 0001624512us-gaap:CommonClassAMemberboxl:AtmProgramMember2025-10-16 0001624512us-gaap:CommonClassAMemberboxl:AtmProgramMember2025-01-012025-12-31 0001624512us-gaap:CommonClassAMemberboxl:AtmProgramMember2025-12-31 0001624512us-gaap:CommonClassAMemberboxl:AtmProgramMember2026-01-212026-01-21 0001624512boxl:EquityWarrantsMember2026-09-30 0001624512boxl:EquityWarrantsMember2025-12-31 0001624512boxl:The2014PlanMember2021-09-30 0001624512boxl:The2021PlanMember2021-09-30 0001624512boxl:The2021PlanMember2021-09-012023-06-30 0001624512us-gaap:EmployeeStockOptionMember2026-01-012026-09-30 0001624512us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-30 0001624512us-gaap:RestrictedStockUnitsRSUMember2025-12-31 0001624512us-gaap:RestrictedStockUnitsRSUMember2026-09-30 0001624512boxl:EquityWarrantsMember2026-01-012026-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMemberboxl:SeniorManagementMember2026-01-012026-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMemberboxl:BoardOfDirectorsMember2026-01-012026-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMemberboxl:BoardOfDirectorsMember2026-01-012026-03-31 0001624512boxl:CashAwardMemberboxl:LtipPlanMember2026-01-012026-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMember2026-09-30 0001624512us-gaap:EmployeeStockOptionMember2026-07-012026-09-30 0001624512us-gaap:EmployeeStockOptionMember2025-07-012025-09-30 0001624512us-gaap:EmployeeStockOptionMember2025-01-012025-09-30 0001624512us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-30 0001624512us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-30 0001624512us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-30 0001624512boxl:EquityWarrantsMember2026-07-012026-09-30 0001624512boxl:EquityWarrantsMember2025-07-012025-09-30 0001624512boxl:EquityWarrantsMember2025-01-012025-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMember2026-07-012026-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMember2025-07-012025-09-30 0001624512boxl:CashAwardMemberboxl:LtipPlanMember2025-01-012025-09-30 0001624512boxl:ConsultingAgreementMemberboxl:FormerChiefExecutiveOfficerMember2022-11-012022-11-01 0001624512boxl:ConsultingAgreementMemberboxl:FormerChiefExecutiveOfficerMember2026-07-012026-09-30 0001624512boxl:ConsultingAgreementMemberboxl:FormerChiefExecutiveOfficerMember2025-07-012025-09-30 0001624512boxl:ConsultingAgreementMemberboxl:FormerChiefExecutiveOfficerMember2026-01-012026-09-30 0001624512boxl:ConsultingAgreementMemberboxl:FormerChiefExecutiveOfficerMember2025-01-012025-09-30 0001624512boxl:ManagementAgreementMemberboxl:FormerChiefExecutiveOfficerAndChairmanMember2018-01-312018-01-31 0001624512boxl:ManagementAgreementMemberboxl:FormerChiefExecutiveOfficerAndChairmanMember2024-01-042024-01-04 0001624512boxl:ManagementAgreementMemberboxl:FormerChiefExecutiveOfficerAndChairmanMember2025-01-012025-09-30 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2025-05-27 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2025-05-272025-05-27 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2025-11-03 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2025-11-032025-11-03 0001624512boxl:ConversionOfInventoryFinanceOutstandingBalanceIntoCommonStockMemberboxl:JjAstorMember2026-04-012026-04-01 0001624512boxl:ConversionOfInventoryFinanceOutstandingBalanceIntoCommonStockMemberboxl:JjAstorMember2026-04-01 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2026-04-01 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2026-04-012026-04-01 00016245122026-04-012026-04-01 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2026-08-172026-08-17 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2026-08-17 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2026-08-192026-08-19 0001624512boxl:ConversionOfRelatedPartyDebtIntoCommonStockMember2026-08-19 0001624512us-gaap:RelatedPartyMember2026-07-012026-09-30 0001624512us-gaap:RelatedPartyMember2026-01-012026-09-30 0001624512us-gaap:RelatedPartyMember2025-07-012025-09-30 0001624512us-gaap:RelatedPartyMember2025-01-012025-09-30 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2026-09-30 0001624512boxl:InventoryFinanceAgreementMemberboxl:JjAstorMember2025-12-31 0001624512us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberboxl:CustomerOneMember2026-07-012026-09-30 0001624512boxl:CustomerOneMember2026-09-30 0001624512us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberboxl:CustomerOneMember2025-07-012025-09-30 0001624512boxl:CustomerOneMember2025-09-30 0001624512us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberboxl:CustomerOneMember2026-01-012026-09-30 0001624512us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberboxl:CustomerOneMember2025-01-012025-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorOneMember2026-07-012026-09-30 0001624512boxl:VendorOneMember2026-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorOneMember2025-07-012025-09-30 0001624512boxl:VendorOneMember2025-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorTwoMember2026-07-012026-09-30 0001624512boxl:VendorTwoMember2026-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorTwoMember2025-07-012025-09-30 0001624512boxl:VendorTwoMember2025-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorThreeMember2026-07-012026-09-30 0001624512boxl:VendorThreeMember2026-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorThreeMember2025-07-012025-09-30 0001624512boxl:VendorThreeMember2025-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorTwoMember2026-01-012026-09-30 0001624512us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMemberboxl:VendorTwoMember2025-01-012025-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:AmericasSegmentMember2026-07-012026-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:EmeaSegmentMember2026-07-012026-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:RestOfWorldSegmentMember2026-07-012026-09-30 0001624512us-gaap:IntersegmentEliminationMember2026-07-012026-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:AmericasSegmentMember2026-01-012026-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:EmeaSegmentMember2026-01-012026-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:RestOfWorldSegmentMember2026-01-012026-09-30 0001624512us-gaap:IntersegmentEliminationMember2026-01-012026-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:AmericasSegmentMember2025-07-012025-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:EmeaSegmentMember2025-07-012025-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:RestOfWorldSegmentMember2025-07-012025-09-30 0001624512us-gaap:IntersegmentEliminationMember2025-07-012025-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:AmericasSegmentMember2025-01-012025-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:EmeaSegmentMember2025-01-012025-09-30 0001624512us-gaap:OperatingSegmentsMemberboxl:RestOfWorldSegmentMember2025-01-012025-09-30 0001624512us-gaap:IntersegmentEliminationMember2025-01-012025-09-30 0001624512boxl:AmericasSegmentMember2026-09-30 0001624512boxl:AmericasSegmentMember2025-12-31 0001624512boxl:EmeaSegmentMember2026-09-30 0001624512boxl:EmeaSegmentMember2025-12-31 0001624512boxl:RestOfWorldSegmentMember2026-09-30 0001624512boxl:RestOfWorldSegmentMember2025-12-31 0001624512boxl:InventoryFinanceAgreementMemberus-gaap:SubsequentEventMember2026-11-03 0001624512us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2026-11-10 0001624512boxl:The2026PlanMemberus-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2026-11-10 0001624512boxl:ReverseStockSplitMembersrt:MaximumMemberus-gaap:SubsequentEventMember2026-11-102026-11-10 0001624512us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2026-11-16

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

 

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

or

 

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File Number 001-37564

 

BOXLIGHT CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada

 

36-4794936

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

2750 Premiere Parkway, Suite 900

Duluth, Georgia 30097

(Address of principal executive offices) (Zip Code)

 

(678) 367-0809

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

 

BOXL

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer

☐

 

Accelerated filer

☐

 

 

 

Non-accelerated filer

☒

 

Smaller reporting company

☒

 

 

 

 

 

 

Emerging growth company

☐

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of the registrant’s Class A common stock on November 16, 2026 was 844,556.


Table of Contents

 

BOXLIGHT CORPORATION

 

TABLE OF CONTENTS

 

 

 

Page No.

 

 

 

 

PART I. Financial Information

 

 

 

 

Item 1.

Unaudited Condensed Consolidated Financial Statements

4

 

 

 

 

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2026 and 2025

4

 

 

 

 

Unaudited Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025

5

 

 

 

 

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity for the three and nine months ended September 30, 2026 and 2025

6

 

 

 

 

Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025

10

 

 

 

 

Notes to the Unaudited Condensed Consolidated Financial Statements

11

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

43

 

 

 

Item 3.

Quantitative and Qualitative Disclosure About Market Risk

56

 

 

 

Item 4.

Controls and Procedures

56

 

 

 

 

PART II. Other Information

 

 

 

 

Item 1.

Legal Proceedings

58

 

 

 

Item 1A.

Risk Factors

58

 

 

 

Item 2.

Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

61

 

 

 

Item 3.

Defaults Upon Senior Securities

63

 

 

 

Item 4.

Mine Safety Disclosures

63

 

 

 

Item 5.

Other Information

63

 

 

 

Item 6.

Exhibits

64

 

 

 

 

Signatures

66

 


Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Boxlight Corporation

Condensed Consolidated Statements of Operations and Comprehensive Loss

For the three and nine months ended September 30, 2026 and 2025

(Unaudited)

(in thousands, except share and per share amounts)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenues, net

 

$

30,063

 

 

$

29,337

 

 

$

78,423

 

 

$

82,612

 

Cost of revenues

 

 

18,909

 

 

 

20,802

 

 

 

47,416

 

 

 

55,244

 

Gross profit

 

 

11,154

 

 

 

8,535

 

 

 

31,007

 

 

 

27,368

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Operating expense:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

General and administrative

 

 

7,906

 

 

 

8,730

 

 

 

24,615

 

 

 

27,289

 

Depreciation and amortization

 

 

2,539

 

 

 

2,627

 

 

 

7,672

 

 

 

7,681

 

Research and development

 

 

944

 

 

 

1,122

 

 

 

2,822

 

 

 

3,162

 

Total operating expense

 

 

11,389

 

 

 

12,479

 

 

 

35,109

 

 

 

38,132

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Loss from operations

 

 

(235

)

 

 

(3,944

)

 

 

(4,102

)

 

 

(10,764

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Other (expense) income:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Interest expense, net

 

 

(1,100

)

 

 

(2,753

)

 

 

(3,434

)

 

 

(7,811

)

Other income (expense), net

 

 

(99

)

 

 

778

 

 

 

(408

)

 

 

3,762

 

Loss on warrant issuance

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(578

)

Change in fair value of derivative liabilities

 

 

161

 

 

 

(235

)

 

 

7

 

 

 

(286

)

Change in fair value of common warrants

 

 

—

 

 

 

(291

)

 

 

—

 

 

 

1,394

 

Total other expense

 

 

(1,038

)

 

 

(2,501

)

 

 

(3,835

)

 

 

(3,519

)

Loss before income taxes

 

$

(1,273

)

 

$

(6,445

)

 

$

(7,937

)

 

$

(14,283

)

Income tax benefit

 

 

255

 

 

 

261

 

 

 

903

 

 

 

137

 

Net loss

 

$

(1,018

)

 

$

(6,184

)

 

$

(7,034

)

 

$

(14,146

)

Fixed dividends - Series B Preferred

 

 

(317

)

 

 

(317

)

 

 

(952

)

 

 

(951

)

Net loss attributable to common stockholders

 

$

(1,335

)

 

$

(6,501

)

 

$

(7,986

)

 

$

(15,097

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Comprehensive loss:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

$

(1,018

)

 

$

(6,184

)

 

$

(7,034

)

 

$

(14,146

)

Other comprehensive loss:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Foreign currency translation adjustment

 

 

(48

)

 

 

134

 

 

 

(349

)

 

 

856

 

Total comprehensive loss

 

$

(1,066

)

 

$

(6,050

)

 

$

(7,383

)

 

$

(13,290

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss per share of Class A common stock – basic and diluted

 

$

(1.78

)

 

$

(67.65

)

 

$

(12.48

)

 

$

(175.48

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Weighted average number of shares of Class A common stock outstanding – basic and diluted

 

 

750,116

 

 

 

96,099

 

 

 

639,855

 

 

 

86,034

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

4


Table of Contents

 

Boxlight Corporation

Condensed Consolidated Balance Sheets

As of September 30, 2026 and December 31, 2025

(in thousands, except share amounts)

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

 

 

​

ASSETS

 

 

 

​

 

 

 

​

Current assets:

 

 

 

​

 

 

 

​

Cash and cash equivalents

 

$

6,289

 

 

$

9,370

 

Accounts receivable – trade, net of allowances for credit losses of $1,012 and $1,055

 

 

20,081

 

 

 

15,358

 

Inventories, net of reserves

 

 

28,805

 

 

 

38,126

 

Prepaid expenses and other current assets

 

 

10,309

 

 

 

6,624

 

Total current assets

 

 

65,484

 

 

 

69,478

 

 

 

 

 

​

 

 

 

​

Property and equipment, net of accumulated depreciation

 

 

1,538

 

 

 

1,770

 

Operating lease right of use asset

 

 

6,421

 

 

 

7,009

 

Intangible assets, net of accumulated amortization

 

 

9,677

 

 

 

17,080

 

Deferred tax assets, net

 

 

1,467

 

 

 

1,472

 

Other assets

 

 

955

 

 

 

734

 

Total assets

 

$

85,542

 

 

$

97,543

 

 

 

 

 

​

 

 

 

​

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

Current liabilities:

 

 

 

​

 

 

 

​

Accounts payable and accrued expenses

 

$

13,868

 

 

$

22,786

 

Accounts payable and accrued expenses - related party

 

 

1,891

 

 

 

3,699

 

Short-term debt

 

 

31,735

 

 

 

1,274

 

Operating lease liabilities, current

 

 

1,585

 

 

 

1,741

 

Deferred revenues, current

 

 

8,716

 

 

 

9,273

 

Derivative liabilities

 

 

1,040

 

 

 

5

 

Derivative liabilities - related party

 

 

592

 

 

 

476

 

Other short-term liabilities

 

 

4,931

 

 

 

3,598

 

Total current liabilities

 

 

64,358

 

 

 

42,852

 

 

 

 

 

​

 

 

 

​

Deferred revenues, non-current

 

 

14,039

 

 

 

14,849

 

Long-term debt

 

 

—

 

 

 

32,877

 

Operating lease liabilities, non-current

 

 

5,159

 

 

 

5,650

 

Other long-term liabilities

 

 

69

 

 

 

60

 

Total liabilities

 

 

83,625

 

 

 

96,288

 

 

 

 

 

​

 

 

 

​

Stockholders’ (deficit) equity:

 

 

 

​

 

 

 

​

Preferred Series A stock, $0.0001 par value, 250,000 shares authorized; 167,972 shares issued and outstanding, at September 30, 2026 and December 31, 2025

 

 

—

 

 

 

—

 

Preferred Series B stock, $0.0001 par value, 1,586,620 shares authorized; 1,586,620 shares issued and outstanding, at September 30, 2026 and December 31, 2025

 

 

—

 

 

 

—

 

Convertible Preferred Series D Stock, $0.0001 par value, 937,500 shares authorized; 661,748 and no shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively

 

 

3,430

 

 

 

—

 

Convertible Preferred Series E Stock, $0.0001 par value, 106,250 shares authorized; 106,250 and no shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively

 

 

850

 

 

 

—

 

Common stock, $0.0001 par value, 55,000,000 shares authorized; 844,556 and 228,335 Class A shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively

 

 

—

 

 

 

—

 

Additional paid-in capital

 

 

158,888

 

 

 

155,123

 

Accumulated deficit

 

 

(163,454

)

 

 

(156,420

)

Accumulated other comprehensive income

 

 

2,203

 

 

 

2,552

 

Total stockholders’ (deficit) equity

 

 

1,917

 

 

 

1,255

 

 

 

 

 

​

 

 

 

​

Total liabilities and stockholders’ (deficit) equity

 

$

85,542

 

 

$

97,543

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

5


Table of Contents

 

Boxlight Corporation

Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity

For the three months ended September 30, 2026

(Unaudited)

(in thousands, except share amounts)

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

Accumulated

 

 

 

 

​

 

 

 

​

 

 

Series A

 

 

Series B

 

 

Series D

 

 

Series E

 

 

Class A

 

 

Additional

 

 

Other

 

 

 

 

​

 

 

 

​

 

 

Preferred Stock

 

 

Preferred Stock

 

 

Convertible Preferred Stock

 

 

Convertible Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

 

 

​

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of June 30, 2026

 

 

167,972

 

 

$

—

 

 

 

1,586,620

 

 

$

—

 

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

 

 

667,348

 

 

$

—

 

 

$

158,762

 

 

$

2,251

 

 

$

(162,436

)

 

$

(1,423

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Shares issued for:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Vesting of restricted share units

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

57

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock financing Convertible Preferred Series D

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

687,500

 

 

 

4,845

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(136

)

 

 

—

 

 

 

—

 

 

 

4,709

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Conversion of Convertible Preferred Series D

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(25,752

)

 

 

(257

)

 

 

—

 

 

 

—

 

 

 

109,861

 

 

 

—

 

 

 

257

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Recognition of embedded derivative liability

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,158

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,158

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock financing Convertible Preferred Series E

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

106,250

 

 

 

850

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

850

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Equity line of credit commitment fee

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

150

 

 

 

—

 

 

 

—

 

 

 

150

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Conversion of related-party debt to common stock

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

67,290

 

 

 

—

 

 

 

167

 

 

 

—

 

 

 

—

 

 

 

167

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

5

 

 

 

—

 

 

 

—

 

 

 

5

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Foreign currency translation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(48

)

 

 

—

 

 

 

(48

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Fixed dividends Preferred Series B

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(317

)

 

 

—

 

 

 

—

 

 

 

(317

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,018

)

 

 

(1,018

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of September 30, 2026

 

 

167,972

 

 

$

—

 

 

 

1,586,620

 

 

$

—

 

 

 

661,748

 

 

$

3,430

 

 

 

106,250

 

 

$

850

 

 

 

844,556

 

 

$

—

 

 

$

158,888

 

 

$

2,203

 

 

$

(163,454

)

 

$

1,917

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

6


Table of Contents

 

Boxlight Corporation

Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity

For the nine months ended September 30, 2026, as adjusted

(Unaudited)

(in thousands, except share amounts)

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

Accumulated

 

 

 

 

​

 

 

 

​

 

 

Series A

 

 

Series B

 

 

Series D

 

 

Series E

 

 

Class A

 

 

Additional

 

 

Other

 

 

 

 

​

 

 

 

​

 

 

Preferred Stock

 

 

Preferred Stock

 

 

Convertible Preferred Stock

 

 

Convertible Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

 

 

​

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Total

 

Balance as of December 31, 2025

 

 

167,972

 

 

$

—

 

 

 

1,586,620

 

 

$

—

 

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

 

 

228,335

 

 

$

—

 

 

$

155,123

 

 

$

2,552

 

 

$

(156,420

)

 

$

1,255

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Shares issued for:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Vesting of restricted share units

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

162

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Reverse stock split fractional adjustment

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

292

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock financing Convertible Preferred Series D

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

687,500

 

 

 

4,845

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(136

)

 

 

—

 

 

 

—

 

 

 

4,709

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Conversion of Convertible Preferred Series D

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(25,752

)

 

 

(257

)

 

 

—

 

 

 

—

 

 

 

109,861

 

 

 

—

 

 

 

257

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Recognition of embedded derivative liability

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,158

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,158

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock financing Convertible Preferred Series E

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

106,250

 

 

 

850

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

850

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Equity line of credit commitment fee

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

150

 

 

 

—

 

 

 

—

 

 

 

150

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

ATM Program

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

338,616

 

 

 

—

 

 

 

3,682

 

 

 

—

 

 

 

—

 

 

 

3,682

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Conversion of related-party debt to common stock

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

167,290

 

 

 

—

 

 

 

723

 

 

 

—

 

 

 

—

 

 

 

723

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

41

 

 

 

—

 

 

 

—

 

 

 

41

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Foreign currency translation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(349

)

 

 

—

 

 

 

(349

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Fixed dividends Preferred Series B

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(952

)

 

 

—

 

 

 

—

 

 

 

(952

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(7,034

)

 

 

(7,034

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of September 30, 2026

 

 

167,972

 

 

$

—

 

 

 

1,586,620

 

 

$

—

 

 

 

661,748

 

 

$

3,430

 

 

 

106,250

 

 

$

850

 

 

 

844,556

 

 

$

—

 

 

$

158,888

 

 

$

2,203

 

 

$

(163,454

)

 

$

1,917

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

7


Table of Contents

 

Boxlight Corporation

Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity

For the three months ended September 30, 2025, as adjusted

(Unaudited)

(in thousands, except share amounts)

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

Accumulated

 

 

 

 

​

 

 

 

​

 

 

Series A

 

 

Class A

 

 

Additional

 

 

Other

 

 

 

 

​

 

 

 

​

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

 

 

​

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of June 30, 2025

 

 

167,972

 

 

$

—

 

 

 

73,549

 

 

$

—

 

 

$

118,994

 

 

$

949

 

 

$

(140,572

)

 

$

(20,629

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Shares issued for:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Prefunded warrants exercised

 

 

—

 

 

 

—

 

 

 

17,986

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Common warrants exercised

 

 

—

 

 

 

—

 

 

 

24,500

 

 

 

—

 

 

 

1,879

 

 

 

—

 

 

 

—

 

 

 

1,879

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Vesting of restricted share units

 

 

—

 

 

 

—

 

 

 

48

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

September 2025 private placement

 

 

—

 

 

 

—

 

 

 

37,037

 

 

 

—

 

 

 

3,587

 

 

 

—

 

 

 

—

 

 

 

3,587

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

65

 

 

 

—

 

 

 

—

 

 

 

65

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Warrant reclassification from liabilities

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,002

 

 

 

—

 

 

 

—

 

 

 

2,002

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Foreign currency translation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

134

 

 

 

—

 

 

 

134

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Fixed dividends Preferred Series B

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(317

)

 

 

—

 

 

 

—

 

 

 

(317

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(6,184

)

 

 

(6,184

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of September 30, 2025

 

 

167,972

 

 

$

—

 

 

 

153,120

 

 

$

—

 

 

$

126,210

 

 

$

1,083

 

 

$

(146,756

)

 

$

(19,463

)

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

8


Table of Contents

 

Boxlight Corporation

Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity

For the nine months ended September 30, 2025, as adjusted

(Unaudited)

(in thousands, except share amounts)

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

Accumulated

 

 

 

 

​

 

 

 

​

 

 

Series A

 

 

Class A

 

 

Additional

 

 

Other

 

 

 

 

​

 

 

 

​

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

 

 

​

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of December 31, 2024

 

 

167,972

 

 

$

—

 

 

 

54,739

 

 

$

—

 

 

$

119,487

 

 

$

227

 

 

$

(132,610

)

 

$

(12,896

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Adjustment to beginning balance

 

 

—

 

 

 

—

 

 

 

(61

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Shares issued for:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Prefunded warrants exercised

 

 

—

 

 

 

—

 

 

 

29,528

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Common warrants exercised

 

 

—

 

 

 

—

 

 

 

24,500

 

 

 

—

 

 

 

1,879

 

 

 

—

 

 

 

—

 

 

 

1,879

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Vesting of restricted share units

 

 

—

 

 

 

—

 

 

 

154

 

 

 

—

 

 

 

(3

)

 

 

—

 

 

 

—

 

 

 

(3

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Reverse stock split fractional adjustment

 

 

—

 

 

 

—

 

 

 

1

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

February 2025 private placement

 

 

—

 

 

 

—

 

 

 

7,222

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

September 2025 private placement

 

 

—

 

 

 

—

 

 

 

37,037

 

 

 

—

 

 

 

3,587

 

 

 

—

 

 

 

—

 

 

 

3,587

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Stock compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

209

 

 

 

—

 

 

 

—

 

 

 

209

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Warrant reclassification from liabilities

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,002

 

 

 

—

 

 

 

—

 

 

 

2,002

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Foreign currency translation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

856

 

 

 

—

 

 

 

856

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Fixed dividends Preferred Series B

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(951

)

 

 

—

 

 

 

—

 

 

 

(951

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(14,146

)

 

 

(14,146

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance as of September 30, 2025

 

 

167,972

 

 

$

—

 

 

 

153,120

 

 

$

—

 

 

$

126,210

 

 

$

1,083

 

 

$

(146,756

)

 

$

(19,463

)

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

9


Table of Contents

 

Boxlight Corporation

Condensed Consolidated Statements of Cash Flows

For the nine months ended September 30, 2026 and 2025

(Unaudited)

(in thousands)

 

 

Nine Months Ended

 

 

 

 

 

​

 

September 30,

 

 

 

September 30,

 

 

2025

 

 

 

2026

 

 

(as revised)

 

Cash flows from operating activities:

 

 

 

​

 

 

 

​

Net loss

 

$

(7,034

)

 

$

(14,146

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

​

 

 

 

​

Amortization of debt premium, discount and issuance cost

 

 

(166

)

 

 

1,950

 

Provision for credit losses

 

 

157

 

 

 

(160

)

Paid-in-kind accrual on short-term debt

 

 

—

 

 

 

150

 

Changes in deferred taxes

 

 

—

 

 

 

(24

)

Change in allowance for sales returns and volume rebates

 

 

72

 

 

 

(1,373

)

Change in fair value of common warrants

 

 

—

 

 

 

(1,394

)

Change in inventory reserve

 

 

115

 

 

 

(1,034

)

Change in fair value of derivative liabilities

 

 

(7

)

 

 

286

 

Stock compensation expense

 

 

281

 

 

 

459

 

Depreciation and amortization

 

 

7,672

 

 

 

7,681

 

Loss on warrant issuance

 

 

—

 

 

 

578

 

Change in right of use assets and lease liabilities

 

 

(51

)

 

 

(329

)

Changes in operating assets and liabilities:

 

 

 

​

 

 

 

​

Accounts receivable – trade

 

 

(5,007

)

 

 

(651

)

Inventories

 

 

9,032

 

 

 

18,303

 

Prepaid expenses and other current assets

 

 

(3,618

)

 

 

(3,510

)

Other assets

 

 

(224

)

 

 

47

 

Accounts payable and accrued expenses

 

 

(8,858

)

 

 

(9,522

)

Other short-term liabilities

 

 

121

 

 

 

118

 

Other liabilities

 

 

9

 

 

 

155

 

Deferred revenues

 

 

(1,158

)

 

 

(801

)

Net cash used in operating activities

 

$

(8,664

)

 

$

(3,217

)

 

 

 

 

​

 

 

 

​

Cash flows from investing activities:

 

 

 

​

 

 

 

​

Purchases of furniture and fixtures, net

 

 

(96

)

 

 

(158

)

Net cash used in investing activities

 

$

(96

)

 

$

(158

)

 

 

 

 

​

 

 

 

​

Cash flows from financing activities:

 

 

 

​

 

 

 

​

Proceeds from short-term debt

 

 

—

 

 

 

2,500

 

Principal payments on short-term debt

 

 

(2,250

)

 

 

(2,666

)

Principal payments on long term debt

 

 

—

 

 

 

(2,387

)

Proceeds in related party accounts payable-inventory financing

 

 

2,063

 

 

 

4,179

 

Payments in related party accounts payable-inventory financing

 

 

(3,148

)

 

 

(2,770

)

Proceeds from issuance of common stock and pre-funded warrants

 

 

3,682

 

 

 

8,288

 

Proceeds from Series D Convertible Preferred Stock Financing

 

 

4,709

 

 

 

—

 

Proceeds from Series E Convertible Preferred Stock Financing

 

 

850

 

 

 

—

 

Net cash provided by financing activities

 

$

5,906

 

 

$

7,144

 

 

 

 

 

​

 

 

 

​

Effect of foreign currency exchange rates

 

 

(227

)

 

 

36

 

 

 

 

 

​

 

 

 

​

Net increase (decrease) in cash and cash equivalents

 

 

(3,081

)

 

 

3,805

 

 

 

 

 

​

 

 

 

​

Cash and cash equivalents, beginning of the period

 

 

9,370

 

 

 

8,007

 

 

 

 

 

​

 

 

 

​

Cash and cash equivalents, end of the period

 

$

6,289

 

 

$

11,812

 

 

 

 

 

​

 

 

 

​

Supplemental cash flow disclosures:

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

Cash paid (received) for income taxes

 

$

(374

)

 

$

746

 

Cash paid for interest

 

$

2,953

 

 

$

5,130

 

 

 

 

 

​

 

 

 

​

Non-cash investing and financing transactions:

 

 

 

​

 

 

 

​

ELOC commitment fee

 

$

150

 

 

$

—

 

Addition of operating lease liabilities

 

$

186

 

 

$

—

 

Recognition of embedded derivative liability

 

$

1,158

 

 

$

—

 

Cash dividends accrued for Series B Preferred stockholders

 

$

952

 

 

$

951

 

Conversion of related-party debt to common stock

 

$

724

 

 

$

—

 

Reclassification of warrant liabilities

 

$

—

 

 

$

2,002

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

10


Table of Contents

 

Boxlight Corporation

Notes to the Unaudited Condensed Consolidated Financial Statements

 

NOTE 1 – ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

 

NATURE OF OPERATIONS

 

Boxlight Corporation, a Nevada Corporation (“Boxlight”), designs, produces and distributes interactive technology solutions for the education, corporate and government markets under its Clevertouch and Mimio brands. Boxlight’s solutions include interactive displays, audio and other accessory products, software, and professional services.

 

BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION

 

The accompanying unaudited condensed consolidated financial statements include the accounts of Boxlight and its direct and indirect wholly owned subsidiaries (collectively, the “Company”, “we”, “us”, and “our”). All significant intercompany balances and transactions have been eliminated in consolidation.

 

The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim unaudited condensed consolidated financial information and interim financial reporting guidelines and rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete condensed consolidated financial statements. The unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company for the year ended  December 31, 2025 and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended  December 31, 2025 (the “2025 Annual Report”). Certain information and note disclosures normally included in consolidated financial statements have been condensed. The  December 31, 2025 balance sheet included herein was derived from the Company’s audited consolidated financial statements, but does not include all disclosures, including notes, required by GAAP for complete financial statements.

 

ESTIMATES AND ASSUMPTIONS

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Note 1 in the Notes to the Consolidated Financial Statements for 2025 contained in the 2025 Annual Report filed with the SEC on April 15, 2026, describes the significant accounting policies that the Company used in preparing its condensed consolidated financial statements. On an ongoing basis, the Company evaluates its estimates and assumptions, including, but not limited to, those related to inventory obsolescence reserves; the recoverability of deferred tax assets; the valuation and recoverability of intangible assets; the fair value of warrants; the classification and accounting for the Company's Series D and Series E preferred stock and related conversion features; the valuation of embedded and freestanding derivative instruments, including related-party conversion features; the accounting for and valuation of the Equity Purchase Agreement; the determination of relative stand-alone selling prices of goods and services; variable consideration; and long-term incentive plans. The Company bases its estimates on historical experience and various other assumptions that management believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

REVERSE STOCK SPLIT

 

On June 22, 2026, the Company effected a 1-for-6 reverse stock split of its Class A common stock. All Class A common share and per-share amounts, as well as common stock equivalents and related conversion and exercise ratios for warrants, stock-based compensation awards, and preferred stock conversion features, have been retrospectively adjusted for all periods presented in the consolidated financial statements and accompanying notes. See Note 11 for information regarding the subsequent increase in authorized Class A common shares during 2026.

 

11


Table of Contents

 

GOING CONCERN

 

The Company’s financial statements are prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business.

 

Historically, the Company has funded its operations through cash flows from operations, debt financing, and equity financing. As of  September 30, 2026, the Company had cash and cash equivalents of $6.3 million and working capital of $1.1 million. The Company has incurred operating losses in recent periods, and as of  September 30, 2026, had an accumulated deficit of $163.5 million.

 

In accordance with Accounting Standards Codification ("ASC") 205-40, Going Concern, the Company’s management evaluates whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. The Company’s management has concluded as of  September 30, 2026, that, due to uncertainties surrounding the Company’s ability to amend or refinance its current debt agreements and the uncertainty as to whether it will have sufficient liquidity to fund its business activities, substantial doubt exists as to its ability to continue as a going concern within one year after the date that the financial statements are issued. The Company’s plans to alleviate the substantial doubt about its ability to continue as a going concern may not be successful, and it may be forced to limit its business activities or be unable to continue as a going concern, which would have a material adverse effect on its results of operations and financial condition.

 

The Company’s ability to continue as a going concern is dependent on generating profitable operating results, having sufficient liquidity, and maintaining compliance with the covenants and other requirements under the Whitehawk Capital Partners Credit Agreement (the “Credit Agreement”). The current Credit Agreement maturity date is April 1, 2027, as modified by the Eleventh Amendment to the Credit Agreement.

 

Based on the Company’s current forecasts, without additional financing, the Company anticipates that it will not have sufficient cash and cash equivalents to fund its ongoing operations and repay amounts due under the Credit Agreement at maturity on April 1, 2027. To fund its ongoing operations and address its upcoming debt obligations, management’s plans include utilizing existing cash on hand, actively managing working capital, implementing additional cost-reduction and expense-management initiatives, and seeking additional debt or equity financing from existing or new lenders and the capital markets (including potential amendments or extensions to the Credit Agreement). There can be no assurance that the Company’s management will be able to effect financing on acceptable terms, execute its cost-management initiatives, or repay this outstanding indebtedness when required, or if at all. The consolidated financial statements included in this Form 10-Q do not include any adjustments that might result from the outcome of the Company’s efforts to address these issues.

 

Furthermore, if the Company cannot raise capital on acceptable terms, it may not, among other things, be able to:

 

 

•

Continue to expand the Company’s research and product investments and sales and marketing organization;

 

•

Continue to respond to competitive pressures or address unanticipated working capital requirements.

 

REVISIONS OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

The Company determined that its arrangement with J.J. Astor & Co. is accounted for as a product financing arrangement under ASC 470-40. The Company recognizes a Related Party Account Payable and the corresponding inventory on the balance sheet. Accordingly, the Company revised certain amounts previously reported in the condensed consolidated statement of cash flows included in its Annual Report on Form 10-K for the year ended  December 31, 2025, and in the condensed consolidated statements of cash flows included in its Quarterly Report on Form 10-Q for the period ended  September 30, 2025, to conform to the current period presentation. The revisions reflect the presentation of cash flows associated with the J.J. Astor & Co. inventory financing arrangement within financing activities rather than operating activities.

 

The Company has evaluated these revisions in accordance with ASC 250, Accounting Changes and Error Corrections, Financial Accounting Standards Board (“FASB”) Concepts Statement No. 2, Qualitative Characteristics of Accounting Information, and SEC Staff Accounting Bulletin ("SAB") No. 99, Materiality, and determined it was not necessary to amend its previously issued fiscal year condensed consolidated financial statements upon overall considerations of both quantitative and qualitative factors. The revisions had no impact on the Balance Sheets, the Statements of Operations and Comprehensive Loss, or Changes in Stockholders’ (Deficit) Equity for the nine months ended September 30, 2025, or for the prior year ended  December 31, 2025.

 

12


Table of Contents

 

The following tables summarize the revisions made to the Company’s previously issued consolidated statements of cash flows for the periods presented below (in thousands):

 

 

 

For the Nine Months Ended September 30, 2025

 

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Cash flows from operating activities

 

 

 

​

 

 

 

​

 

 

 

​

Inventories

 

$

19,712

 

 

$

(1,409

)

 

$

18,303

 

 

 

 

 

​

 

 

 

​

 

 

 

​

Cash flows from financing activities:

 

 

 

​

 

 

 

​

 

 

 

​

Proceeds in related party accounts payable-inventory financing

 

$

—

 

 

$

4,179

 

 

$

4,179

 

Payments in related party accounts payable-inventory financing

 

 

—

 

 

 

(2,770

)

 

 

(2,770

)

 

 

 

For the year ended December 31, 2025

 

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Cash flows from operating activities

 

 

 

​

 

 

 

​

 

 

 

​

Accounts payable and accrued expenses - related party

 

$

3,699

 

 

$

(3,699

)

 

$

—

 

 

 

 

 

​

 

 

 

​

 

 

 

​

Cash flows from financing activities:

 

 

 

​

 

 

 

​

 

 

 

​

Proceeds in related party accounts payable-inventory financing

 

$

—

 

 

$

7,890

 

 

$

7,890

 

Payments in related party accounts payable-inventory financing

 

 

—

 

 

 

(4,191

)

 

 

(4,191

)

 

Additionally, as previously disclosed in its Quarterly Report on Form 10-Q for the period ended  September 30, 2025, the Company reported that it recognized $1.7 million and $5.5 million of revenue during the three and nine months ended September 30, 2025, respectively, that was included in the deferred revenue balance as of  December 31, 2024. The Company has determined that these amounts were understated due to an error in the roll forward calculation supporting this disclosure. The corrected amounts are $2.2 million and $6.9 million for the three and nine months ended September 30, 2025, respectively, representing an understatement of approximately $0.5 million and $1.5 million, respectively, with no effect on the Company’s actual deferred revenue balances, total revenue, or any other amounts presented in its financial statements. The following table summarizes the amount of revenue recognized during the three and nine months ended September 30, 2025, that was included in the deferred revenue balance at the beginning of the respective periods, as reported, as revised, and the adjustment (in thousands):

 

Recognized revenue that was included in the deferred revenue balance as of December 31, 2024

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Three Months Ended September 30, 2025

 

$

1,716

 

 

$

485

 

 

$

2,201

 

For the Nine Months Ended September 30, 2025

 

$

5,450

 

 

$

1,458

 

 

$

6,908

 

 

Further, as previously reported in its Quarterly Report on Form 10-Q for the period ended  September 30, 2025, the Company reported Product Revenue of $27.4 million and Service Revenue of $2.0 million for the three months ended  September 30, 2025, and Product Revenue of $76.9 million and Service Revenue of $5.8 million for the nine months ended September 30, 2025. In the current period, the Company identified an error in the allocation of revenue between product revenue and service revenue, and has determined that the correct amounts were Product Revenue of $26.7 million and Service Revenue of $2.6 million for the three months ended  September 30, 2025, as revised, and Product Revenue of $75.0 million and Service Revenue of $7.6 million for the nine months ended  September 30, 2025, as revised. Total revenue reported for each period was not affected by this error. The Company evaluated the error in accordance with ASC 250, Accounting Changes and Error Corrections, SAB No. 99, Materiality, SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, and after considering both quantitative and qualitative factors, determined that the error was not material to any previously issued interim or annual financial statements. The following table summarizes disaggregated revenue for the three and nine months ended September 30, 2025, as reported, as revised, and the resulting difference (in thousands):

 

13


Table of Contents

 

 

 

Three Months Ended September 30, 2025

 

 

For the Nine Months Ended September 30, 2025

 

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Product revenue

 

$

27,364

 

 

$

(623

)

 

$

26,741

 

 

$

76,860

 

 

$

(1,820

)

 

$

75,040

 

Service revenue

 

 

1,973

 

 

 

623

 

 

 

2,596

 

 

 

5,752

 

 

 

1,820

 

 

 

7,572

 

Total revenues, net

 

$

29,337

 

 

$

—

 

 

$

29,337

 

 

$

82,612

 

 

$

—

 

 

$

82,612

 

 

FAIR VALUE OF FINANCIAL INSTRUMENTS

 

The Company’s financial instruments primarily include cash and cash equivalents, accounts receivable, derivative liabilities, accounts payable, debt, and long-term incentive plan. Due to the short-term nature of cash and cash equivalents, accounts receivable and accounts payable, the carrying amounts of these assets and liabilities approximate their fair value.

 

The Company has determined that the estimated fair value of debt is approximately $27.0 million while the carrying value, excluding premiums, discounts, and issuance costs, is approximately $31.7 million. The fair value of debt was estimated using market rates the Company believes would be available for similar types of financial instruments and represents a Level 2 measurement.

 

Derivative liabilities are recorded at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:

 

 

•

Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

 

•

Level 2 Inputs - Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.

 

 

•

Level 3 Inputs - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.

 

There were no transfers into or out of Level 3 measurements in the first nine months of 2026. Transfers into Level 3 measurements during the nine months ended September 30, 2025 of approximately $1.5 million were related to the 2025 Common Warrants.

 

The following table sets forth, by level within the fair value hierarchy, the Company’s financial liabilities that were accounted for at fair value on a recurring basis as of  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

Markets for

 

 

Other

 

 

Significant

 

 

Carrying

 

 

 

Identical

 

 

Observable

 

 

Unobservable

 

 

Value as of

 

 

 

Assets

 

 

Inputs

 

 

Inputs

 

 

September 30,

 

Description

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

2026

 

Derivative liabilities - related party

 

$

—

 

 

$

—

 

 

$

592

 

 

$

592

 

Derivative liabilities - Series D

 

 

—

 

 

 

—

 

 

 

1,040

 

 

 

1,040

 

Long-term incentive plan

 

 

—

 

 

 

—

 

 

 

165

 

 

 

165

 

 

14


Table of Contents

 

 

 

Markets for

 

 

Other

 

 

Significant

 

 

Carrying

 

 

 

Identical

 

 

Observable

 

 

Unobservable

 

 

Value as of

 

 

 

Assets

 

 

Inputs

 

 

Inputs

 

 

December 31,

 

Description

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

2025

 

Derivative liabilities - warrant instruments

 

$

—

 

 

$

—

 

 

$

5

 

 

$

5

 

Derivative liabilities - related party

 

 

—

 

 

 

—

 

 

 

476

 

 

 

476

 

Long-term incentive plan

 

 

—

 

 

 

—

 

 

 

205

 

 

 

205

 

 

The following tables reconcile the beginning and ending balances of the derivative liabilities, warrant instruments and long-term incentive plan within Level 3 of the fair value hierarchy, for the three and nine months ended September 30, 2026 and 2025, respectively (in thousands):

 

 

 

Related Party

 

 

Series D

 

 

 

 

​

 

 

Derivative

 

 

Derivative

 

 

Long-term

 

 

 

Liabilities

 

 

Liabilities

 

 

Incentive Plan

 

Balance, June 30, 2026

 

$

634

 

 

$

—

 

 

$

101

 

Issuance during period

 

 

—

 

 

 

1,158

 

 

 

64

 

Amount paid in period

 

 

—

 

 

 

—

 

 

 

—

 

Change in fair value

 

 

(42

)

 

 

(118

)

 

 

—

 

Balance, September 30, 2026

 

$

592

 

 

$

1,040

 

 

$

165

 

 

 

 

Warrant Instruments

 

 

Related Party

 

 

Series D

 

 

 

 

​

 

 

Derivative

 

 

Derivative

 

 

Derivative

 

 

Long-term

 

 

 

Liabilities

 

 

Liabilities

 

 

Liabilities

 

 

Incentive Plan

 

Balance, December 31, 2025

 

$

5

 

 

$

476

 

 

$

—

 

 

$

205

 

Issuance during period

 

 

—

 

 

 

—

 

 

 

1,158

 

 

 

240

 

Amount paid in period

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(136

)

Change in fair value

 

 

(5

)

 

 

116

 

 

 

(118

)

 

 

(144

)

Balance, September 30, 2026

 

$

—

 

 

$

592

 

 

$

1,040

 

 

$

165

 

 

 

 

Common

 

 

Warrant Instruments

 

 

 

 

​

 

 

Warrants

 

 

Derivative

 

 

Long-term

 

 

 

Liabilities

 

 

Liabilities

 

 

Incentive Plan

 

Balance, June 30, 2025

 

$

1,711

 

 

$

52

 

 

$

71

 

Issuance during period

 

 

—

 

 

 

—

 

 

 

46

 

Reclass to equity

 

 

(2,002

)

 

 

—

 

 

 

—

 

Amount paid in period

 

 

—

 

 

 

—

 

 

 

(236

)

Change in fair value

 

 

291

 

 

 

235

 

 

 

236

 

Balance, September 30, 2025

 

$

—

 

 

$

287

 

 

$

117

 

 

 

 

Common

 

 

Warrant Instruments

 

 

 

 

​

 

 

Warrants

 

 

Derivative

 

 

Long-term

 

 

 

Liabilities

 

 

Liabilities

 

 

Incentive Plan

 

Balance, December 31, 2024

 

$

—

 

 

$

1

 

 

$

358

 

Issuance during period

 

 

3,396

 

 

 

—

 

 

 

220

 

Reclass to equity

 

 

(2,002

)

 

 

—

 

 

 

—

 

Amount paid in period

 

 

—

 

 

 

—

 

 

 

(461

)

Change in fair value

 

 

(1,394

)

 

 

286

 

 

 

—

 

Balance, September 30, 2025

 

$

—

 

 

$

287

 

 

$

117

 

 

See Note 9 and Note 12 for discussion of the valuation techniques and inputs and reconciliation of the opening and closing balances of the fair value of warrants and long-term incentive plan, respectively.

 

15


Table of Contents

 

INCOME (LOSS) PER SHARE OF COMMON STOCK

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to Class A common stockholders by the weighted-average number of shares of Class A common stock outstanding during the period. For purposes of this calculation, options to purchase Class A common stock, restricted stock units subject to vesting, and pre-funded warrants to purchase Class A common stock were considered to be Class A common stock equivalents. Diluted net income (loss) per share of Class A common stock is determined using the weighted-average number of shares of Class A common stock outstanding during the period, adjusted for the dilutive effect of Class A common stock equivalents. The dilutive effect of convertible instruments is determined using the if-converted method, presuming share settlement. Under the if-converted method, securities are assumed to be converted at the beginning of the period, and the resulting shares of Class A common stock are included in the denominator of the diluted calculation for the entire period being presented. In periods when losses are reported, the weighted-average number of shares of Class A common stock outstanding excludes Class A common stock equivalents, because their inclusion would be anti-dilutive.

 

For the three and nine months ended September 30, 2026, potentially dilutive securities excluded in the diluted per share calculation because they would be anti-dilutive comprise no shares from options to purchase shares of common stock, no unvested restricted stock units, and 15.9 thousand shares issuable upon exercise of warrants. Potentially dilutive securities of 11.8 million from the assumed conversion of preferred stock, including Series A, Series D and Series E Convertible Preferred Stock are excluded from the denominator because they would be anti-dilutive.  For the three and nine months ended September 30, 2025, potentially dilutive securities excluded in the diluted per share calculation because they would be anti-dilutive comprise no shares from options to purchase shares of common stock, and 25 thousand shares of Class A common stock issuable upon exercise of warrants. Additionally, potentially dilutive securities of 11.1 thousand from the assumed conversion of preferred stock are excluded from the denominator because they would be anti-dilutive.

 

REVENUE RECOGNITION

 

The Company recognizes revenue at the amount to which it expects to be entitled when control of the products or services is transferred to its customers. Control is generally transferred when the Company has a present right to payment and the title, and the significant risks and rewards of ownership of the products or services, have been transferred to its customers. Product revenue is derived from the sale of interactive devices and related software and accessories to distributors, resellers and end users. Service revenue is derived from hardware maintenance services, product installation, training, software maintenance and subscription services.

 

Nature of Products and Services and Related Contractual Provisions

 

The Company’s sales of interactive devices, including panels, whiteboards, and other interactive devices generally include hardware maintenance services, a license to use software, and the provision of related software maintenance. We also distribute science, technology, engineering, and math (or “STEM”) products, including a robotics and coding system, 3D printing solution and portable science lab. In most cases, interactive devices are sold with hardware maintenance services with terms of approximately 30-60 months. Software maintenance includes technical support, product updates performed on a when and if available basis, and error correction services. At times, non-interactive projectors are also sold with hardware maintenance services with terms of approximately 60 months. The Company also licenses software independently of its interactive devices, in which case it is bundled with software maintenance, and in some cases, subscription services that include access to online content and cloud-based applications. The Company’s software subscription services provide access to content and software applications on an as needed basis over the Internet, but do not provide the right to take delivery of the software applications.

 

The Company’s product sales, including those with software and related services, generally include a single payment up front for the products and services, and revenue is recorded net of estimated sales returns and rebates based on the Company’s expectations and historical experience. For most of the Company’s product sales, control transfers and, therefore, revenue is recognized when products are shipped at the point of origin. When the Company transfers control of its products to the customer prior to the related shipping and handling activities, the Company has adopted a policy of accounting for shipping and handling activities as a fulfillment cost rather than a performance obligation. For many of the Company’s software product sales, control is transferred when shipped at the point of origin since the software is installed on the interactive hardware device in advance of shipping. For software product sales, control is transferred when the customer receives the related interactive hardware since the customer’s connection to the interactive hardware activates the software license, at which time the software is made available to the customer. For the Company’s software maintenance, hardware maintenance and subscription services, revenue is recognized ratably over time as the services are provided since time is the best output measure of how those services are transferred to the customer.

 

16


Table of Contents

 

The Company excludes all taxes assessed by a governmental agency that are both imposed on and concurrent with the specific revenue-producing transaction from revenue (for example, sales and use taxes). In essence, the Company is reporting these amounts collected on behalf of the applicable government agency on a net basis as though they are acting as an agent. The taxes collected and not yet remitted to the governmental agency are included in accounts payable and accrued expenses in the accompanying consolidated balance sheets.

 

Significant Judgments

 

For contracts with multiple performance obligations, each of which represent promises within a contract that are distinct, the Company allocates revenue to all distinct performance obligations based on their relative stand-alone selling prices (“SSPs”). The Company’s products and services included in its contracts with multiple performance obligations generally are not sold separately and there are no observable prices available to determine the SSP for those products and services. Since observable prices are not available, SSPs are established that reflect the Company’s best estimates of what the selling prices of the performance obligations would be if they were sold regularly on a stand-alone basis. The Company’s process for estimating SSPs without observable prices considers multiple factors that may vary depending upon the unique facts and circumstances related to each performance obligation including, when applicable, the estimated cost to provide the performance obligation, market trends in the pricing for similar offerings, product-specific business objectives, and competitor or other relevant market pricing and margins. Because observable prices are generally not available for the Company’s performance obligations that are sold in bundled arrangements, the Company does not apply the residual approach to determining SSP.

 

The Company has applied the portfolio approach to its allocation of the transaction price for certain portfolios of contracts that are executed in the same manner, contain the same performance obligations, and are priced in a consistent manner. The Company believes that the application of the portfolio approach produces the same result as if they were applied at the contract level.

 

Contract Balances

 

The timing of invoicing to customers often differs from the timing of revenue recognition and these timing differences can result in receivables, contract assets, or contract liabilities (deferred revenue) on the Company’s consolidated balance sheets. Fees for the Company’s product and most service contracts are fixed, except as adjusted for rebate programs when applicable, and are generally due within 30-60 days of contract execution. Fees for installation, training and professional development services are fixed and generally become due as the services are performed. The Company has an established history of collecting under the terms of its contracts without providing refunds or concessions to its customers. The Company’s contractual payment terms do not vary when products are bundled with services that are provided over multiple years. In these contracts where services are expected to be transferred on an ongoing basis for several years after the related payment, the Company has determined that the contracts generally do not include a significant financing component. The upfront invoicing terms are designed (1) to provide customers with a predictable way to purchase products and services where the payment is due in the same timeframe as when the products, which constitute the predominant portion of the contractual value, are transferred, and (2) to ensure that the customer continues to use the related services; so that the customer can receive the optimal benefit from the products during the course of such product’s lifetime. Additionally, the Company has elected the practical expedient to exclude any financing component from consideration for contracts where, at contract inception, the period between the transfer of services and the timing of the related payment is not expected to exceed one year.

 

The Company has an unconditional right to consideration for all products and services transferred to the customer. That unconditional right to consideration is reflected in accounts receivable in the accompanying condensed consolidated balance sheets in accordance with ASC 606, Revenue from Contracts with Customers. Contract liabilities are reflected in deferred revenue in the accompanying condensed consolidated balance sheets and reflect amounts allocated to performance obligations that have not yet been transferred to the customer related to software maintenance, hardware maintenance, and subscription services. The Company had no material contract assets as of  September 30, 2026 or  December 31, 2025. During the three months ended  September 30, 2026 and  September 30, 2025, as revised, respectively, the Company recognized $2.2 million and $2.2 million of revenue that was included in the deferred revenue balance as of  December 31, 2025 and  December 31, 2024, respectively. During the nine months ended September 30, 2026 and  September 30, 2025, as revised, respectively, the Company recognized $7.1 million and $6.9 million of revenue that was included in the deferred revenue balance as of  December 31, 2025 and  December 31, 2024, respectively.

 

17


Table of Contents

 

Variable Consideration

 

The Company’s otherwise fixed consideration may vary when refunds or credits are provided for sales returns, stock rotation rights, price protection provisions, or in connection with certain other rebate provisions. The Company generally does not allow product returns other than under assurance warranties or hardware maintenance contracts. However, the Company, on a case-by-case basis, will grant exceptions, mostly for “buyer’s remorse” where the distributor or reseller’s end customer either did not understand what they were ordering or otherwise determined that the product did not meet their needs. An allowance for sales returns is estimated based on an analysis of historical trends. In very limited situations, a customer may return previous purchases held in inventory for a specified period of time in exchange for credits toward additional purchases. The Company provides rebates to certain customers based on the achievement of certain sales targets. The provision for rebates is estimated based on customers’ contracted rebate programs and our historical experience of rebates paid. The Company includes variable consideration in its transaction price when there is a basis to reasonably estimate the amount of the fee and it is probable there will not be a significant reversal. These estimates are generally made using the most likely method based on historical experience and are measured at each reporting date. There was no material revenue recognized in the three and nine months ended September 30, 2026 related to changes in estimated variable consideration that existed at  December 31, 2025.

 

Remaining Performance Obligations

 

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of accounting within the contract. The transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied by transferring the promised good or service to the customer. The Company identifies performance obligations at contract inception so that it can monitor and account for the obligations over the life of the contract. Remaining performance obligations represent the portion of the transaction price in a contract allocated to products and services not yet transferred to the customer. As of  September 30, 2026 and  December 31, 2025, the aggregate amount of the contractual transaction prices allocated to remaining performance obligations was $22.8 million and $24.1 million, respectively. The Company expects to recognize revenue on approximately 38% of the remaining performance obligations during the next 12 months, 28% in the following 12 months, 20% in the 12 months ended  September 30, 2029, 11% in the 12 months ended  September 30, 2030, with the remaining 3% recognized thereafter.

 

In accordance with Topic 606, the Company has elected not to disclose the value of remaining performance obligations for contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed (for example, a time-and-materials professional services contracts). In addition, the Company has elected not to disclose the value of remaining performance obligations for contracts with performance obligations that are expected, at contract inception, to be satisfied over a period that does not exceed one year.

 

Disaggregated Revenue

 

The Company disaggregates revenue based upon the nature of its products and services and the timing and in the manner which it is transferred to the customer. Although all products are transferred to the customer at a point in time, hardware and some software which comes pre-installed on an interactive device is transferred at the point of shipment, while some software is transferred to the customer at the time the hardware is received by the customer or when software product keys are delivered electronically to the customer. All service revenue is transferred over time to the customer; however, professional services are generally transferred to the customer within a year from the contract date as measured based upon hours or time incurred while software maintenance, hardware maintenance, and subscription services are generally transferred over three to five years from the contract execution date as measured based upon the passage of time.

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

(in thousands)

 

 

(in thousands)

 

 

 

 

 

​

 

2025

 

 

 

 

​

 

2025

 

 

 

2026

 

 

(as revised)

 

 

2026

 

 

(as revised)

 

Product revenue

 

$

27,509

 

 

$

26,741

 

 

$

70,807

 

 

$

75,040

 

Service revenue

 

 

2,554

 

 

 

2,596

 

 

 

7,616

 

 

 

7,572

 

Total revenues, net

 

$

30,063

 

 

$

29,337

 

 

$

78,423

 

 

$

82,612

 

 

18


Table of Contents

 

Contract Costs

 

The Company capitalizes incremental costs to obtain a contract with a customer if the Company expects to recover those costs. The incremental costs to obtain a contract are those that the Company incurs to obtain a contract with a customer that it would not have otherwise incurred if the contract were not obtained (e.g., a sales commission). The Company capitalizes the costs incurred to fulfill a contract only if those costs meet all the following criteria:

 

 

•

The costs relate directly to a contract or to an anticipated contract that the Company can specifically identify;

 

 

•

The costs generate or enhance resources of the Company that will be used in satisfying (or in continuing to satisfy) performance obligations in the future; and

 

 

•

The costs are expected to be recovered.

 

Certain sales commissions incurred by the Company are determined to be incremental costs to obtain the related contracts, which are deferred and amortized ratably over the estimated economic benefit period. For these sales commissions that are incremental costs to obtain where the period of amortization would be recognized over a period that is one year or less, the Company has elected the practical expedient to expense those costs as incurred. Commission costs that are deferred are classified as current or non-current assets based on the timing of when the Company expects to recognize the expense and are included in prepaid and other current assets and other assets, respectively, in the accompanying condensed consolidated balance sheets. Total deferred commissions, net of accumulated amortization, as of each of  September 30, 2026 and  December 31, 2025 were less than $0.4 million, respectively.

 

The Company has not historically incurred any material fulfillment cost that meet the criteria for capitalization.

 

SEGMENT REPORTING

 

ASC 280, Segment Reporting, establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (CODM) in deciding how to allocate resources and in assessing performance. Our CODM is our Executive Committee.

 

The Company’s operations are organized, managed and classified into three reportable segments – Europe, Middle East, and Africa (“EMEA”), North and Central America (the “Americas”) and all other geographic regions (“Rest of World”). Our EMEA segment consists of the operations of Sahara Holding Limited and its subsidiaries (the “Sahara Entities”). Our Americas segment consists primarily of the operations of Boxlight, Inc. and its subsidiaries, and the Rest of World segment consists primarily of the operations of Boxlight Australia, PTY LTD (“Boxlight Australia”).

 

Each of our operating segments are primarily engaged in the sale of education technology products and services in the education market but which are also sold into the health, government and corporate sectors and derive a majority of their revenues from the sale of flat-panel displays, audio and other hardware accessory products, software solutions and professional services. Generally, our displays produce higher net operating revenues but lower gross profit margins than our accessory solutions and professional services. The Americas operating segment includes salaries and overhead for corporate functions that are not allocated to the Company’s individual reporting segments. Transfers between segments are generally valued at market and are eliminated in consolidation.

 

The CODM evaluates the performance of each segment based on revenues, gross profit, and operating income, with operating income being the primary GAAP measure. Gross margin can influence key decisions as margins can be indicative of the level of saturation in the market with existing products or can be indicative of changes in manufacturing or shipping costs. If trends are sustained, the CODM may seek to adjust operations to more favorable markets or may evaluate whether the Company should introduce new products in a given area. Operating income provides the CODM with an overview of the profitability of a given segment and whether resources should be allocated or removed to ensure sustained profitability for both the segment and the consolidated entity. Since the Company’s operating segments are organized by geography, this structure allows the CODM to be responsive to needs of customers and can execute strategic plans and initiatives accordingly.

 

RESEARCH AND DEVELOPMENT EXPENSES

 

Research and development costs are expensed as incurred and consist primarily of personnel related costs, prototype and sample costs, design costs, and global product certifications mostly for wireless certifications.

 

19


Table of Contents

 

RECENTLY ADOPTED AND PENDING ACCOUNTING STANDARDS

 

In November 2024, the FASB issued ASU 2024-03, Income Statement-reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40), which improves the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, SG&A, and research and development). This change is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. This change will apply on a prospective basis to annual financial statements for periods beginning after the effective date. However, retrospective application in all prior periods presented is permitted. The Company is currently evaluating the impact of this ASU on its financial statements.

 

In November 2024, the FASB issued ASU 2024-04, Debt-Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, to improve the relevance and consistency in application of the induced conversion guidance in (Subtopic 470-20): Debt-Debt with Conversion and Other Options. The Company adopted ASU 2024-04 effective January 1, 2026. The adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.

 

In January 2025, the FASB issued ASU 2025-01, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The Board is issuing this Update to clarify the effective date of ASU No. 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The change is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its financial statements.

 

NOTE 2 – ACCOUNTS RECEIVABLE - TRADE

 

Accounts receivable consisted of the following as of  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

2026

 

 

2025

 

Accounts receivable – trade

 

$

21,093

 

 

$

16,413

 

Allowance for credit losses

 

 

(1,012

)

 

 

(1,055

)

Accounts receivable - trade, net of allowances

 

$

20,081

 

 

$

15,358

 

 

NOTE 3 – INVENTORIES

 

Inventories consisted of the following as of  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

2026

 

 

2025

 

Finished goods

 

$

30,410

 

 

$

40,103

 

Spare parts

 

 

590

 

 

 

571

 

Reserve for inventory obsolescence

 

 

(2,195

)

 

 

(2,548

)

Inventories, net

 

$

28,805

 

 

$

38,126

 

 

NOTE 4 – PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consisted of the following at  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

2026

 

 

2025

 

Prepayments to vendors

 

$

3,114

 

 

$

625

 

Prepaid licenses and other

 

 

7,195

 

 

 

5,999

 

Prepaid expenses and other current assets

 

$

10,309

 

 

$

6,624

 

 

Prepaid expenses and other current assets as of  September 30, 2026 and  December 31, 2025 are net of reserves of $1.4 million related to vendor receivables.

 

20


Table of Contents

 

NOTE 5 – INTANGIBLE ASSETS

 

Intangible Assets

 

Intangible assets consisted of the following as of  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

Useful lives

 

 

 

 

​

 

 

 

​

 

 

(years)

 

 

2026

 

 

2025

 

Patents

 

4 - 10

 

 

$

100

 

 

$

100

 

Customer relationships

 

8 - 15

 

 

 

50,353

 

 

 

50,973

 

Technology

 

3 - 5

 

 

 

8,563

 

 

 

8,615

 

Non-compete

 

3

 

 

 

391

 

 

 

391

 

Tradenames

 

2 - 10

 

 

 

12,573

 

 

 

12,659

 

Intangible assets, at cost

 

 

​

 

 

71,980

 

 

 

72,738

 

Accumulated amortization

 

 

​

 

 

(62,303

)

 

 

(55,658

)

Intangible assets, net of accumulated amortization

 

 

​

 

$

9,677

 

 

$

17,080

 

 

For the three months ended  September 30, 2026 and 2025, the Company recorded amortization expense of $2.4 million and $2.5 million, respectively. For the nine months ended September 30, 2026 and 2025, the Company recorded amortization expense of $7.4 million and $7.3 million, respectively. The gross carrying amount of recognized intangible assets included $2.1 million and $2.8 million of translation adjustments as of  September 30, 2026, and  December 31, 2025, respectively.  As of  December 31, 2025, the Company’s patent and non-compete intangible assets were fully amortized.

 

NOTE 6 – LEASES

 

The Company has entered into various operating leases for certain offices, support locations and vehicles with terms extending through December 2038. Generally, these leases have initial lease terms of five years or less.

 

As of  September 30, 2026, the Company had no leases classified as finance leases. The Company is currently not a lessor in any lease arrangement.

 

Operating lease expense was $557 thousand and $589 thousand for the three months ended  September 30, 2026 and 2025, respectively and $1.6 million and $1.8 million for the nine months ended September 30, 2026 and 2025, respectively. Variable and short-term lease cost was $242 thousand and $229 thousand for the three months ended  September 30, 2026 and 2025, respectively and $1.1 million and $1.0 million for the nine months ended September 30, 2026 and 2025, respectively. Cash paid for amounts included in the measurement of lease liabilities was $0.5 million and $0.6 million for the three months ended  September 30, 2026 and 2025, respectively and $1.5 million and $1.8 million for the nine months ended September 30, 2026 and 2025, respectively.

 

Future maturities of the Company’s operating lease liabilities are summarized as follows (in thousands):

 

Fiscal year ended,

 

(in thousands)

 

2026

 

$

982

 

2027

 

 

2,069

 

2028

 

 

1,665

 

2029

 

 

959

 

2030

 

 

876

 

Thereafter

 

 

6,173

 

Total lease liabilities

 

 

12,724

 

Less: Imputed interest

 

 

(5,980

)

Present value of lease liabilities

 

$

6,744

 

 

The following is supplemental lease information as of  September 30, 2026 and  December 31, 2025:

 

 

 

2026

 

 

2025

 

Weighted-average remaining lease term (years)

 

 

9.6

 

 

 

9.9

 

Weighted-average discount rate

 

 

9.1

%

 

 

9.5

%

 

21


Table of Contents

 

NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

2026

 

 

2025

 

Accounts payable

 

$

8,592

 

 

$

17,108

 

Accounts payable - related party

 

 

1,891

 

 

 

3,699

 

Accrued expenses

 

 

5,245

 

 

 

5,454

 

Other

 

 

31

 

 

 

224

 

Accounts payable and accrued expenses

 

$

15,759

 

 

$

26,485

 

 

NOTE 8 – DEBT

 

The following is a summary of the Company’s debt as of  September 30, 2026 and  December 31, 2025 (in thousands):

 

 

 

2026

 

 

2025

 

Note payable - Whitehawk

 

$

29,993

 

 

$

32,243

 

Total Third Party Debt

 

 

29,993

 

 

 

32,243

 

Plus: Net premium, discount and issuance costs

 

 

1,742

 

 

 

1,908

 

Total debt (net of premium, discount and issuance costs)

 

$

31,735

 

 

$

34,151

 

 

 

 

 

 

 

 

 

 

Current portion of debt

 

$

31,735

 

 

$

1,274

 

Long-term debt

 

 

-

 

 

 

32,877

 

Total debt (net of premium, discount and issuance costs)

 

$

31,735

 

 

$

34,151

 

 

Interest expense, net was $1.1 million and $2.8 million for the three months ended  September 30, 2026 and 2025, respectively, and $3.4 million and $7.8 million for the nine months ended September 30, 2026 and 2025, respectively. Expense for the amortization of debt premium, discount and issuance costs, net was $(144) thousand and $704 thousand for the three months ended  September 30, 2026 and 2025, respectively, and $(166) thousand and $1,950 thousand for the nine months ended September 30, 2026 and 2025, respectively. 

 

Whitehawk Finance LLC

 

On March 24, 2025, the Company entered into an eighth amendment to the Credit Agreement with Whitehawk Capital Partners, LP, as Collateral Agent, and Whitehawk Finance LLC, as Lender (the “Eighth Amendment”) to (i) provide the Company with an additional $2.5 million working capital bridge loan and (ii) waive any events of default that may have arisen as a result of the Company’s failure to (A) maintain the required ratio of indebtedness to adjusted EBITDA (defined more specifically as the “Senior Leverage Ratio” in the Credit Agreement) for the periods ended December 31, 2024 and March 31, 2025 and (B) maintain a value of specified assets in excess of certain borrowings (defined more specifically as a “Borrowing Base” in the Credit Agreement) for the months ended December 31, 2024, January 31, 2025 and February 28, 2025. In addition, no payments were required to be made by the Company to pay down the borrowing base defaults for December 2024, January 2025, and February 2025. The Company was required to pay a fee equal to 6% of the working capital bridge loan under the Eighth Amendment. The bridge loan, including the related fee, was due and payable in full on August 31, 2025, and was not subject to prepayment penalties.

 

On August 13, 2025, the Company entered into a forbearance agreement and ninth amendment and waiver to the Credit Agreement with the Collateral Agent and Lender (the “Ninth Amendment”) to waive any events of default that may have arisen directly as a result of (1) the Financial Covenant Event of Default (as defined in the Ninth Amendment) for the period ended June 30, 2025, (2) the Borrowing Base defaults described in the Ninth Amendment for the months ended April 30, 2025, May 31, 2025, June 30, 2025, and July 31, 2025, and (3) the failure to comply with the Recapitalization Requirement. Pursuant to the Ninth Amendment, the Company agreed to increase its quarterly principal payment due on September 30, 2025 from the scheduled $0.7 million to $1.0 million and to change interest payments from being due quarterly to being due monthly beginning in August 2025.

 

22


Table of Contents

 

On December 2, 2025, the Company entered into the tenth amendment to the Credit Agreement with the Collateral Agent and Lender (the “Tenth Amendment”). The Tenth Amendment does not modify the maturity date. Pursuant to the Tenth Amendment, the Lenders agreed to waive certain “Specified Events of Default” that had occurred or were anticipated to occur under the Credit Agreement. These Specified Events of Default included:

 

 

•

Failure to maintain the required Senior Leverage Ratio of 1.75:1.00 for the period ended September 30, 2025; and

 

•

Borrowing base non-compliance for the months ending July 31 through November 30, 2025.

 

•

The Lenders waived the right to receive the post-default interest rate with respect to these Specified Events of Default through December 31, 2025, provided the Company complies with the terms of the Tenth Amendment. Although the Company obtained waivers with respect to the foregoing past instances of the Credit Agreement noncompliance, in view of the Company’s history of noncompliance and its current situation, there can be no guarantee that the Company will not breach provisions of the Credit Agreement in the future, which could lead to declared events of default, acceleration of obligations and other material negative consequences.

 

The Tenth Amendment required the Company to pay a voluntary prepayment of the loans in the amount of not less than $3.0 million, for which no prepayment premium is required. From December 2 through December 31, 2025, the “Applicable Margin” is set at 6.50% for Secured Overnight Financing Rate ("SOFR") loans and 5.50% for reference rate loans. The definition of “Floor” was amended to 4.25% per annum, and the “Reference Rate” was amended to 5.25% per annum. Additionally, the borrowing base allowance for the value of the Company’s intellectual property was reduced from a maximum of $11.2 million to $8.0 million. The Tenth Amendment also required that 100% of net cash proceeds from any equity issuances be applied first to reduce any existing indebtedness in excess of the Borrowing Base, with the remainder applied to prepay the loans.

 

On December 18, 2025, the Company entered into the Eleventh Amendment to the Credit Agreement with the Collateral Agent and Lender (the “Eleventh Amendment”). Pursuant to the Eleventh Amendment, the Lender agreed to extend the final maturity date of the loans under the Credit Agreement from December 31, 2025 to April 1, 2027. Mandatory quarterly amortization payments on the initial term loan are suspended for the period commencing on the Eleventh Amendment’s effective date through, and including, June 30, 2026, with the first amortization payment thereafter due on September 30, 2026. The “Applicable Margin” is set at 6.50% for SOFR loans and 5.50% for reference rate loans, the same as in the Tenth Amendment. Additionally, the definition of the “Reference Rate” was amended to 5.50% per annum from the previous 5.25% per annum. In conjunction with obtaining the waiver, the Company was also required to comply with the following covenants:

 

 

•

The Company must maintain qualified cash at all times of at least (i) $1.0 million from and after January 1, 2025 until the Eleventh Amendment, and (ii) $1.5 million from and after the Eleventh Amendment effective date.

 

•

Pursuant to the amendment, the financial covenant requiring compliance with the Senior Leverage Ratio was removed and the Company is subject to a Minimum Consolidated Adjusted EBITDA covenant commencing with the period ending March 31, 2026 (set at $1.9 million for such period), and varying thereafter as set forth in the Eleventh Amendment.

 

•

Certain covenants related to business, management, and governance oversight were added.

 

In addition, the Eleventh Amendment modifies the mandatory prepayment provisions regarding net cash proceeds from equity offerings and certain permitted additional indebtedness, requiring 50% (or 100% if an event of default exists) of such proceeds to be applied to prepay the Credit Agreement, provided that the loan parties may retain up to $5.0 million of such proceeds for working capital and general corporate purposes. The Eleventh Amendment permits the Credit Agreement indebtedness in excess of maximum amounts in an aggregate amount not to exceed for the months ending December 31, 2025, $4.0 million; January 31, 2026, $4.5 million; February 28, 2026, $5.5 million and from and after March 31, 2026 (and each month thereafter), $4.0 million.

 

Covenant Compliance and Liquidity Considerations

 

The Company’s Credit Agreement, as amended to date, requires compliance with certain covenants, which include provisions regarding over advance limitations based upon a borrowing base, a minimum consolidated adjusted EBITDA covenant, a minimum liquidity requirement, and previously a Senior Leverage Ratio.

 

23


Table of Contents

 

The Company was not in compliance with the Senior Leverage Ratio covenant at December 31, 2024, and was not in compliance with the borrowing base covenant for the months ended December 31, 2024, January 31, 2025, and February 28, 2025. On March 24, 2025, the Company entered into an eighth amendment to the Credit Agreement with the Collateral Agent and Lender (the “Eighth Amendment”) to (i) provide the Company with an additional $2.5 million working capital bridge loan in March 2025 and (ii) waive any events of default that may have arisen directly as a result of (1) the Financial Covenant Event of Default (as defined in the Eighth Amendment) for the periods ended December 31, 2024 and March 31, 2025 and (2) the Borrowing Base defaults described in the Eighth Amendment for the months ended December 31, 2024, January 31, 2025 and February 28, 2025. In addition, no payments were required to be made by the Company to pay down the borrowing base defaults for December 2024, January 2025, and February 2025. The Company is required to pay a fee equal to 6% of the working capital bridge loan under the Eighth Amendment. The bridge loan, including the related fee, was due and payable in full on August 31, 2025. In conjunction with obtaining the Eighth Amendment, the Company also was required to comply with the following covenants:

 

 

•

Initiate recapitalization efforts and/or other financing arrangements with target completion milestones starting on March 21, 2025 through an expected completion of the recapitalization and/or repayment of the debt by June 16, 2025 (the “Recapitalization Requirement”). Not meeting these dates was an event of default under the Credit Agreement. The Company did not meet this requirement.

 

 

•

Provide budgets to the Lender with variances in excess of specified thresholds resulting in an event of default at the discretion of the Lender. The Company is also required to meet with a financial advisor, as designated by the Lender, if requested.

 

The Company’s noncompliance with its financial covenant related to the borrowing base under the Credit Agreement at March 31, 2025 was cured by the payment of approximately $1.3 million under the Credit Agreement in April and May 2025. The Company applied these payments to the bridge loan and related fee. In addition, the Eighth Amendment prohibits the Company from paying dividends or distributions to the Preferred Stockholders and reduces the borrowing base calculations by reducing the value assigned to its intellectual property to $11.2 million.

 

On August 13, 2025, the Company entered into a forbearance agreement and ninth amendment and waiver to the Credit Agreement with the Collateral Agent and Lender (the “Ninth Amendment”) to waive any events of default that may have arisen directly as a result of (1) the Financial Covenant Event of Default (as defined in the Ninth Amendment) for the period ended June 30, 2025, (2) the Borrowing Base defaults described in the Ninth Amendment for the months ended April 30, 2025, May 31, 2025, June 30, 2025, and July 31, 2025, and (3) the failure to comply with the Recapitalization Requirement. Pursuant to the Ninth Amendment, the Company agreed to increase its quarterly principal payment due on September 30, 2025 from the scheduled $0.7 million to $1.0 million and to change interest payments from being due quarterly to being due monthly beginning in August 2025.

 

The Company was not in compliance with the Senior Leverage Ratio covenant as of September 30, 2025 and was not in compliance with the borrowing base covenant for the months ended August 31, 2025 through November 30, 2025. On December 2, 2025, the Company entered into the tenth amendment to Credit Agreement with the Collateral Agent and Lender (the “Tenth Amendment”). The Tenth Amendment does not modify the maturity date. Pursuant to the Tenth Amendment, the Lenders agreed to waive certain “Specified Events of Default” that had occurred or were anticipated to occur under the Credit Agreement. These Specified Events of Default included:

 

 

•

Failure to maintain the required Senior Leverage Ratio of 1.75:1.00 for the period ended September 30, 2025; and

 

 

•

Borrowing base non-compliance for the months ending July 31 through November 30, 2025.

 

 

•

The Lenders waived the right to receive the post-default interest rate with respect to these Specified Events of Default through December 31, 2025, provided the Company complies with the terms of the Tenth Amendment. Although the Company obtained waivers with respect to the foregoing past instances of Credit Agreement noncompliance, in view of the Company’s history of noncompliance and its current situation, there can be no guarantee that the Company will not breach provisions of the Credit Agreement in the future, which could lead to declared events of default, acceleration of obligations, and other material negative consequences.

 

24


Table of Contents

 

On December 18, 2025, the Company entered into a forbearance agreement and eleventh amendment and waiver to the Credit Agreement with the Collateral Agent and Lender (the “Eleventh Amendment”). The Eleventh Amendment extended the final maturity date of the loans from December 31, 2025 to April 1, 2027, and suspended mandatory quarterly amortization payments on the initial term loan through June 30, 2026, with the first payment thereafter due September 30, 2026. The Applicable Margin remains at 6.50% for SOFR loans and 5.50% for reference rate loans, and the Reference Rate was amended to 5.50% per annum from the prior 5.25% per annum. In conjunction with the Eleventh Amendment, the Senior Leverage Ratio covenant was replaced with a Minimum Consolidated Adjusted EBITDA covenant commencing with the period ending March 31, 2026 (set at $1.9 million), the Company is required to maintain a minimum qualified cash of $1.5 million, and certain business, management, and governance covenants were added. The Eleventh Amendment also requires that 50% (or 100% if an event of default exists) of net cash proceeds from equity offerings and certain permitted additional indebtedness be applied to prepay Credit Agreement loans, with the loan parties permitted to retain up to $5.0 million for working capital and general corporate purposes, and permits borrowing base indebtedness in excess of maximum amounts not to exceed $4.0 million at December 31, 2025, $4.5 million at January 31, 2026, $5.5 million at February 28, 2026, and $4.0 million from and after March 31, 2026. The Company was in compliance with the borrowing base covenant and the minimum qualified cash balance requirement under the Credit Agreement for the period ended December 31, 2025. Pursuant to the Eleventh Amendment, the Senior Leverage Ratio covenant was replaced with a minimum consolidated adjusted EBITDA covenant commencing with the period ending March 31, 2026.

 

The Company was not in compliance with the borrowing base and Minimum Consolidated Adjusted EBITDA covenants as of September 30, 2026. Pursuant to the March 2026 Forbearance Agreement, the Lenders waived the underlying borrowing base defaults for January and February 2026. Pursuant to the May 2026 Forbearance Agreement, the Lenders granted a limited waiver of the borrowing base and Minimum Consolidated Adjusted EBITDA defaults for the periods ended March 31, 2026 and April 30, 2026. Pursuant to the August 2026 Forbearance Agreement, the Lenders granted a limited waiver of the borrowing base and Minimum Consolidated Adjusted EBITDA defaults for the periods ended May 31, 2026, June 30, 2026, and July 31, 2026. 

 

On November 10, 2026, the Company and the other Loan Parties entered into a Forbearance Agreement and Waiver to Credit Agreement with the Lenders and Whitehawk Capital Partners LP, as administrative agent (the “November 2026 Waiver”). Pursuant to the November 2026 Waiver, the Loan Parties acknowledged that (i) for each of the months ended August 31, 2026 and September 30, 2026, and, as anticipated, for the month ending October 31, 2026, they were in an over advance in excess of the Permitted Over Advance, were not in borrowing base compliance and did not make the mandatory prepayment required under Section 2.05(c)(vii) of the Credit Agreement in an amount equal to such excess, (ii) they were not in compliance with the financial covenant set forth in Section 7.03(a) of the Credit Agreement for the eight, nine and ten fiscal months ended August 31, 2026, September 30, 2026 and October 31, 2026, respectively, and (iii) they had not been in compliance with the financial covenant set forth in Section 7.03(b) of the Credit Agreement since the date of the August 2026 Waiver (collectively, the “Specified Events of Default”). The Lenders granted a limited waiver of the Specified Events of Default. The waiver does not apply to any other existing or future default or event of default and is conditioned upon the Loan Parties’ continued compliance with the provisions of the November 2026 Waiver. Any failure to comply with the November 2026 Waiver would constitute an immediate event of default and render the waiver null and void. Notwithstanding the waiver, the Post-Default Rate under Section 3.03 of the Credit Agreement remains applicable until the Loan Parties achieve compliance with the borrowing base and other requirements of the Credit Agreement. In addition, the Loan Parties acknowledged that the Lenders’ right to receive interest at the Post-Default Rate has continued since the effective date of the Eleventh Amendment and for periods prior thereto. As of the date of the November 2026 Waiver, the Lenders had not accelerated the obligations outstanding under the Credit Agreement.

 

As of September 30, 2026, the debt outstanding from Boxlight to Whitehawk is classified as short-term debt.

 

Pursuant to the August 2026 Forbearance Agreement, the mandatory quarterly amortization payments on the initial term loan remain suspended through September 30, 2026, with the first payment due on December 31, 2026. In addition, the August 2026 Forbearance Agreement amended the Credit Agreement’s mandatory prepayment provisions to require that 50% (or 100% if an Event of Default exists) of net cash proceeds from subordinated indebtedness in addition to equity issuances be applied to prepay the Credit Agreement loan, with any retained proceeds restricted from being used to make payments on equity interests, redeemable preferred stock, or subordinated indebtedness.

 

In August 2026, the Company completed an equity raise, the proceeds of which were required to be applied to repay a portion of the outstanding Credit Agreement, resulting in a principal repayment of approximately $2.25 million and a prepayment penalty of $0.14 million.

 

25


Table of Contents

 

In September 2026, the Company completed a second equity raise, the proceeds of which were required to be applied to repay a portion of the outstanding Credit Agreement, resulting in an October 2026 principal repayment of approximately $425 thousand and prepayment penalty of $26 thousand. See additional disclosure in Note 17 Subsequent Events. 

 

Although the Company has obtained waivers and amendments with respect to each of the foregoing instances of non-compliance, there can be no guarantee that the Company will not breach provisions of the Credit Agreement in the future. Any such breach could result in declared events of default, acceleration of obligations, and other material adverse consequences to the Company.

 

Issuance Cost and Warrants

 

In conjunction with its receipt of the Initial Loan, the Company issued to the Lender (i) 367 shares of Class A common stock (the “Shares”), which Shares were registered pursuant to its existing shelf registration statement and were delivered to the Lender in January 2022, (ii) a warrant to purchase 1,419 shares of Class A common stock (subject to increase to the extent that 3% of any Series B and Series C convertible Preferred Stock converted into Class A common stock), exercisable at $2,880.00 per share (the “Warrant”), which Warrant was subject to repricing on March 31, 2022 based on the arithmetic volume weighted average prices for the 30 trading days prior to March 31, 2022, in the event the Company’s stock is then trading below $2,880.00 per share, (iii) a 3% fee of $1,800,000, and (iv) a $500,000 original issue discount. In addition, the Company agreed to register for resale the shares issuable upon exercise of the Warrant. The Company also incurred agency fees, legal fees, and other costs in connection with the execution of the Credit Agreement totaling approximately $1.7 million. Under the terms of the warrant issued to Whitehawk on December 31, 2021, the exercise price of the warrants would reprice if the stock price on March 31, 2022 was less than the original exercise price, at which time the number of warrants would also be increased proportionately, so that after such adjustment the aggregate exercise price payable for the increased number of warrant shares would be the same as the aggregate exercise price previously in effect. The warrants repriced on March 31, 2022 to $1,713.60 per share and the shares increased to 2,385.

 

On July 22, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with an accredited institutional investor. According to the terms of the Credit Agreement, as amended, the Purchase Agreement triggered a reduction of the exercise price of the warrants and a revaluation of the derivative liability. The Whitehawk warrants were repriced to $1,584.00, and shares increased to 2,580.

 

On February 19, 2025, the Company entered into a Securities Purchase Agreement (the “2025 Purchase Agreement”) with certain institutional accredited investors (the “2025 Investors”). According to the terms of the Credit Agreement, as amended, the 2025 Purchase Agreement triggered a reduction of the exercise price of the warrants and a revaluation of the derivative liability. The Whitehawk warrants were repriced to $698.04, and shares increased to 5,854.

 

On September 23, 2025, the Company entered into a Securities Purchase Agreement with certain institutional accredited investors. According to the terms of the Credit Agreement, as amended, the Purchase Agreement triggered a reduction of the exercise price of the warrants and a revaluation of the derivative liability. The Whitehawk warrants were repriced to $543.96 per share, and the number of shares issuable upon exercise increased to 7,513 shares.

 

On April 1, 2026, the Company entered into an amendment to its inventory finance agreement with J.J. Astor & Co., a related party, converting $556,200 of outstanding debt into 100,000 shares of Class A common stock at $5.562 per share. This conversion triggered a reduction of the exercise price of the Whitehawk warrants and a revaluation of the derivative liability. The Whitehawk warrants were repriced to $468.29 per share, and the number of shares issuable upon exercise increased to 8,727.

 

On August 5, 2026, the Company entered into a Securities Purchase Agreement with certain institutional accredited investors. According to the terms of the Credit Agreement, as amended, the Purchase Agreement triggered a reduction of the exercise price of the warrants and a revaluation of the derivative liability. The Whitehawk warrants were repriced to $411.75 per share, and the number of shares issuable upon exercise increased to 9,925 shares.

 

On August 17, 2026, and August 19, 2026, the Company entered into two separate amendments to its inventory finance agreement with J.J. Astor & Co.. The Company converted $167,966 of outstanding debt into 67,290 shares of Class A common stock at $2.50 per share. The conversion triggered a reduction of the exercise price and a revaluation of the derivative liability.  The Whitehawk warrants were repriced to $379.58 per share, and the number of shares issuable upon exercise increased to 10,766 shares.

 

On September 30, 2026, the Company entered into a securities purchase agreement with J.J. Astor & Co. relating to the Series E Convertible Preferred Stock. The issuance triggered an increase of the exercise price and a revaluation of the derivative liability. The Whitehawk warrants were repriced to $380.58 per share, and the number of shares issuable upon exercise decreased to 10,738 shares.

 

26


Table of Contents

 

NOTE 9 – DERIVATIVE LIABILITIES

 

Warrants 

 

The Company determined that certain warrants to purchase common stock do not satisfy the criteria for classification as equity instruments due to the existence of certain net cash and non-fixed settlement provisions that are not within the sole control of the Company. Conversion and exercise prices may be lowered if the Company issues securities at lower prices in the future. Such warrants are measured at fair value at each reporting date, and the changes in fair value are included in determining net income (loss) for the period. The Company used a Monte Carlo Simulation model to determine the fair value of the derivative liabilities.

 

The embedded conversion feature contained in the Company's Series D Convertible Preferred Stock is accounted for as a derivative liability under ASC 815. The derivative liability is initially recognized at fair value and subsequently remeasured at fair value at each reporting date, with changes in fair value recognized in the condensed consolidated statement of operations and comprehensive loss. Because the valuation incorporates significant unobservable inputs, the derivative liability is classified within Level 3 of the fair value hierarchy.

 

 

 

September 30, 2026

 

Common stock issuable upon exercise of warrants

 

 

10,738

 

Market value of common stock on measurement date

 

$

4.77

 

Exercise price

 

$

380.58

 

Risk free interest rate (1)

 

 

3.95

%

Expected life in years

 

 

0.5

 

Expected volatility (2)

 

 

152.0

%

Expected dividend yields (3)

 

 

—

%

 

​

​

December 31, 2025

​

Common stock issuable upon exercise of warrants

​

​

7,513

​

Market value of common stock on measurement date

​

$

10.20

​

Exercise price

​

$

543.96

​

Risk free interest rate (1)

​

​

3.42

%

Expected life in years

​

​

1

​

Expected volatility (2)

​

​

187.0

%

Expected dividend yields (3)

​

​

—

%

 

 

(1)

The risk-free interest rate was determined using the applicable (six month) Treasury Bill as of the measurement date.

 

(2)

The historical trading volatility was based on historical fluctuations in stock price for Boxlight.

 

(3)

The Company does not expect to pay a dividend in the foreseeable future.

 

Series D Convertible Preferred Stock Embedded Derivative Liability

 

The embedded conversion feature contained in the Company's Series D Convertible Preferred Stock is accounted for as a derivative liability under ASC 815. The derivative liability is initially recognized at fair value and subsequently remeasured at fair value at each reporting date, with changes in fair value recognized in the condensed consolidated statement of operations and comprehensive loss. The fair value of the derivative liability was estimated using a probability-weighted discounted cash flow model that considered multiple potential settlement outcomes, including scenarios in which the Exchange Cap is lifted and scenarios reflecting alternative conversion outcomes available to investors. Because the valuation incorporates significant unobservable inputs, the derivative liability is classified within Level 3 of the fair value hierarchy.

 

 

 

September 30, 2026

 

Fair value of embedded derivative liability - Series D, per preferred share

 

$

1.57

 

Expected payoff upon conversion

 

$

12.50

 

Calibrated probability - exchange cap lifted

 

 

63.4

%

Calibrated probability - downside investor

 

 

36.6

%

Calibrated discount rate

 

 

15.8% to 16.1%

 

Expected payoff date - exchange cap lifted

 

 

November 10, 2026

 

Expected payoff date - downside investor

 

 

April 01, 2027

 

 

27


Table of Contents


Equity Purchase Agreement (Equity Line of Credit) Derivative Liability

 

The Company evaluated the Equity Purchase Agreement executed on August 5, 2026 and determined that the related put option had a de minimis fair value at inception and at September 30, 2026; therefore, no derivative asset or liability was recorded.

NOTE 10 – INCOME TAXES 

 

Pretax (loss) resulting from domestic and foreign operations is as follows (in thousands):

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

United States

 

$

(210

)

 

$

(4,902

)

 

$

(3,510

)

 

$

(12,997

)

Foreign

 

 

(1,063

)

 

 

(1,543

)

 

 

(4,427

)

 

 

(1,286

)

Total pretax book loss

 

$

(1,273

)

 

$

(6,445

)

 

$

(7,937

)

 

$

(14,283

)

 

The Company recorded income tax benefit of $255 thousand and $261 thousand for the three months ended  September 30, 2026 and 2025, respectively, and income tax benefit of $903 thousand and $137 thousand for the nine months ended September 30, 2026 and 2025, respectively. The effective tax rate was 20.0% and 4.1% for the three months ended September 30, 2026 and 2025, respectively, and 11.4% and 1.0% for the nine months ended September 30, 2026 and 2025, respectively, due to various permanent differences for Boxlight and a change in the valuation allowance for certain deferred assets.

 

On July 4, 2025, the President signed H.R. 1 (commonly known as the One Big Beautiful Bill Act) ("OBBBA") into law. The law introduces many significant federal income tax changes with various effective dates. ASC 740, Income Taxes, requires that the effects of a change in tax laws or rates should be recorded in the interim period that includes the enactment date. The Company does not expect a material impact on the effective tax rate, but does expect a current tax benefit from utilizing the tax law changes under OBBBA related to expensing of prior year unamortized Domestic IRC Sec. 174 costs, 100% bonus depreciation on personal property, and interest deferred rule changes under IRC Sec. 163J.

 

The Company operates in the United States, United Kingdom, and other jurisdictions. Income taxes have been provided based upon the tax laws and rates of the countries in which operations are conducted and income is earned.

 

The legacy Boxlight entities are in a net deferred tax asset position in the United States and other jurisdictions, primarily driven by the net operating losses. The recoverability of these deferred tax assets depends on the Company’s ability to generate taxable income in the jurisdiction to which the carryforward applies. It also depends on specific tax provisions in each jurisdiction that could impact utilization. For example, in the United States, a change in ownership, as defined by federal income tax regulations, could significantly limit the Company’s ability to utilize its U.S. net operating loss carryforwards. Additionally, because U.S. tax laws limit the time during which the net operating losses generated prior to 2018 may be applied against future taxes, if the Company fails to generate U.S. taxable income prior to the expiration dates, the Company may not be able to fully utilize the net operating loss carryforwards to reduce future income taxes. The Company has evaluated both positive and negative evidence as to the ability of its legacy entities in each jurisdiction to generate future taxable income. Based on its long history of cumulative losses in those jurisdictions, it believes it is appropriate to maintain a full valuation allowance on its net deferred tax asset at  September 30, 2026 and  December 31, 2025.

 

In the U.S. federal jurisdiction, the Company’s income tax returns for 2023 and subsequent years remain subject to examination by the tax authorities. For earlier years, tax authorities may recompute and adjust net operating loss carryforwards and other tax attributes originating in those years to the extent they are utilized in open tax years. The tax years from 2022 to 2026 remain open to examination in the U.K. Statutes of limitations vary in other immaterial jurisdictions.

 

28


Table of Contents

 

NOTE 11 – EQUITY

 

Preferred Stock

 

The Company’s articles of incorporation, as amended, provide that the Company is authorized to issue 50,000,000 shares of Preferred Stock, par value of $0.0001 per share, of which (1) 250,000 shares are designated as non-voting Series A Preferred Stock; (2) 1,586,620 shares are designated Series B Preferred Stock, which have no voting rights other than as require by law; (3) 937,500 shares are designated as Series D Convertible Preferred Stock; (4) 106,250 shares are designated as Series E Convertible Preferred Stock; and (5) the remaining shares constitute “blank check” Preferred Stock to be designated by the Company’s Board of directors. No shares of Series C Preferred Stock remain outstanding. Each authorized series of Preferred Stock is described below.

 

Issuance of Preferred Stock

 

Series A Preferred Stock

 

At the time of the Company’s initial public offering, the Company issued 250,000 shares of the Company’s non-voting convertible Series A Preferred Stock to Vert Capital for the acquisition of Genesis Collaboration LLC. As of  September 30, 2026, a total of 167,972 shares of Series A Preferred Stock remained outstanding which can be converted into 6,693 shares of Class A common stock, at the discretion of the Series A stockholder.

 

Series B Preferred Stock and Series C Preferred Stock

 

On September 25, 2020, in connection with the acquisition of Sahara Holding Limited (“Sahara”), the Company issued 1,586,620 shares of Series B Preferred Stock and 1,320,850 shares of Series C Preferred Stock. The Series B Preferred Stock has a stated and liquidation value of $10.00 per share and pays a dividend out of the earnings and profits of the Company at the rate of 8% per annum, payable quarterly. The Series B Preferred Stock is convertible into the Company’s Class A common stock at a conversion price of $66.40 per share which was the closing price of BOXL’s Class A common stock on the Nasdaq Stock Market on September 25, 2020 (the “Conversion Price”) either (i) at the option of the holder at any time after January 1, 2024 or (ii) automatically upon the Company’s Class A common stock trading at 200% of the Conversion Price for 20 consecutive trading days (based on a volume weighted average price). The Series C Preferred Stock has a stated and liquidation value of $10.00 per share and is convertible into the Company’s Class A common stock at the Conversion Price either (i) at the option of the holder at any time after January 1, 2026, or (ii) automatically upon the Company’s Class A common stock trading at 200% of the Conversion Price for 20 consecutive trading days (based on a volume weighted average price).

 

On October 1, 2025, the Company converted all outstanding Series C Preferred Stock into common stock and amended the Series B preferred stock to eliminate redemption and conversion features, reducing potential future cash obligations.

 

Pursuant to the agreement with the holders of the Series B Stock and Series C Stock ("the “Agreement”) converted all outstanding shares of Series C Stock - constituting a total of 1,320,850 shares - into a total of 5,525 shares of Class A Common Stock, par value $0.0001 per share (“Common Stock”) as adjusted for the 1-for-6 reverse stock splits effected on December 22, 2025, and June 22, 2026.

 

In addition, the holders agreed with the Company to amend the terms of the Series B Stock. Specifically, the right of the holders to convert their Series B Stock into Common Stock at their option, and a provision that provided for automatic conversion if the price of the Common Stock on the Nasdaq Capital Market reached a certain level, were eliminated. The right of the holders to cause the Company to redeem their Series B Stock at their option was also eliminated.

 

The dividend provisions of the Series B Stock were amended to provide that the current 8% per annum dividend, currently accruing on a non-compounding cumulative basis, would begin accruing at 9% per annum on October 2, 2027, 10% on October 2, 2028, 11% on October 2, 2029 and 12% on October 2, 2030 and thereafter. The cumulative dividends are payable only when and if declared, or in the event of a liquidation of the Company. No dividends can be declared or paid on junior classes of capital stock, including the Common Stock, unless unpaid cumulative dividends on the Series B Stock are first paid. Although the dividends are payable only when and if declared or upon a liquidation, dividends that do become payable but remain unpaid will accrue interest at a fixed rate of 12% until such dividend and interest shall be paid in full.

 

29


Table of Contents

 

In the Agreement, the Company agreed to apply up to 20% of the net proceeds of future primary equity securities offerings undertaken by the Company for capital-raising purposes to redeem or repurchase the Series B Stock at a redemption price per share of $10.00 until all such shares are redeemed and repurchased. The obligation to repurchase or redeem the Series B Stock is subject to possible limitations based on legal or stock market listing standard considerations.  As of September 30, 2026, no redemption were required on the Series B Stock.

 

Series D Convertible Preferred Stock Financing

 

On August 5, 2026, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with the purchasers (collectively, the “Purchasers”), pursuant to which the Company agreed to sell to the Purchasers an aggregate of 937,500 shares of the Company’s newly designated Series D Convertible Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), at a purchase price of $8.00 per share, each share having a stated value of $10.00, reflecting a 20% original issue discount (“OID”). The Preferred Stock is convertible into shares of the Company’s Class A Common Stock, par value $0.0001 per share (the “Common Stock”), in accordance with the terms of the Certificate of Designation.

 

The Company agreed to issue and sell the Preferred Stock in two tranches: Tranche One, in the amount of $5,500,000 (687,500 shares of Preferred Stock), payable on or before the Closing Date; and Tranche Two, in the amount of $2,000,000 (the “Effectiveness Tranche Amount”) (250,000 shares of Preferred Stock), payable upon effectiveness of the resale registration statement, subject to a 60-calendar-day outside date and to the Company obtaining the Required Stockholder Approvals and remaining current in its SEC reporting obligations.

 

In connection with the closing of the transaction, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Nevada pursuant to NRS 78.1955, establishing up to 937,500 shares of Series D Convertible Preferred Stock. The Preferred Stock ranks senior to the Company’s Class A Common Stock and Class B Common Stock with respect to liquidation distributions, does not accrue dividends in the ordinary course, and is convertible at any time after the Initial Issuance Date at a conversion price generally based on a discount to recent market prices, subject to an applicable floor price, a 4.99% beneficial ownership limitation, and (absent the Required Stockholder Approvals) a 19.99% exchange cap under Nasdaq Listing Rule 5635(d). Upon the occurrence of a Dividend Trigger Event, a cumulative Default Dividend at a rate of 20% per annum accrues on the stated value of the outstanding Preferred Stock, payable monthly solely in kind.

 

The Company evaluated the embedded conversion feature contained in the Series D Convertible Preferred Stock under ASC 815. The Company determined that the conversion feature requires separate accounting as a derivative liability. Accordingly, the fair value of the conversion feature was recorded as a derivative liability upon issuance and is subsequently remeasured at fair value at each reporting date, with changes in fair value recognized in earnings. For the three and nine months ended September 30, 2026, the Company recognized a gain on change in fair value of derivative liabilities of $118 thousand, related primarily to the embedded conversion feature associated with the Series D Convertible Preferred Stock.

 

On September 30, 2026, in connection with the Series D financing, the Company entered into a First Amendment to the Series D Securities Purchase Agreement and filed a Certificate of Amendment to the Certificate of Designation governing its Series D Convertible Preferred Stock with the holders of all outstanding shares of Series D Convertible Preferred Stock. The amendment modifies certain provisions of the Series D Certificate of Designation to permit the issuance of the Series E Convertible Preferred Stock and related transaction documents, limits the $10.00 per-share liquidation preference to a voluntary or involuntary liquidation, dissolution or winding up and adds a protective provision requiring the consent of the holders of Series D Convertible Preferred Stock before the Company consummates, or enters into an agreement to consummate, specified fundamental transactions. 

 

In connection with the Series E financing, on October 6, 2026, the holders of Series D Convertible Preferred Stock ratified a consent, waiver and ratification, (effective as of September 30, 2026), which was further amended on October 9, 2026. The consent was acknowledged by the Company and J.J. Astor & Co.. Pursuant to the consent, the holders of Series D Convertible Preferred Stock waived certain most-favored-nation and variable-rate transaction provisions contained in the Series D transaction documents that otherwise may have been triggered by the issuance of the Series E Convertible Preferred Stock.

 

30


Table of Contents

 

Equity Purchase Agreement (Equity Line of Credit)

 

Concurrently with the closing of the transaction, the Company entered into an Equity Purchase Agreement, dated August 5, 2026, with Secure Net Capital LLC (the “Investor”), establishing an equity line facility under which the Company may sell to the Investor up to $15,000,000 (the “Maximum Commitment Amount”) of shares of the Company’s Class A Common Stock over a 36-month commitment period, at a purchase price equal to 95% of the applicable market price, subject to the Maximum Regular Put Amount and Maximum Intraday Put Amount and a 4.99% beneficial ownership limitation (subject to adjustment up to 9.99% upon 61 days’ prior notice).  

 

In connection with the Equity Purchase Agreement, the Company approved a form of Pre-Funded Warrant to purchase shares of Class A Common Stock, which the Investor may elect to receive in lieu of Commitment Shares (including True-Up Commitment Shares). The Pre-Funded Warrants carry a nominal exercise price of $0.0001 per share, are exercisable at any time until exercised in full with no fixed expiration date, permit cashless exercise, and are subject to a 4.99% beneficial ownership limitation (subject to adjustment up to 9.99% upon 61 days’ prior notice). As consideration for entering into the Equity Purchase Agreement, the Company became obligated to pay a $150,000 commitment fee, payable in 48,702 initial Commitment Shares or, at the Investors' election, Pre-Funded Warrants, plus any True-Up Commitment Shares required so that the aggregate Commitment Shares equal $150,000 divided by the True-Up Commitment Share Reference Price. No Commitment Shares or Pre-Funded Warrants had been issued as of September 30, 2026. Accordingly, the Company recorded the commitment fee as a deferred charge, with a corresponding amount included in equity issuable pending issuance of the applicable equity instruments.

 

The Company determined that the put option in the ELOC Purchase Agreement is a derivative within the scope of ASC Topic 815, Derivatives and Hedging, to be initially measured and recorded at fair value with subsequent changes in fair value to be recorded in earnings. However, as the exercise price is floating and is a discounted price to the exercise date fair value of the common stock, we have determined that the put option has a de minimis value (effectively zero value) and will not be recorded.

 

Registration Rights Agreement; Lock-Up Agreements; Placement Agent Agreement

 

In connection with the Series D Securities Purchase Agreement, the Company and the Series D purchasers entered into a Registration Rights Agreement, dated August 5, 2026, pursuant to which the Company agreed to file an initial resale registration statement within 30 calendar days following the closing of the private placement on August 5, 2026, (the “Closing Date”), and to use its best efforts to have it declared effective within 60 calendar days of the Closing Date. On September 22, 2026, we filed a registration statement on Form S-1, which was amended on October 23 and November 10, 2026 (File No. 333-299084), registering the resale of shares issuable upon conversion of the Series D Convertible Preferred Stock. The registration statement has not yet been declared effective. The Company has not obtained a written waiver of these deadlines; as of the date of this report, no purchaser has demanded payment of liquidated damages. The Company’s directors, executive officers, and certain stockholders entered into Lock-Up Agreements, dated August 5, 2026, restricting transfers of Common Stock for 180 calendar days following the Closing Date. The Company also entered into a Placement Agent Agreement, dated August 5, 2026, with RBW Capital Partners LLC and Dawson James Securities, Inc., pursuant to which the Company agreed to pay a cash fee equal to 7.0% of aggregate gross proceeds from the Placement and 2.0% of amounts drawn under the Equity Purchase Agreement.

 

Series E Convertible Preferred Stock Financing

 

On September 30, 2026, the Company entered into a securities purchase agreement (the “Series E Securities Purchase Agreement”) with J.J. Astor & Co., pursuant to which the Company sold an aggregate of 106,250 shares of its newly designated Series E convertible preferred stock, par value $0.0001 per share (the “Series E Preferred Stock”), at a purchase price of $8.00 per share and a stated value of $10.00 per share, reflecting a 20% original issue discount (“OID”), for aggregate gross proceeds of $850,000. The Series E Preferred Stock is convertible into shares of the Company’s Class A Common Stock in accordance with the terms of the Series E Certificate of Designation. J.J. Astor & Co. is an entity of which Michael Pope, the Company’s Executive Chairman, is the chief executive officer and which is beneficially owned by a private investment fund managed by Mr. Pope. Accordingly, the transaction is considered a related-party transaction. See Note 13, Related Party Transactions. All 106,250 shares of Series E Preferred Stock were issued, and the full $850,000 was received, on or before September 30, 2026.

 

31


Table of Contents

 

In connection with the closing of the transaction, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock (the “Series E Certificate of Designation”) with the Nevada Secretary of State pursuant to NRS 78.1955, establishing up to 106,250 shares of Series E Preferred Stock. The Series E Preferred Stock ranks senior to the Company’s Class A and Class B Common Stock and junior to the Series D Convertible Preferred Stock with respect to liquidation distributions. The Series E Preferred Stock does not accrue dividends in the ordinary course. Subject to the Series D consent described in the paragraph below, it is convertible at a conversion price equal to the greater of the Adjusted Floor Price (initially $0.95 per share and subject to six-month and specified full-ratchet resets, and which ceases to apply if the Class A Common Stock is delisted to the OTC Markets) and 80% of the lowest closing price during the five trading days before conversion, subject to a 19.99% beneficial ownership limitation and, absent stockholder approval, a 19.99% exchange cap under Nasdaq Listing Rule 5635(d). The Series E Preferred Stock votes with the Class A Common Stock on an as-converted basis (Series E required stockholder approvals related to a 19.99% voting limitation were obtained at the special meeting of stockholders held on November 10, 2026). Upon the occurrence of a Dividend Trigger Event, a cumulative default dividend accrues at a rate of 20% per annum on the stated value of the outstanding shares and is payable solely in kind.

 

In connection with the Series E financing, on October 6, 2026, the holders of Series D Convertible Preferred Stock ratified a consent, waiver and ratification (effective as of September 30, 2026), which was further amended on October 9, 2026. The consent was acknowledged by the Company and J.J. Astor. Pursuant to the consent, the holders of all outstanding Series D Convertible Preferred Stock waived certain most-favored-nation and variable-rate transaction provisions contained in the Series D transaction documents that otherwise may have been triggered by the issuance of the Series E Convertible Preferred Stock. It was also agreed and acknowledged that the Series E Convertible Preferred Stock may not be converted, and the resale of the underlying shares may not be registered, until the earlier of the time no Series D Convertible Preferred Stock remains outstanding and the effectiveness of a resale registration statement covering the Series D conversion shares together with receipt of the Series D Required Stockholder Approvals.

 

The amendment and consent were obtained in connection with, and were necessary to facilitate, the consummation of the Series E financing transaction. See Note 17, Subsequent Events.

 

Common Stock

 

Following the Company’s 1-for-6 reverse stock split in June 2026, the Company’s common stock consisted of 694,445 shares of Class A voting common stock and 50,000,000 shares of Class B non-voting common stock. Class A and Class B common stock have the same rights except that Class A common stock is entitled to vote per share while Class B common stock has no voting rights. Upon any public or private sale or disposition by any holder of Class B common stock, such shares of Class B common stock shall automatically convert into shares of Class A common stock. As of  September 30, 2026, and  December 31, 2025, the Company had 844,556 and 228,335 shares of Class A common stock issued and outstanding, respectively. No Class B shares were outstanding as of  September 30, 2026, or  December 31, 2025.

 

On April 20, 2026, the Company received a notice from Nasdaq indicating that, based on the Company’s Annual Report on Form 10-K for the year ended  December 31, 2025, it no longer complied with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), because the Company reported stockholders’ equity of approximately $1.255 million, which is below the $2.5 million minimum required for continued listing on the Nasdaq Capital Market.

 

On July 1, 2026, the Company received a determination letter from the Listing Qualifications Staff of The Nasdaq that it is not in compliance with the $2.5 million stockholders’ equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b). The Company requested a hearing before the Nasdaq Hearings Panel (the “Panel”), which was held on August 13, 2026. On September 2, 2026, the Panel notified the Company that it has regained compliance with the Nasdaq Listing Rule, which requires listed companies to maintain a minimum of $2.5 million in stockholders’ equity (the “Equity Rule”), and granted the Company’s request for continued listing on Nasdaq. As of  September 30, 2026, the Company had stockholders’ equity of approximately $1.9 million, which is below the $2.5 million minimum required. Accordingly, based on the Company’s reported stockholders’ equity as of  September 30, 2026, the Company does not satisfy the Equity Rule. If Nasdaq Staff determines during the Monitoring Period that the Company is again not in compliance with the Equity Rule or another applicable continued-listing requirement, the Company will not be eligible to submit a compliance plan to Nasdaq Staff, Nasdaq Staff will not be permitted to provide additional time to regain compliance, and the Company will not be afforded an otherwise applicable cure or compliance period. Instead, Nasdaq Staff would issue a Staff Delisting Determination. As of the filing date of this Quarterly Report, the Company has not received written notice from Nasdaq regarding the Company’s compliance with the Equity Rule based on its September 30, 2026 stockholders’ equity. If the Company receives a Staff Delisting Determination, the Company intends to timely request a hearing before the Nasdaq Hearings Panel. A timely request is expected to stay any suspension or delisting action pending completion of the hearings process and the expiration of any additional extension period granted by the Panel, if any. There can be no assurance that the Panel would grant continued listing, that the Company would regain compliance, or that the Company’s Class A common stock would continue to be listed on Nasdaq.

 

32


Table of Contents

 

On July 23, 2026, at the Company’s reconvened Annual Meeting of Shareholders, shareholders approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of Class A common stock from 694,445 shares to 55,000,000 shares. The amendment provides the Company with additional flexibility for future corporate purposes, subject to applicable law, Nasdaq listing requirements, and Board approval.

 

February 2025 Private Placement

 

On February 19, 2025, the Company entered into a Securities Purchase Agreement (the “2025 Purchase Agreement”) with certain institutional accredited investors, pursuant to which the Company agreed to issue and sell, in a private placement priced at-the-market under the rules of The Nasdaq Stock Market (the “2025 Private Placement”), an aggregate of (i) 7,222 shares (the “2025 Shares”) of the Company’s Class A common stock, (ii) prefunded warrants (the “2025 Prefunded Warrants”) to purchase up to an aggregate of 29,528 shares of Class A Common Stock (the “2025 Prefunded Warrant Shares”), and (iii) warrants (the “2025 Common Warrants” and, together with the 2025 Prefunded Warrants, the “2025 Warrants”) to purchase up to an aggregate of 36,750 shares of Class A Common Stock (the “2025 Common Warrant Shares” and, together with the 2025 Prefunded Warrant shares, the “2025 Warrant Shares”). The purchase price of each 2025 share and accompanying 2025 common warrant was $76.68, and the purchase price of each 2025 Prefunded Warrant and accompanying 2025 Common Warrant was $76.68. The 2025 Private Placement closed on February 21, 2025, and the Company issued the 2025 shares and executed and delivered the 2025 Warrant Shares. The gross proceeds from the 2025 Private Placement were approximately $2.8 million, before deducting placement agent fees and other private placement expenses. Each 2025 Prefunded Warrant has an initial exercise price of $0.0036 per share (subject to adjustments as set forth therein), is immediately exercisable upon issuance and will expire when exercised in full. Each 2025 Common Warrant has an initial exercise price of $76.68 per share (subject to adjustments as set forth therein), is exercisable six months following the date of issuance and will expire five and a half years from the date of issuance. Pursuant to the Purchase Agreement, the Company filed a registration statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) on April 7, 2025 to register the resale of the 2025 Shares and the 2025 prefunded warrant shares. The Registration Statement was declared effective by the SEC on April 24, 2025. Through December 31, 2025, the holders exercised all of the prefunded warrants.

 

September 2025 Registered Direct Offering

 

On September 23, 2025, the Company entered into a placement agency agreement with a placement agent and a securities purchase agreement with certain purchasers, pursuant to which the Company issued and sold, in a registered direct offering, an aggregate of 37,037 shares of the Company’s Class A common stock at a price of $108.00 per share. The offering closed on September 24, 2025. The gross proceeds to the Company were approximately $4.0 million, before deducting the Placement Agent’s fees and other offering expenses payable by the Company.

 

At-the-Market Offering (“ATM Program”)

 

On October 16, 2025, the Company entered into a sales agreement with A.G.P./Alliance Global Partners, pursuant to which the Company could offer and sell shares of its Class A common stock, par value $0.0001 per share, having an aggregate offering price of up to $4.8 million, through an “at the market” offering program (“ATM Program”) in accordance with Rule 415(a)(4) under the Securities Act of 1933, as amended.

 

During the year ended December 31, 2025, the Company sold 69,659 shares of its Class A Common Stock under the ATM Program for gross proceeds of approximately $1.06 million. The Company paid the sales agent commissions of 3.0% of the gross proceeds, totaling approximately $0.03 million. In addition, the Company incurred professional and other offering expenses of approximately $0.37 million related to the ATM Program. After deducting commissions and offering expenses, the Company received net proceeds of approximately $0.66 million. As of January 21, 2026, the Company sold the remaining shares available under the “at the market offering” program (“ATM Program”). In total, the Company sold 408,276 shares of Class A Common Stock under the program for aggregate proceeds of approximately $4.6 million, after deducting sales agent commissions of $0.14 million but before offering expenses, thereby fully exhausting the capacity of the program.

 

Warrants

 

The Company had equity warrants outstanding of 15,858 and 24,883 as of  September 30, 2026 and  December 31, 2025, respectively.

 

33


Table of Contents

 

NOTE 12 – STOCK COMPENSATION

 

The Company has issued grants under two equity incentive plans, both of which have been approved by the Company’s shareholders: (i) the 2014 Equity Incentive Plan, as amended (the “2014 Plan”), pursuant to which a total of 4,438 shares of the Company’s Class A common stock have been approved for issuance, and (ii) the 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which a total of 3,472 shares of the Company’s Class A common stock have been approved for issuance. Upon approval of the 2021 Plan in September 2021, any shares remaining available for issuance under the 2014 Plan were cancelled, and all future grants were issued under the 2021 Plan. The 2021 Plan allows for issuance of shares of our Class A common stock, whether through restricted stock, restricted stock units, options, stock appreciation rights or otherwise, to the Company’s officers, directors, employees, and consultants. Prior to the second quarter of 2023, the Company had issued 4,305 shares under the 2021 Plan such that the Company was over the authorized share number.

 

Stock Options

 

Under our Equity Incentive Plans, an employee may receive an award of stock option grants that provides the opportunity in the future to purchase the Company’s shares at the market price of our stock on the date the award is granted (strike price). The options become exercisable over a range of immediately vested to four-year vesting periods and expire five years from the grant date, unless stated differently in the option agreements, if they are not exercised. We record compensation expense based on the estimated fair value of the awards which is amortized as compensation expense on a straight-line basis over the vesting period. Accordingly, total expense related to the award is reduced by the fair value of options that are forfeited by employees that leave the Company prior to vesting as they occur.

 

There was no stock option activity during the nine months ended September 30, 2026. As of  September 30, 2026, 22 stock options were outstanding and exercisable.

 

Restricted Stock Units

 

Under our Equity Incentive Plans, the Company may grant restricted stock units (“RSUs”) to certain employees, contractors, and non-employee directors. Upon granting the RSUs, the Company recognizes a fixed compensation expense equal to the fair market value of the underlying shares of RSUs granted on a straight-line basis over the requisite service period for the RSUs. Compensation expense related to the RSUs is reduced by the fair value of units that are forfeited by employees that leave the Company prior to vesting as they occur. The RSUs vest over a range of immediately vested to four-year vesting periods in accordance with the terms of the applicable RSU grant agreement.

 

The following is a summary of the RSU activities during the nine months ended September 30, 2026:

 

 

 

Number of

 

 

 

Units

 

Outstanding, December 31, 2025

 

 

117

 

Granted

 

 

—

 

Vested

 

 

(64

)

Forfeited

 

 

(5

)

Outstanding, September 30, 2026

 

 

48

 

 

Warrants

 

The following is a summary of the warrant activities for warrants to purchase Class A common stock during the nine months ended September 30, 2026:

 

 

 

Number of

 

 

 

Units

 

Outstanding, December 31, 2025

 

 

24,883

 

Granted

 

 

—

 

Exercised

 

 

(12,250

)

Increase in warrant shares from anti-dilution adjustment

 

 

3,225

 

Outstanding, September 30, 2026

 

 

15,858

 

Exercisable, September 30, 2026

 

 

15,858

 

 

34


Table of Contents

 

Stock Compensation Expense

 

Long-term incentive plan

 

On August 15, 2024, the Company granted a long-term incentive plan (LTIP) cash award pursuant to its 2021 Equity Incentive Plan to members of the Company’s Board of Directors and senior management. The amount of each award earned will depend on the performance of the Company relative to certain performance targets related to share price appreciation of the Company’s Class A common stock during the respective performance cycles. The LTIP awarded to the Company’s Board of Directors have a performance period ended on March 31, 2026, whereas the LTIP awarded to senior management have three consecutive 12-month performance periods ending June 30, 2025, June 30, 2026, and June 30, 2027. The target payout under the LTIP awarded to the Board of Directors and senior management is $0.4 million and $0.1 million, respectively. If the Company’s performance relative to the performance goal during the performance cycle is not equal to the performance target, the target Cash LTIP Award will be adjusted based on actual performance. Consequently, the actual payout in the nine months ended September 30, 2026, under the LTIP awarded to the Board was $86 thousand for the performance period ended on March 31, 2026, due to the change in stock price. At no time during the performance cycle shall the payout be less than 1/3 or exceed 3 times the target cash LTIP Award, unless a change in control has occurred. Cash payments are subject to the Company’s compliance with all covenants contained in the Company’s credit facilities in effect at the conclusion of each performance cycle. $50 thousand of the LTIP payout in the nine months ended September 30, 2026, was attributable to executive departures. As amounts earned for the awards are based on changes in the Company’s stock price, the Company will recognize a liability for compensation cost each reporting period based on the fair value as of each reporting date proportionally with the elapsed time at each reporting period. The liability is recognized in other short-term liabilities in the consolidated balance sheets. The Company used a Monte Carlo Simulation model to determine the fair value of the LTIP as of  September 30, 2026 to be $165 thousand. Key inputs to the valuation of the awards include the stock price as of the award effective date and the valuation date, the discount rate, and historical volatility in the Company’s stock price.

 

 

 

September 30, 2026

 

Market value of common stock on measurement date

 

$

4.77

 

Risk free interest rate (1)

 

 

3.95

%

Expected life in years

 

 

0.50

 

Expected volatility (2)

 

 

152

%

 

 

(1)

The risk-free interest rate was determined using the applicable (six month) Treasury Bill as of the measurement date.

 

(2)

The historical trading volatility was based on historical fluctuations in stock price for Boxlight.

 

For the three and nine months ended September 30, 2026 and 2025, the Company recorded the following stock compensation in general and administrative expense (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Stock options

 

$

—

 

 

$

—

 

 

$

—

 

 

$

12

 

Restricted stock units

 

 

5

 

 

 

65

 

 

 

41

 

 

 

197

 

Equity based warrants

 

 

—

 

 

 

—

 

 

 

—

 

 

 

30

 

Long-term incentive plan

 

 

64

 

 

 

46

 

 

 

240

 

 

 

220

 

Total stock compensation expense

 

$

69

 

 

$

111

 

 

$

281

 

 

$

459

 

 

As of  September 30, 2026, there was approximately $0.14 million of unrecognized compensation expense related to unvested options and RSUs, which will be amortized over the remaining vesting period.

 

35


Table of Contents

 

NOTE 13 – RELATED PARTY TRANSACTIONS

 

Management Agreement

 

On November 1, 2022, the Company entered into a consulting agreement with Mark Elliott, former Chief Executive Officer of Boxlight and a current member of the Board of Directors. Under the terms of the agreement, Mr. Elliott is to provide sales, marketing, management and related consulting services to assist the Company in sourcing and entering into agreements with one or more customers to provide products and services for specified school districts. The Company will pay Mr. Elliott a fixed payment of $4 thousand per month and commissions equal to 15% of gross profit derived by the Company based on total purchase order revenue. The agreement, unless cancelled, will automatically renew on December 31, 2026. For the three months ended September 30, 2026 and 2025, the Company paid $44 thousand and $52 thousand under the agreement, respectively. For the nine months ended September 30, 2026 and 2025, the Company paid $171 thousand and $91 thousand under the agreement, respectively.

 

On January 31, 2018, the Company entered into a management agreement (the “Management Agreement”) with an entity owned and controlled by our former Chief Executive Officer and Chairman, Michael Pope. The Management Agreement is separate and apart from Mr. Pope’s employment agreement with the Company. The Management Agreement became effective as of the first day of the same month that Mr. Pope’s employment with the Company terminated, and will be in effect for a period of 13 months, in which Mr. Pope will provide consulting services to the Company including sourcing and analyzing strategic acquisitions, assisting with financing activities, and other services. As consideration for the services provided, the Company will pay Mr. Pope a management fee equal to 0.375% of the consolidated net revenues of the Company, payable in monthly installments, not to exceed $250,000 in any calendar year. At his option, Mr. Pope may defer payment until the end of each year and/or receive payment in the form of shares of Class A common stock of the Company.

 

On January 4, 2024, Mr. Pope’s employment with the Company terminated. In accordance with the Management Agreement, Mr. Pope is expected to continue providing consulting services to the Company for the subsequent 13 months. For the nine months ended September 30, 2025, the Company paid $43 thousand under the agreement. Mr. Pope currently serves as the Executive Chairman of the Company.

 

Inventory Finance Agreement 

 

On May 27, 2025, the Company entered into an Inventory Finance Agreement with J.J. Astor & Co., a Utah corporation (“J.J. Astor”). Michael Pope is the chief executive officer of J.J Astor, which is beneficially owned, directly or indirectly, by a private investment fund managed by Mr. Pope.

 

Under the Inventory Finance Agreement, the Company may finance the purchase of certain finished goods inventory from one of the Company’s manufacturers and suppliers of such inventory up to an aggregate outstanding amount of $6 million. The term of the Agreement is one year. Each advance under the Agreement is payable by the Company within 90 days at a rate of 5.35% of the amount advanced by J.J. Astor. Title to the product remains with J.J. Astor until payment is made by the Company. Any failure by the Company to make a payment in full when due under the Agreement constitutes an event of default. In the event of such default by the Company, the aggregate outstanding balance owing to J.J. Astor is automatically increased by 10% and begins to accrue interest at the rate of 19% per annum, compounded daily.

 

On November 3, 2025, the Company and J.J. Astor entered into an amendment and restatement of the Agreement (the “Restated Agreement”). Under the Restated Agreement, the Company may finance 80% of the purchase of certain finished goods inventory from one of the Company’s manufacturers and suppliers of such inventory up to an aggregate outstanding amount of $9 million, a $3 million increase from the maximum amount under the original Agreement. Each advance under the Restated Agreement remains payable by the Company within 90 days at a rate of $1.0535 per $0.80 advanced. The Company and J.J. Astor & Co, entered into a First Amendment to the Restated Agreement, dated November 3, 2026, which extended the term of the agreement by one year, through November 3, 2027. The amendment did not modify the maximum financing capacity, advance rate, repayment terms or other material economic provisions of the Restated Agreement.

 

Under the Restated Agreement, J.J. Astor may elect from time to time to convert all or a portion of the amounts owed by the Company into shares of the Company’s common stock, par value $0.0001 per share. J.J. Astor can require the Company to register any such shares for public resale with the Securities & Exchange Commission.

 

36


Table of Contents

 

On April 1, 2026, we entered into an amendment to the inventory finance agreement, pursuant to which $556,200 of the outstanding balance was converted into 100,000 shares of common stock (the “Conversion Shares”) at a conversion price of $5.562 per share. The amendment also increased the aggregate Maximum Inventory Purchase Amount available under the agreement from $9.0 million to $10.0 million. Further, the parties agreed that, if the aggregate proceeds from the sale of the Conversion Shares are less than $556,200, the Company shall pay the shortfall in cash within five trading days. Michael Pope, Chairman of the Company’s Board of Directors, and its former president and chief executive officer, is the chief executive officer of J.J. Astor. J.J. Astor is beneficially owned, directly or indirectly, by a private investment fund managed by Mr. Pope.

 

On August 17, 2026 and August 19, 2026, the Company entered into two separate amendments to the inventory finance agreement, the “Second Amendment” and the “Third Amendment”, respectively. Pursuant to the Second Amendment, $75,608 of the outstanding balance under the Inventory Finance Agreement was converted into 30,290 shares of common stock at a conversion price of $2.50 per share. Pursuant to the Third Amendment, $92,358 of the outstanding balance under the Inventory Finance Agreement was converted into 37,000 shares of common stock at the conversion price of $2.50 per share.

 

Subsequent to September 30, 2026, on November 10, 2026, the Company and J.J. Astor executed a First Amendment to the Amended and Restated Inventory Finance Agreement, which extended the term of the agreement by one year, through November 3, 2027. All inventory purchase amounts, any applicable default interest and other fees must be paid in full on or before expiration of the extended term. The parties acknowledged that the agreement remained in full force and effect without interruption from November 3, 2026, and that all obligations outstanding as of November 3, 2026, remain outstanding. The amendment did not modify the maximum financing capacity, advance rate, repayment terms or other material economic provisions of the Restated Agreement.

 

For the three and nine months ending September 30, 2026, the Company received $0 and $2.1 million, respectively, in advances under the Inventory Finance Agreement and made cash payments of $0.7 million and $3.6 million, respectively, in principal, interest and fees. For the three and nine months ending September 30, 2025, the Company received $1.4 million and $4.2 million, respectively, in advances under the Inventory Finance Agreement and made cash payments of $3.0 million and $3.1 million, respectively, in principal, interest and fees.

 

Series E Convertible Preferred Stock Financing

 

On September 30, 2026, the Company entered into the Securities Purchase Agreement relating to the issuance of Series E Convertible Preferred Stock with J.J. Astor & Co., which is considered a related party because Michael Pope, the Company’s Executive Chairman, is its chief executive officer and it is beneficially owned by a private investment fund managed by Mr. Pope. J.J. Astor & Co. holds all outstanding shares of the Company’s Series E Convertible Preferred Stock, which it purchased in the Series E financing. Mr. Pope recused himself, and the Series E transaction was negotiated and approved by the disinterested members of the Company’s Board of Directors in accordance with its related-party transaction procedures.

 

NOTE 14 – COMMITMENTS AND CONTINGENCIES

 

Contingencies

 

The Company assesses its exposure related to legal matters and other items that arise in the regular course of its business. If the Company determines that it is probable a loss has been incurred, the amount of the loss, or an amount within the range of loss, that can be reasonably estimated is recorded. The Company has not identified any legal matters that could have a material adverse effect on our consolidated results of operations, financial position or cash flows.

 

Purchase Commitments

 

The Company is legally obligated to fulfill certain purchase commitments made to vendors that supply materials used in the Company’s products. As of  September 30, 2026, the total amount of such open inventory purchase orders was $22.9 million.

 

37


Table of Contents

 

Inventory Financing Arrangement

 

On November 3, 2025, we entered into an amended and restated inventory finance agreement with J.J. Astor & Co. (the “Inventory Purchaser”), pursuant to which the Inventory Purchaser may, from time to time, finance up to $9.0 million (increased to $10.0 million pursuant to the April 1, 2026, amendment) of our finished goods inventory purchases from our contract manufacturers. Under this arrangement, we are required to pay a deposit equal to 20% of the purchase price of the applicable inventory, and the Inventory Purchaser funds the remaining balance directly to the supplier and takes title to the inventory.

 

We have determined that this arrangement results in the recognition of the financed inventory and a corresponding financing obligation on our consolidated balance sheets, as the risks and rewards of ownership are substantially retained by us during the financing period. Accordingly, financed inventory is included within inventories, net of reserves, and the related payment obligations are presented as related party accounts payable on our consolidated balance sheets.

 

For each inventory purchase financed under the agreement, we are obligated to pay the Inventory Purchaser an amount equal to the funded purchase amount plus a contractual premium within 90 days of the funding date. The agreement also requires us to pay monthly monitoring fees and provides for additional fees based on unused financing availability. In the event we fail to satisfy our payment obligations when due, the Inventory Purchaser may accelerate amounts owed, impose default interest and penalties, and sell the inventory collateral. We would remain liable for any deficiency resulting from such sale.

 

The agreement further provides the Inventory Purchaser with the right, at its election, to convert certain outstanding payment obligations into shares of our Class A common stock, subject to ownership limitations and other contractual restrictions.

 

As of  September 30, 2026 and  December 31, 2025, the aggregate outstanding obligation under this arrangement was $1.9 million and $3.7 million, respectively, recorded as related party accounts payable on our consolidated balance sheets. This arrangement represents a form of short-term inventory financing and exposes us to material liquidity, cash flow, and operational risks.

 

NOTE 15 – CUSTOMER AND SUPPLIER CONCENTRATION

 

There was one customer that accounted for greater than 10% of the Company’s consolidated revenues for the three and nine months ended September 30, 2026, and no customer for the three and nine months ended September 30, 2025.

 

 

​

 

Total revenues

 

 

 

 

​

 

Total revenues

 

 

 

 

​

 

​

 

from the customer

 

 

Accounts receivable

 

 

from the customer

 

 

Accounts receivable

 

 

​

 

as a percentage

 

 

from the customer

 

 

as a percentage

 

 

from the customer

 

 

​

 

of total revenues

 

 

as of

 

 

of total revenues

 

 

as of

 

 

​

 

three months ended

 

 

September 30,

 

 

three months ended

 

 

September 30,

 

 

​

 

September 30,

 

 

2026

 

 

September 30,

 

 

2025

 

Customer

 

 

2026

 

 

(in thousands)

 

 

2025

 

 

(in thousands)

 

1

 

 

 

20.5

%

 

$

3,396

 

 

 

—

%

 

$

—

 

 

 

​

 

Total revenues

 

 

 

 

​

 

Total revenues

 

 

 

 

​

 

​

 

from the customer

 

 

Accounts receivable

 

 

from the customer

 

 

Accounts receivable

 

 

​

 

as a percentage

 

 

from the customer

 

 

as a percentage

 

 

from the customer

 

 

​

 

of total revenues

 

 

as of

 

 

of total revenues

 

 

as of

 

 

​

 

nine months ended

 

 

September 30,

 

 

nine months ended

 

 

September 30,

 

 

​

 

September 30,

 

 

2026

 

 

September 30,

 

 

2025

 

Customer

 

 

2026

 

 

(in thousands)

 

 

2025

 

 

(in thousands)

 

1

 

 

 

13.1

%

 

$

3,396

 

 

 

—

%

 

$

—

 

 

38


Table of Contents

 

For the three ended September 30, 2026 and 2025, the Company’s purchases were concentrated primarily with two vendors, and one vendor for the nine months ended September 30, 2026 and 2025. Details are as follows:

 

 

​

 

Total purchases

 

 

 

 

​

 

Total purchases

 

 

 

 

​

 

​

 

from the vendor

 

 

 

 

​

 

from the vendor

 

 

 

 

​

 

​

 

as a percentage

 

 

Accounts payable

 

 

as a percentage

 

 

Accounts payable

 

 

​

 

of total cost of

 

 

to the vendor

 

 

of total cost of

 

 

to the vendor

 

 

​

 

revenues for the

 

 

as of

 

 

revenues for the

 

 

as of

 

 

​

 

three months ended

 

 

September 30,

 

 

three months ended

 

 

September 30,

 

 

​

 

September 30,

 

 

2026

 

 

September 30,

 

 

2025

 

Vendor

 

 

2026

 

 

(in thousands)

 

 

2025

 

 

(in thousands)

 

1

 

 

 

18.3

%

 

$

1,363

 

 

 

—

%

 

$

—

 

2

 

 

 

16.2

%

 

 

1,089

 

 

 

25.0

%

 

 

2,863

 

3

 

 

 

—

%

 

 

—

 

 

 

14.6

%

 

 

3,033

 

 

 

​

 

Total purchases

 

 

 

 

​

 

Total purchases

 

 

 

 

​

 

​

 

from the vendor

 

 

 

 

​

 

from the vendor

 

 

 

 

​

 

​

 

as a percentage

 

 

Accounts payable

 

 

as a percentage

 

 

Accounts payable

 

 

​

 

of total cost of

 

 

to the vendor

 

 

of total cost of

 

 

to the vendor

 

 

​

 

revenues for the

 

 

as of

 

 

revenues for the

 

 

as of

 

 

​

 

nine months ended

 

 

September 30,

 

 

nine months ended

 

 

September 30,

 

 

​

 

September 30,

 

 

2026

 

 

September 30,

 

 

2025

 

Vendor

 

 

2026

 

 

(in thousands)

 

 

2025

 

 

(in thousands)

 

1

 

 

 

27.0

%

 

$

1,089

 

 

 

17.6

%

 

$

2,863

 

 

The Company believes that alternative suppliers are available if the referenced vendors become unavailable or no longer competitive.

 

NOTE 16 – SEGMENTS

 

Information about our Company’s operations by operating segment is shown in the following tables (in thousands):

 

 

 

For the three months ended

 

 

 

September 30, 2026

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

Eliminations

 

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

and

 

 

 

 

​

 

 

Americas

 

 

EMEA

 

 

Rest of World

 

 

Adjustments (1)

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenues, net

 

$

15,733

 

 

$

15,130

 

 

$

279

 

 

$

(1,079

)

 

$

30,063

 

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Cost of sales

 

 

9,534

 

 

 

10,163

 

 

 

141

 

 

 

(929

)

 

 

18,909

 

Segment gross profit

 

 

6,199

 

 

 

4,967

 

 

 

138

 

 

 

(150

)

 

 

11,154

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

General and administrative expenses

 

 

3,761

 

 

 

3,973

 

 

 

172

 

 

 

—

 

 

 

7,906

 

Depreciation and amortization

 

 

574

 

 

 

1,965

 

 

 

—

 

 

 

—

 

 

 

2,539

 

Research and development expenses

 

 

883

 

 

 

209

 

 

 

—

 

 

 

(148

)

 

 

944

 

Interest expense

 

 

1,100

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,100

 

Income tax benefit

 

 

(202

)

 

 

(53

)

 

 

—

 

 

 

—

 

 

 

(255

)

Other segment items (3)

 

 

(167

)

 

 

4

 

 

 

(5

)

 

 

106

 

 

 

(62

)

Net income (loss)

 

$

250

 

 

$

(1,131

)

 

$

(29

)

 

$

(108

)

 

$

(1,018

)

 

39


Table of Contents

 

 

 

For the nine months ended

 

 

 

September 30, 2026

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

Eliminations

 

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

and

 

 

 

 

​

 

 

Americas

 

 

EMEA

 

 

Rest of World

 

 

Adjustments (1)

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenues, net

 

$

36,545

 

 

$

43,273

 

 

$

884

 

 

$

(2,279

)

 

$

78,423

 

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Cost of sales

 

 

20,612

 

 

 

28,221

 

 

 

433

 

 

 

(1,850

)

 

 

47,416

 

Segment gross profit

 

 

15,933

 

 

 

15,052

 

 

 

451

 

 

 

(429

)

 

 

31,007

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

General and administrative expenses

 

 

11,495

 

 

 

12,737

 

 

 

383

 

 

 

—

 

 

 

24,615

 

Depreciation and amortization

 

 

1,849

 

 

 

5,823

 

 

 

—

 

 

 

—

 

 

 

7,672

 

Research and development expenses

 

 

2,649

 

 

 

626

 

 

 

—

 

 

 

(453

)

 

 

2,822

 

Interest expense

 

 

3,434

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

3,434

 

Income tax (benefit) expense

 

 

(1,267

)

 

 

364

 

 

 

—

 

 

 

—

 

 

 

(903

)

Other segment items (3)

 

 

(181

)

 

 

597

 

 

 

(15

)

 

 

—

 

 

 

401

 

Net (loss) income

 

$

(2,046

)

 

$

(5,095

)

 

$

83

 

 

$

24

 

 

$

(7,034

)

 

(1)

Eliminations and adjustments represent net sales between the Americas, EMEA and Rest of World segments. Sales between these segments are generally valued at market.

(2)

The significant expense categories and amounts align with the segment-level information that is regularly provided to the Chief Operating Decision Maker.

(3)

Other Segment items for each reportable segment includes:

 

Research and development - consists primarily of personnel related costs, prototype and sample costs, design costs, and global product certifications mostly for wireless certifications.

 

Other expense - consists of interest expense associated with our debt financing arrangements, the effects of changes in the fair value of derivative liabilities and warrants.

 

 

 

For the three months ended

 

 

 

September 30, 2025

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

Eliminations

 

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

and

 

 

 

 

​

 

 

Americas

 

 

EMEA

 

 

Rest of World

 

 

Adjustments (1)

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenues, net

 

$

14,437

 

 

$

15,318

 

 

$

234

 

 

$

(652

)

 

$

29,337

 

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Cost of sales

 

 

11,251

 

 

 

9,927

 

 

 

114

 

 

 

(490

)

 

 

20,802

 

Segment gross profit

 

 

3,186

 

 

 

5,391

 

 

 

120

 

 

 

(162

)

 

 

8,535

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

General and administrative expenses

 

 

4,296

 

 

 

4,340

 

 

 

94

 

 

 

—

 

 

 

8,730

 

Depreciation and amortization

 

 

656

 

 

 

1,971

 

 

 

—

 

 

 

—

 

 

 

2,627

 

Research and development expenses

 

 

1,088

 

 

 

206

 

 

 

—

 

 

 

(172

)

 

 

1,122

 

Interest expense

 

 

2,667

 

 

 

86

 

 

 

—

 

 

 

—

 

 

 

2,753

 

Income tax (benefit) expense

 

 

(590

)

 

 

329

 

 

 

—

 

 

 

—

 

 

 

(261

)

Other segment items (3)

 

 

527

 

 

 

383

 

 

 

—

 

 

 

(1,162

)

 

 

(252

)

Net (loss) income

 

$

(5,458

)

 

$

(1,924

)

 

$

26

 

 

$

1,172

 

 

$

(6,184

)

 

40


Table of Contents

 

 

 

For the nine months ended

 

 

 

September 30, 2025

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

Eliminations

 

 

 

 

​

 

 

 

 

​

 

 

 

​

 

 

 

​

 

and

 

 

 

 

​

 

 

Americas

 

 

EMEA

 

 

Rest of World

 

 

Adjustments (1)

 

 

Total

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenues, net

 

$

40,110

 

 

$

43,399

 

 

$

826

 

 

$

(1,723

)

 

$

82,612

 

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Cost of sales

 

 

26,324

 

 

 

29,794

 

 

 

353

 

 

 

(1,227

)

 

 

55,244

 

Segment gross profit

 

 

13,786

 

 

 

13,605

 

 

 

473

 

 

 

(496

)

 

 

27,368

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

less (2)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

General and administrative expenses

 

 

15,624

 

 

 

11,374

 

 

 

291

 

 

 

—

 

 

 

27,289

 

Depreciation and amortization

 

 

1,975

 

 

 

5,706

 

 

 

—

 

 

 

—

 

 

 

7,681

 

Research and development expenses

 

 

3,128

 

 

 

596

 

 

 

—

 

 

 

(562

)

 

 

3,162

 

Interest expense

 

 

7,507

 

 

 

304

 

 

 

—

 

 

 

—

 

 

 

7,811

 

Income tax benefit

 

 

(26

)

 

 

(111

)

 

 

—

 

 

 

—

 

 

 

(137

)

Other segment items (3)

 

 

(518

)

 

 

(2,240

)

 

 

3

 

 

 

(1,537

)

 

 

(4,292

)

Net (loss) income

 

$

(13,904

)

 

$

(2,024

)

 

$

179

 

 

$

1,603

 

 

$

(14,146

)

 

 

(1)

Eliminations and adjustments represent net sales between the Americas, EMEA and Rest of World segments. Sales between these segments are generally valued at market.

 

(2)

The significant expense categories and amounts align with the segment-level information that is regularly provided to the Chief Operating Decision Maker.

 

(3)

Other Segment items for each reportable segment includes:

 

 

Research and development - consists primarily of personnel related costs, prototype and sample costs, design costs, and global product certifications mostly for wireless certifications.

Other expense - consists of interest expense associated with our debt financing arrangements, (gains) or losses on settlements of debt, and the effects of changes in the fair value of derivative liabilities.

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Identifiable Assets

 

 

 

​

 

 

 

​

Americas

 

$

44,952

 

 

$

40,329

 

EMEA

 

 

39,298

 

 

 

55,833

 

Rest of World

 

 

1,292

 

 

 

1,381

 

Total Identifiable Assets

 

$

85,542

 

 

$

97,543

 

 

NOTE 17 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from September 30, 2026, through November 16, 2026, the date the condensed consolidated financial statements were issued.

 

Series E Convertible Preferred Stock Financing

 

In connection with the Series E financing, on October 6, 2026, the holders of Series D Preferred Stock ratified a consent, waiver and ratification (effective as of September 30, 2026), which was further amended on October 9, 2026. The consent was acknowledged by the Company and J.J. Astor. Pursuant to the consent, the holders of Series D Preferred Stock waived certain most-favored-nation and variable-rate transaction provisions contained in the Series D transaction documents that otherwise may have been triggered by the issuance of the Series E Convertible Preferred Stock. It was also agreed and acknowledged that the Series E Convertible Preferred Stock may not be converted, and the resale of the underlying shares may not be registered, until the earlier of the time no Series D Convertible Preferred Stock remains outstanding and the effectiveness of a resale registration statement covering the Series D conversion shares together with receipt of the Series D Required Stockholder Approvals.

 

41


Table of Contents

 

Inventory Finance Agreement 

 

On November 10, 2026, the Company entered into a First Amendment to its Amended and Restated Inventory Finance Agreement with J.J. Astor & Co., a related party. The amendment enforced continuity of the Agreement in full force and effect without interruption from November 3, 2026 to November 10, 2026 and extended the term of the agreement for an additional one-year period through November 3, 2027. The amendment did not modify the maximum financing capacity of $10.0 million, the advance rate, repayment terms, or other material economic provisions of the agreement.

 

Common Stock, Exchange Caps and 2026 Incentive Plan

 

On November 10, 2026, at the Company's Special Meeting of Shareholders, shareholders approved an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of Class A common stock from 55,000,000 shares to 500,000,000 shares. Shareholders also approved the Boxlight Corporation 2026 Equity Incentive Plan (the "2026 Plan"), including the reservation of 6,500,000 shares of Class A common stock for issuance thereunder. The 2026 Plan authorizes the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other equity-based awards to eligible employees, directors and consultants and became effective upon shareholder approval. Shareholders also approved the Series D Required Stockholder Approvals and the Series E Required Stockholder Approvals, as a result of which the 19.99% exchange caps applicable to conversions of the Series D and Series E Convertible Preferred Stock no longer apply. At the Special Meeting, shareholders also approved (i) one or more reverse stock splits at a ratio of up to 1-for-1,000 within three years, (ii) issuances below the exercise price of the Whitehawk warrant, (iii) for purposes of Nasdaq Listing Rules 5635(b), 5635(c) and 5635(d), issuances in excess of 19.99% under the Inventory Finance Agreement.

 

On November 14, 2026, effective on November 16, 2026, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State, to effect the increase of the number of authorized shares of Class A common stock to 500,000,000 shares.

 

Whitehawk Finance LLC

 

On November 10, 2026, the Company, certain of its subsidiaries, the lenders party thereto and Whitehawk Capital Partners LP, as administrative agent, entered into a Forbearance Agreement and Waiver under the Credit Agreement. Pursuant to the agreement, the lenders agreed to waive specified events of default relating to (i) borrowing-base over-advances and related payment defaults for the months ended August 31, 2026 and September 30, 2026, (ii) anticipated borrowing-base over-advances and related payment defaults for the month ending October 31, 2026, and (iii) certain financial covenant violations under the Credit Agreement. The waiver is limited to the specific defaults identified in the agreement and does not constitute a waiver of any other existing or future defaults under the Credit Agreement.

 

Credit Agreement Prepayment

 

In October 2026, the Company applied approximately $425 thousand of the net proceeds of the Series E Convertible Preferred Stock financing to prepay a portion of the loans under the Credit Agreement and paid a prepayment premium of approximately $26 thousand.

 

42


Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following Management’s Discussion and Analysis (“MD&A”) should be read in conjunction with the financial statements and the related notes thereto included elsewhere herein. The MD&A contains forward-looking statements that involve risks and uncertainties, such as statements of the Company’s plans, objectives, expectations, and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this report. The actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors.

 

Historical results may not be indicative of future performance. The Company’s forward-looking statements reflect its current views about future events, are based on assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements. We undertake no obligation to publicly update or revise any forward-looking statements, including any changes that might result from any facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements.

 

Unless the context otherwise requires, the terms “the Company,” “we,” “us,” and “our” in this Quarterly Report refer to Boxlight Corporation and its consolidated direct and indirect subsidiaries, and the term “Boxlight” refers to Boxlight Inc., a Washington corporation and a wholly owned subsidiary of Boxlight Corporation. The terms “quarter” and “year to date” refer to our quarter ending September 30th.

 

FORWARD LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (including the section regarding Management’s Discussion and Analysis and Results of Operations, the “Quarterly Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions, and are based on our management’s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Factors that may cause actual results to differ materially from current expectations include, among other things

 

 

•

our ability to continue to operate as a going concern;

 

 

•

our ability to comply with certain covenants, minimum liquidity, and borrowing base requirements under our existing credit agreement, or in the alternative, to continue to obtain forbearances or waivers from the lender thereunder with respect to defaults thereunder, including existing defaults;

 

 

•

our history of operating losses;

 

 

•

our ability to raise additional capital;

 

 

•

our ability to maintain compliance with the Nasdaq Capital Market continued listing requirements and maintain a listing of our Class A common stock on the Nasdaq Capital Market;

 

 

•

our substantial indebtedness, which matures April 1, 2027;

 

 

•

changes in the sales of our display products;

 

43


Table of Contents

 

 

•

market adoption of our new Symphony product line;

 

 

•

changes in U.S. administrative policy, including the imposition of or increases in tariffs, changes to existing trade agreements and any resulting changes in international trade relations, such as trade wars;

 

 

•

changes in the spending policies or budget priorities for government funding of schools, colleges, universities, other education providers or government agencies;

 

 

•

seasonal fluctuations in our business;

 

 

•

changes in our working capital requirements and cash flow fluctuations;

 

 

•

competition in our industry;

 

 

•

our ability to enhance our products and to develop, introduce and sell new technologies and products at competitive prices and in a timely manner;

 

 

•

our reliance on resellers and distributors to promote and sell our products;

 

 

•

the success of our strategy to increase sales in the business and government market;

 

 

•

changes in market saturation for our products;

 

 

•

challenges growing our sales in foreign markets;

 

 

•

our dependency on third-party suppliers;

 

 

•

our reliance on highly skilled personnel;

 

 

•

our ability to enter into and maintain strategic alliances with third parties;

 

 

•

unfavorable global economic or political conditions, including the ongoing conflict between Russia and Ukraine, and Israel and Hamas;

 

 

•

war, terrorism, other acts of violence, or potential effects of future epidemics, pandemics, or other health crises;

 

 

•

a breach in security of our electronic data or our information technology systems, including any cybersecurity attack;

 

 

•

our ability to keep pace with developments in technology;

 

 

•

consumer product and environmental laws;

 

 

•

risks inherently related to our foreign operations;

 

 

•

our compliance with the Foreign Corrupt Practices Act;

 

 

•

income taxation for our worldwide operations;

 

 

•

our ability to ship and transport components and final products efficiently and economically across long distances and borders;

 

 

•

compliance with export control laws;

 

 

•

fluctuations in foreign currencies;

 

 

•

unstable market and economic conditions and potential disruptions in the credit markets;

 

44


Table of Contents

 

 

•

defects in our products and detection thereof;

 

 

•

patents or other intellectual property rights necessary to protect our proprietary technology and business;

 

 

•

assertions against us relating to intellectual property rights;

 

 

•

our ability to anticipate consumer preferences and successfully develop attractive products;

 

 

•

our ability to develop, implement and maintain an effective system of internal control over financial reporting;

 

 

•

our possible or assumed future results of operations;

 

 

•

our ability to attract and retain customers;

 

 

•

our ability to sell additional products and services to customers;

 

 

•

our cash needs and financing plans;

 

 

•

our potential growth opportunities;

 

 

•

expected technological advances by us or by third parties and our ability to leverage them;

 

 

•

the effects of future regulation;

 

 

•

our ability to protect or monetize our intellectual property;

 

 

•

and those other risks referenced herein, including those risks referred to in Part II, Item 1A–“Risk Factors” in this Quarterly Report and those risks discussed in our other filings with the Securities and Exchange Commission (“SEC”), including those risks discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, which discussion is incorporated herein by this reference.

 

Given these uncertainties, you should not place undue reliance on these forward-looking statements. You should read this Quarterly Report and the documents that we reference in this Quarterly Report and have filed as exhibits thereto completely and with the understanding that our actual future results may be materially different from what we expect. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

 

Overview

 

We are a technology company that is seeking to become a worldwide leading innovator and integrator of interactive products and software for schools, education, business, and government interactive spaces. We currently design, produce and distribute interactive displays, collaboration software, supporting accessories and professional services. We also distribute science, technology, engineering, and math (or “STEM”) products, including a robotics and coding system, 3D printing solution and portable science lab. The Company’s products are integrated into its software suite that provides tools for presentation creation and delivery, assessment, and collaboration.

 

Our operations are organized, managed, and classified into three reportable segments – Europe, Middle East, and Africa (“EMEA”), North and Central America (“Americas”), and all other geographic regions (“Rest of World”). Our EMEA segment consists of the operations of Sahara Holding Limited and its subsidiaries. Our Americas segment consists primarily of the operations of Boxlight, Inc. and its subsidiaries, and the Rest of World segment consists primarily of the operations of Boxlight Australia, PTY LTD (“Boxlight Australia”).

 

45


Table of Contents

 

Each of our operating segments are primarily engaged in the sale of education technology products and services in the education market but which are also sold into the health, government and corporate sectors and derive a majority of their revenues from the sale of flat-panel displays, audio and other hardware accessory products, software solutions and professional services. Generally, our displays produce higher net operating revenues but lower gross profit margins than our accessory solutions and professional services.

 

To date, we have generated substantially all of the Company’s revenue from the sale of hardware (primarily consisting of interactive displays and audio products) and software to the educational market in the United States and Europe.

 

We have also implemented a comprehensive plan to reach and maintain profitability from our core business operations. Highlights of the plan include:

 

 

•

Integrating products of the acquired companies and cross training sales representatives to increase their offerings and productivity;

 

 

•

Hiring new sales representatives with significant industry experience in their respective territories, and

 

 

•

Expanding our reseller partner network both in key territories and in new markets, thereby increasing our penetration and reach.

 

Components of our Results of Operations and Financial Condition

 

Revenues are comprised of hardware products, software services, and professional development revenues less sales discounts.

 

 

•

Product revenue. Product revenue is derived from the sale of our hardware (interactive displays), peripherals, and accessories, along with other third-party products, directly to our customers, as well as through our network of domestic and international distributors.

 

 

•

Professional service revenue. We receive revenue from providing professional development services through third parties and our network of distributors.

 

Cost of revenues

 

Our cost of revenues is comprised of the following:

 

 

•

costs to purchase components and finished goods directly;

 

 

•

third-party logistics costs;

 

 

•

inbound and outbound freight costs, and customs and duties charges;

 

 

•

costs associated with the repair of products under warranty;

 

 

•

write-downs of inventory carrying value to adjust for excess and obsolete inventory and periodic physical inventory counts; and

 

 

•

cost of professionals to deliver professional development training related to the use of our products.

 

We outsource some of our warehouse operations and order fulfillment and purchase products from related and third parties. Our product costs will vary directly with volume and the costs of underlying product components as well as the prices we are able to negotiate with our contract manufacturers. Shipping costs fluctuate with volume as well as with the method of shipping chosen in order to meet customer demand. As a global company with suppliers centered in Asia and customers located worldwide, we have used, and may in the future use, air shipping to deliver our products directly to our customers. Air shipping is more costly than sea or ground shipping or other delivery options. We primarily use air shipping to meet the demand for our products during peak seasons and new product launches.

 

46


Table of Contents

 

Gross profit and gross profit margin

 

Gross profit and gross profit margin have been, and may in the future be, influenced by several factors including: competitive pricing within the industry, product, channel and geographical revenue mix; changes in product costs related to the release of projector models; and component, contract manufacturing and supplier pricing, freight, duties, and other shipping costs, and foreign currency exchange. As we primarily procure our product components and manufacture our products in Asia, our suppliers incur many costs, including labor costs, in other currencies. To the extent that exchange rates move unfavorably for our suppliers, they may seek to pass these additional costs on to us, which could have a material impact on future average selling prices and unit costs. Gross profit and gross profit margin may fluctuate over time based on the factors described above.

 

Operating expenses

 

We classify our operating expenses into three categories: general and administrative, depreciation and amortization, and research and development.

 

General and administrative. General and administrative expense consists of personnel related costs, which include salaries and stock-based compensation, as well as the costs of professional services, such as accounting and legal, facilities, information technology, depreciation and amortization and other administrative expenses. General and administrative expense may fluctuate as a percentage of revenue, notably in the second and third quarters of our fiscal year when we have historically experienced our highest levels of revenue.

 

Depreciation and amortization. Depreciation and amortization expense consists of depreciation of property and equipment and amortization of capitalized intangible assets over their estimated useful lives.

 

Research and development. Research and development expense consists primarily of personnel related costs, prototype and sample costs, design costs and global product certifications mostly for wireless certifications.

 

Other (expense) income, net

 

Other (expense) income, net primarily consists of interest expense associated with our debt financing arrangements, the effects of changes in the fair value of derivative liabilities and changes in the fair value of warrants.

 

Income tax expense

 

We are subject to income taxes in the jurisdictions in which we do business, including the United States, Canada, United Kingdom, Mexico, Sweden, Finland, Holland, Australia, Denmark and Germany. The United Kingdom, Mexico, Sweden, Finland, Holland, Germany, Australia, Canada, and Denmark have a statutory tax rate different from that of the United States. Additionally, certain jurisdictions of the Company’s international earnings are also taxable in the United States. Accordingly, our effective tax rates will vary depending on the relative proportion of foreign to U.S. income, the absorption of foreign tax credits, changes in the valuation of our deferred tax assets and liabilities and changes in tax laws. We regularly assess the likelihood of adverse outcomes resulting from the examination of our tax returns by the U.S. Internal Revenue Service, or IRS, and other tax authorities to determine the adequacy of our income tax reserves and expense. Should actual events or results differ from our current expectations, charges or credits to our income tax expense may become necessary. Any such adjustments could have a significant impact on our results of operations.

 

Operating Results – Boxlight Corporation 

 

For the three-month periods ended September 30, 2026 and 2025

 

Revenues. Total revenues for the three months ended September 30, 2026 were $30.1 million as compared to $29.3 million for the three months ended September 30, 2025, resulting in a 2.5% increase. The increase in revenues was driven by higher sales volume compared to the prior year quarter, reflecting higher global demand for interactive flat panel displays. 

 

Cost of Revenues. Cost of revenues for the three months ended September 30, 2026 were $18.9 million as compared to $20.8 million for the three months ended September 30, 2025, resulting in a 9.1% decrease. The decrease in cost of revenues was primarily attributable to the normalized tariff rates in 2026 as compared to higher tariff rates in 2025.

 

47


Table of Contents

 

Gross Profit. Gross profit for the three months ended September 30, 2026 was $11.2 million as compared to $8.5 million for the three months ended September 30, 2025, an increase of 30.7%. Gross profit margin was 37.1% for the three months ended September 30, 2026 and 29.1% for the three months ended September 30, 2025. The increase in gross profit margin was primarily driven by the impact of normalized tariffs in the current year along with the increase in sales.

 

General and Administrative Expenses. General and administrative expenses for the three months ended September 30, 2026 were $7.9 million, representing 26.3% of revenue as compared to $8.7 million representing 29.8% of revenue for the three months ended September 30, 2025. The decrease in general and administrative expenses for the period ended September 30, 2026 was due to decreases of $0.3 million in professional fees, $0.2 million in credit loss expenses, $0.2 million in contract and consulting expenses, and a $0.1 million decrease in sales and marketing expenses.

 

Depreciation and Amortization Expenses. Depreciation and amortization expenses for the three months ended September 30, 2026 were $2.5 million, representing 8.4% of revenue as compared to $2.6 million representing 9.0% of revenue for the three months ended September 30, 2025.

 

Research and Development Expenses. Research and development expenses for the three months ended September 30, 2026 and 2025 were $0.9 million and $1.1 million, respectively and represented 3.1% and 3.8% of revenue, respectively. Research and development expense primarily consists of costs associated with the development of proprietary technology. The decrease was attributable to the streamlining of research and development expenses.

 

Other Expense. Other expense, net for the three months ended September 30, 2026 was $1.0 million as compared to $2.5 million for the three months ended September 30, 2025, representing a decrease of $1.5 million. The decrease in other expense was primarily driven by a $1.7 million decrease in interest expense on our term loan, a $0.4 million decrease in losses from change in fair value of derivative liability, and a $0.3 million decrease in losses from change in fair value of common warrants offset by an increase in other expense of $0.9 million.

 

Net Income (Loss). Net loss was approximately $1.0 million for the three months ended September 30, 2026, and $6.2 million for the three months ended September 30, 2025, respectively, and was a result of the changes noted above. 

 

For the nine-month periods ended September 30, 2026 and 2025

 

Revenues. Total revenues for the nine months ended September 30, 2026 were $78.4 million as compared to $82.6 million for the nine months ended September 30, 2025, resulting in a 5.1% decrease. The decrease in revenues was driven by lower sales volume in the audio segment.

 

Cost of Revenues. Cost of revenues for the nine months ended September 30, 2026 were $47.4 million as compared to $55.2 million for the nine months ended September 30, 2025, resulting in a 14.2% decrease. The decrease in cost of revenues was attributable to the decrease in units sold offset by the favorable savings from normalized tariff rates and a $2.8 million tariff refund.

 

Gross Profit. Gross profit for the nine months ended September 30, 2026 was $31.0 million as compared to $27.4 million for the nine months ended September 30, 2025, an increase of 13.3%. Gross profit margin was 39.5% for the nine months ended September 30, 2026 and 33.1% for the nine months ended September 30, 2025. The increase in gross profit margin was primarily driven by the $2.8 million in tariff refunds, which reduced current year cost of revenues. 

 

General and Administrative Expenses. General and administrative expenses for the nine months ended September 30, 2026 were $24.6 million, representing 31.4% of revenue as compared to $27.3 million representing 33.0% of revenue for the nine months ended September 30, 2025. The decrease in general and administrative expenses for the period ended September 30, 2026 was due to decreases of $0.8 million in employee related expenses, $0.7 million in contract and consulting expenses, $0.3 million in professional fee expenses, $0.2 million in sales and marketing expenses, $0.2 million in stock compensation expense, $0.2 million in occupancy expenses, and a $0.2 million decrease in credit loss expense.

 

48


Table of Contents

 

Depreciation and Amortization Expenses. Depreciation and amortization expenses for the nine months ended September 30, 2026 were $7.7 million, representing 9.8% of revenue as compared to $7.7 million representing 9.3% of revenue for the nine months ended September 30, 2025.

 

Research and Development Expenses. Research and development expenses for the nine months ended September 30, 2026 and 2025 were $2.8 million and $3.2 million, respectively and represented 3.6% and 3.8% of revenue, respectively. Research and development expense primarily consists of costs associated with the development of proprietary technology. The decrease was attributable to the streamlining of research and development expenses.

 

Other Expense. Other expense, net for the nine months ended September 30, 2026 was $3.8 million as compared to $3.5 million for the nine months ended September 30, 2025, representing an increase of $0.3 million. The increase in other expense reflected decreases of $4.4 million in interest expense on our term loan, $0.3 million in losses from change in fair value of derivative liability, and $0.6 million in loss on warrant issuance more than offset by a $4.2 million increase in other expense, net, and a $1.4 million decrease in gains from change in fair value of common warrants.

 

Net Loss. Net loss was approximately $7.0 million and $14.1 million for the nine months ended September 30, 2026 and 2025, respectively, and was a result of the changes noted above.

 

Use of Non-GAAP financial measures

 

To provide investors with additional insight and allow for a more comprehensive understanding of the information used by management in its financial and decision-making surrounding operations, we supplement our condensed consolidated financial statements which are prepared in accordance with GAAP with EBITDA and Adjusted EBITDA, both non-GAAP financial measures of earnings.

 

EBITDA represents net loss before income tax expense, interest income, interest expense, depreciation and amortization. Adjusted EBITDA represents EBITDA, plus stock compensation expense, the change in fair value of derivative liabilities, purchase accounting impact of fair valuing inventory and deferred revenue, change in fair value of warrants, loss on warrant issuance and severance charges. Management uses EBITDA and Adjusted EBITDA as financial measures to evaluate the profitability and efficiency of the Company’s business model, and to assess the strength of the underlying operations of our business. These adjustments, and the non-GAAP financial measure that is derived from them, provide supplemental information to analyze our operations between periods and over time. Investors should consider the Company’s non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP.

 

The following table contains reconciliations of net income (loss) to EBITDA and adjusted EBITDA for the periods presented:

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

(in thousands)

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Net loss

 

$

(1,018

)

 

$

(6,184

)

 

$

(7,034

)

 

$

(14,146

)

Depreciation and amortization

 

 

2,539

 

 

 

2,627

 

 

 

7,672

 

 

 

7,681

 

Interest expense

 

 

1,100

 

 

 

2,753

 

 

 

3,434

 

 

 

7,811

 

Income tax (benefit)

 

 

(255

)

 

 

(261

)

 

 

(903

)

 

 

(137

)

EBITDA

 

$

2,366

 

 

$

(1,065

)

 

$

3,169

 

 

$

1,209

 

Stock compensation expense

 

 

69

 

 

 

111

 

 

 

281

 

 

 

459

 

Change in fair value of derivative liabilities

 

 

(161

)

 

 

235

 

 

 

(7

)

 

 

286

 

Change in fair value of common warrants

 

 

—

 

 

 

291

 

 

 

—

 

 

 

(1,394

)

Loss on warrant issuance

 

 

—

 

 

 

—

 

 

 

—

 

 

 

578

 

Purchase accounting impact of fair valuing deferred revenue

 

 

—

 

 

 

16

 

 

 

—

 

 

 

219

 

Severance charges

 

 

114

 

 

 

—

 

 

 

174

 

 

 

57

 

Adjusted EBITDA

 

$

2,388

 

 

$

(412

)

 

$

3,617

 

 

$

1,414

 

 

49


Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Discussion of Effect of Seasonality on Financial Condition

 

Certain accounts in our financial statements are subject to seasonal fluctuations. As our business and revenues grow, we expect these seasonal trends to be reduced. The bulk of our products are shipped to our educational customers prior to the beginning of the school year, usually in July, August or September. To prepare for each school year, we generally build up inventories during the second quarter of the year. As a result, inventories tend to be at their highest levels at that point in time. In the third quarter of the year, inventories tend to decline significantly as products are delivered to customers. Thereafter, during the fourth quarter, we do not generally need to restock inventories at the same inventory levels. Accounts receivable balances tend to be at the highest levels in the third quarter, at which point we record the highest level of sales.

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had cash and cash equivalents of $6.3 million, a working capital balance of approximately $1.1 million, and a current ratio of 1.02. As of September 30, 2025, we had $11.8 million of cash and cash equivalents, a working capital balance of $1.5 million, and a current ratio of 1.02. The change in net working capital was attributable to the reclassification of the term loan from long-term to short-term debt, resulting from its maturity occurring within twelve months of September 30, 2026.

 

For the nine months ended September 30, 2026 and the nine months ended September 30, 2025, as revised, we had net cash used in operating activities of $8.7 million and $3.2 million, as revised, respectively. Cash used in operating activities primarily relates to net loss for the nine months ended September 30, 2026 as well as changes in working capital management. We had net cash used in investing activities of $0.1 million and $0.2 million for the nine months ended September 30, 2026, and the nine months ended September 30, 2025, as revised, respectively. Cash used in investing activities is related to purchases of property and equipment. For the nine months ended September 30, 2026, and nine months ended September 30, 2025, as revised, we had net cash provided by financing activities of approximately $5.9 million and $7.1 million, as revised, respectively. Cash provided by financing activities in the nine months ended September 30, 2026 is primarily related to proceeds from the At-the-Market offering program of $3.7 million, Series D and Series E Convertible Preferred Stock Financing of $4.7 million and $0.9 million, respectively offset by principal payments on short-term debt $2.3 million and net repayments of approximately $1.1 million under the related-party inventory financing.

 

Our liquidity needs have been funded by available cash flows and the proceeds of equity and debt financings, as our operating activities used cash in the nine months ended September 30, 2026. Our cash requirements consist primarily of day-to-day operating expenses, debt service under our Credit Agreement, payments under our related-party inventory financing arrangement, capital expenditures and contractual obligations with respect to facility leases. We lease all of our office facilities. We have limited credit available from our major vendors and are required to prepay a percentage of our inventory purchases, which further constrains our cash liquidity. In addition, our industry is seasonal with many sales to educational customers occurring during the second and third quarters when schools make budget appropriations and classes are not in session limiting disruptions related to product installation. This seasonality makes our needs for cash vary significantly from quarter to quarter.

 

As of September 30, 2026, the Company had approximately $30.0 million of indebtedness outstanding under its Credit Agreement with Whitehawk Capital Partners, LP, as Collateral Agent, and Whitehawk Finance LLC, as Lender.

 

During the fiscal year ended December 31, 2025, the Company entered into the Eighth, Ninth, Tenth, and Eleventh Amendments to the Credit Agreement (collectively, the “2025 Amendments”) to address prior instances of non-compliance with certain financial covenants and to restructure key terms of the facility. In particular, the Company had not maintained compliance with the Senior Leverage Ratio and borrowing base covenants at various measurement dates during 2025. The Lender waived each of these events of default in connection with the respective amendments.

 

50


Table of Contents

 

Most significantly, on December 18, 2025, the Company entered into the Eleventh Amendment. The Eleventh Amendment extended the final maturity date of the loans from December 31, 2025, to April 1, 2027, suspended mandatory quarterly amortization payments through June 30, 2026, and replaced the Senior Leverage Ratio financial covenant with a Minimum Consolidated Adjusted EBITDA covenant commencing with the quarter ending March 31, 2026. The Company is also required to maintain qualified cash of at least $1.5 million. The Company is also required to meet Borrowing Base covenants with allowed over advance for the month ending December 31, 2025, $4,000,000; for the month ending January 31, 2026, $4,500,000; for the month ending February 28, 2026, $5,500,000 and from and after the month ending March 31, 2026 (and each Fiscal Month thereafter), $4,000,000 (the “Permitted Over Advance”). The Eleventh Amendment includes revised mandatory prepayment provisions requiring 50% (or 100% if in default) of net cash proceeds from equity offerings and certain debt to be applied to loan prepayments, with up to $5.0 million allocable for working capital and general corporate purposes.

 

Pursuant to the March 2026 Forbearance Agreement, the Lenders waived the underlying borrowing base defaults for January and February 2026. Pursuant to the May 2026 Forbearance Agreement, the Lenders granted a limited waiver of the borrowing base and Minimum Consolidated Adjusted EBITDA defaults for the periods ended March 31, 2026 and April 30, 2026. Pursuant to the August 2026 Forbearance Agreement, the Lenders granted a limited waiver of the borrowing base and Minimum Consolidated Adjusted EBITDA defaults for the periods ended May 31, 2026, June 30, 2026, and July 31, 2026.  

 

On November 10, 2026, the Company and the other Loan Parties entered into a Forbearance Agreement and Waiver to Credit Agreement with the Lenders and Whitehawk Capital Partners LP, as administrative agent (the “November 2026 Waiver”). Pursuant to the November 2026 Waiver, the Loan Parties acknowledged that (i) for each of the months ended August 31, 2026 and September 30, 2026, and, as anticipated, for the month ending October 31, 2026, they were in an over advance in excess of the Permitted Over Advance, were not in borrowing base compliance and did not make the mandatory prepayment required under Section 2.05(c)(vii) of the Credit Agreement in an amount equal to such excess, (ii) they were not in compliance with the financial covenant set forth in Section 7.03(a) of the Credit Agreement for the eight, nine and ten fiscal months ended August 31, 2026, September 30, 2026 and October 31, 2026, respectively, and (iii) they had not been in compliance with the financial covenant set forth in Section 7.03(b) of the Credit Agreement since the date of the August 2026 Waiver (collectively, the “Specified Events of Default”). The Lenders granted a limited waiver of the Specified Events of Default. The waiver does not apply to any other existing or future default or event of default and is conditioned upon the Loan Parties’ continued compliance with the provisions of the November 2026 Waiver. Any failure to comply with the November 2026 Waiver would constitute an immediate event of default and render the waiver null and void. Notwithstanding the waiver, the Post-Default Rate under Section 3.03 of the Credit Agreement remains applicable until the Loan Parties achieve compliance with the borrowing base and other requirements of the Credit Agreement. In addition, the Loan Parties acknowledged that the Lenders’ right to receive interest at the Post-Default Rate has continued since the effective date of the Eleventh Amendment and for periods prior thereto. As of the date of the November 2026 Waiver, the Lenders had not accelerated the obligations outstanding under the Credit Agreement.

 

In August 2026, the Company closed the first tranche of a private placement of Series D Convertible Preferred Stock (the “Series D PIPE”) for $5.5 million in gross proceeds ($4.7 million, net of fees), entered into an equity purchase agreement for the sale of up to $15 million of Class A common stock over 36 months (the “Equity Line”), and used a portion of the proceeds to repay approximately $2.25 million of principal and $0.14 million of prepayment penalty under its Whitehawk Credit Agreement.

 

On September 30, 2026, the Company issued 106,250 shares of Series E Convertible Preferred Stock to J.J. Astor & Co., an entity affiliated with the Company’s Executive Chairman, for gross proceeds of $850,000. Amounts outstanding under the Company’s inventory finance agreement with JJA, the term of which was extended to November 3, 2027, approximately $2.3 million as of October 21, 2026, are convertible into Class A common stock at J.J. Astor & Co.’s election. See additional disclosure in Note 17 Subsequent Events. 

 

Although the Company has obtained waivers and amendments with respect to each of the foregoing instances of non-compliance, there can be no guarantee that the Company will not breach provisions of the Credit Agreement in the future. Any such breach could result in declared events of default, acceleration of obligations, and other material adverse consequences to the Company.

 

Capital Raise

 

In September 2025, the Company completed a registered direct offering of 37,037 shares of Class A common stock at $108.00 per share, generating approximately $4.0 million in gross proceeds. Net proceeds were used for working capital and debt reduction pursuant to the Company’s agreement with its senior lender. This offering was conducted through the Company’s effective shelf registration statement on Form S-3.

 

In December 2025 and until exhaustion of the “at the market” equity offering program (“ATM Program”) in January 2026 the Company has shown the ability to raise capital to fund operations. Past success is not indicative of future results, and the Company has evaluated the going concern consideration as such.

 

51


Table of Contents

 

On July 23, 2026, at the Company's reconvened Annual Meeting of Shareholders, shareholders approved an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of Class A common stock from 694,445 shares to 55,000,000 shares. Subsequently, on November 10, 2026, at the Company's Special Meeting of Shareholders, shareholders approved a further amendment to the Company's Articles of Incorporation increasing the authorized shares of Class A common stock from 55,000,000 shares to 500,000,000 shares. These amendments provide the Company with additional flexibility to pursue future financing transactions, equity issuances, equity-based compensation arrangements, strategic acquisitions, and other corporate purposes, subject to applicable law, Nasdaq listing requirements, and Board approval.

 

On August 5, 2026, the Company entered into a securities purchase agreement (the “Series D Securities Purchase Agreement”) with the purchasers identified therein, pursuant to which the Company agreed to sell an aggregate of 937,500 shares of Series D convertible preferred stock, par value $0.0001 per share (the “Series D Preferred Stock”), at a purchase price of $8.00 per share, each share having a stated value of $10.00, reflecting a 20% original issue discount. The Preferred Stock was to be issued in two tranches: Tranche One, in the amount of $5,500,000 (687,500 shares), which was funded on August 6, 2026; and Tranche Two, in the amount of $2,000,000 (250,000 shares), payable upon effectiveness of the resale registration statement, subject to a 60-calendar-day outside date and to the Company obtaining the Series D Required Stockholder Approvals (which were obtained on November 10, 2026) and remaining current in its SEC reporting obligations.

 

Concurrently, the Company entered into an equity purchase agreement (the “Equity Purchase Agreement”) establishing an equity line facility under which the Company may sell to Secure Net Capital LLC (the “Investor”) up to $15,000,000 of shares of Class A Common Stock over a 36-month commitment period, at a purchase price equal to 95% of the applicable market price.

 

On September 30, 2026, the Company entered into a securities purchase agreement (the “Series E Securities Purchase Agreement) with J.J. Astor & Co., a related party, pursuant to which it sold 106,250 shares of Series E convertible preferred stock (the “Series E Preferred Stock”) at a purchase price of $8.00 per share, each having a stated value of $10.00, for gross proceeds of $850,000. Pursuant to the Credit Agreement, approximately $425 thousand of the net proceeds received from the Series E sale was applied in October 2026 to prepay the Whitehawk Credit Agreement loan, together with a prepayment premium of approximately $26 thousand.

 

Tariff Environment

 

On February 20, 2026, the Supreme Court of the United States ruled that the International Emergency Economic Powers Act (“IEEPA”) does not authorize the imposition of tariffs, effectively invalidating IEEPA-based tariffs that had been in effect since February 2025. The administration subsequently enacted new tariffs under alternative statutory authority. Accordingly, although the specific tariffs previously imposed under IEEPA have been invalidated, the overall tariff environment remains subject to ongoing change. Following the Supreme Court’s February 20, 2026 ruling and the subsequent March 4, 2026 order from the Court of International Trade directing U.S. Customs and Border Protection (CBP) to refund IEEPA amounts collected (with interest), the Company applied for and received approval from CBP for a $2.9 million refund related to IEEPA tariffs and interests during the quarter ended June 30, 2026. This approved refund was recorded as a reduction to Cost of Sales. As of September 30, 2026, the Company received the full amount of this refund.

 

The Company’s diversified supply chain and global revenue base have historically provided a degree of insulation from direct tariff impacts. The elimination of these tariffs is expected to reduce input cost pressures and improve the purchasing environment for the Company’s education and government customers. We will continue to monitor developments and update our disclosures as circumstances evolve.

 

Going Concern Assessment

 

The Company has evaluated conditions and events, in the aggregate, that may raise doubt about its ability to continue as a going concern within one year after the date these financial statements are issued, in accordance with ASC 205-40.

 

The Company acknowledges that it has a history of operating losses, has incurred recurring negative cash flows from operations, and has required multiple amendments, waivers and forbearance agreements under its Credit Agreement due to non-compliance with financial covenants in prior periods. The Company acknowledges it is a reasonable concern that compliance will be maintained at all future measurement dates or obtain further waivers.

 

52


Table of Contents

 

Management believes that the following factors may help alleviate cash restrictions over the next year, although they are not sufficient to alleviate substantial doubt about the Company’s ability to continue as a going concern:

 

 

•

The extension of the Credit Agreement maturity to April 1, 2027, pursuant to the Eleventh Amendment, provides the Company with an extended runway within which to execute its operational and any recapitalization, if necessary, plans;

 

 

•

The replacement of the Senior Leverage Ratio covenant with the Minimum Consolidated Adjusted EBITDA covenant establishes a financial compliance framework that management believes is more favorable;

 

 

•

The suspension of mandatory quarterly amortization payments through September 30, 2026, pursuant to the August 2026 Forbearance Agreement, provided near-term cash flow relief, with the first amortization payment due December 31, 2026;

 

 

•

The Series D Convertible Preferred Stock financing in August 2026 (net proceeds of approximately $4.7 million) and the Series E Convertible Preferred Stock financing in September 2026 (gross proceeds of $850,000) demonstrated continued access to capital, although the Series E was purchased by a related party and a portion of the proceeds of each was required to be applied to prepay the Credit Agreement loans;

 

 

•

The invalidation of IEEPA tariffs by the Supreme Court in February 2026 reduced supply chain cost pressures seen during 2025 and resulted in a refund of approximately $2.9 million received by the Company in 2026; and

 

 

•

Management’s continued focus on operational efficiency, expense reduction, and revenue diversification into the corporate and government markets as well as an expansion with a new product offering coming to market in 2026.

 

Notwithstanding the foregoing, there is substantial doubt as to the Company’s ability to continue as a going concern as the Company is dependent upon its ability to maintain compliance with the financial covenants under the Credit Agreement as amended, achieve positive cash flow from operations, and, if necessary, access additional financing. There can be no assurance that the Company will be successful in maintaining compliance with its financial covenants, achieving profitability, or raising additional capital on acceptable terms or at all. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

On August 5, 2026, we entered into an Equity Purchase Agreement establishing an equity line of credit (the “ELOC”) providing for a maximum aggregate commitment of up to $15.0 million over a 36-month commitment period. On June 2, 2026, at the Company’s 2026 Annual Meeting of Stockholders, stockholders approved the future issuance of Class A common stock (and/or convertible securities) equal to 20% or more of outstanding shares in a non-public transaction, in accordance with Nasdaq Listing Rule 5635(d). On November 10, 2026, at a special meeting, stockholders approved the Series D Required Stockholder Approvals and the Series E Required Stockholder Approvals. On June 22, 2026, the Company effected a 1-for-6 reverse stock split of its Class A common stock, which proportionately reduced authorized shares of Class A common stock to 694,445. A related proposal to increase authorized Class A shares to 55,000,000 (on a post-split basis) did not receive the requisite approval at the Annual Meeting and was adjourned; at a reconvened meeting held July 23, 2026, stockholders approved the amendment, increasing authorized Class A shares from 694,445 to 55,000,000. Subject to the mandatory prepayment requirements of the Credit Agreement described below, we intend to use the proceeds for general working capital purposes, pay down outstanding debt to Whitehawk and to support the commercialization of our Symphony product line. On September 22, 2026, we filed a registration statement on Form S-1, which was amended on October 23 and November 10, 2026 (File No. 333-299084), registering the resale of shares issuable under the ELOC and upon conversion of the Series D Convertible Preferred Stock. The registration statement has not yet been declared effective.

 

We may not sell shares under the ELOC until the resale registration statement has been declared effective, our ability to sell shares is also conditioned on, among other things, the continued listing of our Class A common stock on Nasdaq, the absence of an Event of Default or Material Adverse Effect (each as defined in the Equity Purchase Agreement), the accuracy of our representations, and, for regular puts, a closing price of at least $1.00 per share on the put date (unless waived by the Investor). Under the Credit Agreement, 50% (or 100% while an Event of Default exists) of the net cash proceeds of ELOC sales must be applied to prepay the loans, and we must pay the placement agents a cash fee of 2.0% of amounts drawn, which will limit the proceeds available to us for other purposes. In addition, without the consent of J.J. Astor, as holder of a majority of the Series E Preferred Stock, we may not enter into any Variable Rate Transaction other than the existing ELOC. There can be no assurance that the registration statement will be declared effective or that we will be able to access the ELOC on the terms described or at all. If we are unable to obtain sufficient funding, we may need to reduce or cease operations or pursue other strategic options.

 

53


Table of Contents

 

Preferred Stock and Capital Structure Considerations

 

On February 20, 2025, we filed with the Secretary of State of the State of Nevada (i) an Amendment to the Certificate of Designation of our Series B Preferred Stock (the “Series B Amendment”) and (ii) an Amendment to the Certificate of Designation of our Series C Preferred Stock (the “Series C Amendment” and, together with the Series B Amendment, the “Amendments”). Each Amendment was approved by the holders of a majority of the outstanding shares of Series B Preferred Stock or Series C Preferred Stock, as applicable, in accordance with the applicable Certificate of Designation. Pursuant to the Amendments, neither the Series B Preferred Stock nor the Series C Preferred Stock shall be convertible into Class A Common Stock until the earlier of (1) the effectiveness of an amendment to the articles of incorporation of the Company increasing the number of shares of authorized Class A Common Stock to at least 25,000,000 shares (subject to adjustments as set forth therein) and (2) August 19, 2025.

 

On October 1, 2025, the Company converted all outstanding Series C preferred stock into common stock and amended the Series B preferred stock to eliminate redemption and conversion features, reducing potential future cash obligations.

 

At-the-Market Offering (“ATM Program”)

 

During the year ended December 31, 2025, the Company raised approximately $0.66 million of net proceeds through sales of its Class A Common Stock under its “at the market” offering program (“ATM Program”). In January 2026, the Company sold the remaining shares available under the ATM. In total, the Company sold 408,276 shares of Class A Common Stock under the program for aggregate proceeds of approximately $4.6 million, after deducting sales agent commissions of $0.14 million but before offering expenses, thereby fully exhausting the capacity of the program. The proceeds were used for working capital and general operating purposes. See Note 11 – Equity to the consolidated financial statements for additional information regarding the ATM Program.

 

Given the uncertainty surrounding global supply chains, global markets, and general global uncertainty as a result of the fluid U.S. tariff policy, trade wars, and the ongoing and widespread conflicts across multiple regions, the availability of debt and equity capital has been reduced, and the cost of capital has increased. Furthermore, recent adverse developments affecting the financial services industry including events involving limited liquidity, defaults, non-performance, or other adverse developments that affect financial institutions may lead to market-wide liquidity problems. This in turn could result in a reduction in our ability to access funding sources and credit arrangements in amounts adequate to finance our current and future business operations. Increasing our capital through equity issuance at this time could cause significant dilution to our existing stockholders. However, there can be no guarantee we will be able to access capital when needed or be able to manage through the current challenges in the equity and debt finance markets by managing payment terms with our customers and vendors.

 

Cash and cash equivalents, along with anticipated cash flows from operations, may not provide sufficient liquidity for our working capital needs, debt service requirements, or to maintain minimum liquidity requirements under our Credit Agreement, and we may need to raise capital to meet current working capital requirements including maintaining sufficient inventory levels to meet future sales demand.

 

Inventory Financing Agreement

 

On November 3, 2025, we entered into an amended and restated inventory finance agreement with J.J. Astor & Co. (the “Inventory Purchaser”), pursuant to which the Inventory Purchaser may, from time to time, finance up to $9.0 million (increased to $10.0 million pursuant to the April 1, 2026, amendment) of our finished goods inventory purchases from our contract manufacturers. Under this arrangement, we are required to pay a deposit equal to 20% of the purchase price of the applicable inventory, and the Inventory Purchaser funds the remaining balance directly to the supplier and takes title to the inventory.

 

We have determined that this arrangement results in the recognition of the financed inventory and a corresponding financing obligation on our consolidated balance sheets, as the risks and rewards of ownership are substantially retained by us during the financing period. Accordingly, financed inventory is included within inventories, net of reserves, and the related payment obligations are presented as related party accounts payable on our consolidated balance sheets.

 

54


Table of Contents

 

For each inventory purchase financed under the agreement, we are obligated to pay the Inventory Purchaser an amount equal to the funded purchase amount plus a contractual premium within 90 days of the funding date. The agreement also requires us to pay monthly monitoring fees and provides for additional fees based on unused financing availability. In the event we fail to satisfy our payment obligations when due, the Inventory Purchaser may accelerate amounts owed, impose default interest and penalties, and sell the inventory collateral. We would remain liable for any deficiency resulting from such sale.

 

The agreement further provides the Inventory Purchaser with the right, at its election, to convert certain outstanding payment obligations into shares of our Class A common stock, subject to ownership limitations and other contractual restrictions.

 

On April 1, 2026, the Company amended its inventory financing arrangement with J.J. Astor & Co., an entity affiliated with Michael Pope, the Company’s Executive Chairman, pursuant to which $556,200 of outstanding inventory financing obligations was converted into 100,000 shares of Class A common stock at a conversion price of $5.562 per share. The amendment also increased the aggregate Maximum Inventory Purchase Amount available under the agreement from $9.0 million to $10.0 million. Further, the parties agreed that, if the aggregate proceeds from the sale of the Conversion Shares are less than $556,200, the Company shall pay the shortfall in cash within five trading days. Michael Pope, the Company’s Executive Chairman and its former president and chief executive officer, is the chief executive officer of J.J. Astor & Co. J.J. Astor & Co. is beneficially owned, directly or indirectly, by a private investment fund managed by Mr. Pope. On August 17, 2026 and August 19, 2026, an aggregate of $167,966 of outstanding obligations under the agreement was converted into 67,290 shares of Class A common stock at a conversion price of $2.49615 per share. On November 10, 2026, the Company and J.J. Astor executed a First Amendment to the Amended and Restated Inventory Finance Agreement, extending the term of the agreement through November 3, 2027. The amendment does not waive any default under the agreement. See Note 13 and Note 17.

 

As of September 30, 2026, and December 31, 2025, the aggregate outstanding obligation under this arrangement was $1.9 million and $3.7 million, respectively, and is recorded as related party accounts payable on our condensed consolidated balance sheets. This arrangement represents a form of short-term inventory financing and exposes us to material liquidity, cash flow, and operational risks.

 

Additional information regarding this inventory financing arrangement is included in Note 14 - Commitments and Contingencies to our consolidated financial statements.

 

Financing

 

See Note 8 – Debt for a discussion of our existing debt financing arrangements.

 

Off Balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, results of operations or liquidity and capital resources.

 

Critical Accounting Policies and Estimates

 

Our condensed consolidated financial statements are prepared in accordance with GAAP. In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends, and other factors that management believes to be relevant at the time our condensed consolidated financial statements are prepared. On a regular basis, we review the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

 

Our significant accounting policies are discussed in the notes to the unaudited condensed consolidated financial statements and in Note 1 in the Company’s 2025 Annual Report, which was filed with the SEC on April 15, 2026. We believe that the following accounting estimates are the most critical to aid in fully understanding and evaluating our reported financial results, and they require our most difficult, subjective, or complex judgments, resulting from the need to make estimates about the effect of matters that are inherently uncertain:

 

 

1.

Revenue Recognition

 

55


Table of Contents

 

 

2.

Inventory Reserve

 

 

3.

Intangible Assets

 

 

4.

Share-based Compensation

 

 

5.

Warrants, Derivative Liabilities, including the Series D Convertible Preferred Stock Embedded Conversion Feature

 

 

6.

Convertible Preferred Stock

 

 

 

 

7.

Equity purchase agreement valuation

 

 

 

 

8.

Income Taxes

 

Recent Accounting Pronouncements

 

For information on accounting pronouncements that have impacted or are expected to materially impact our consolidated financial condition, results of operations or cash flows, see Note 1 to our unaudited condensed consolidated financial statements.

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk

 

As a “smaller reporting company,” this item is not required.

 

Item 4. Controls and Procedures

 

 

(a)

Evaluation of disclosure controls and procedures.

 

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report (the “Evaluation Date”) pursuant to Rule 13a-15(b) under the Exchange Act. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of the Evaluation Date due to the material weaknesses in internal control over financial reporting previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on April 15, 2026, which related to deficiencies in the Company's control environment, review and monitoring controls over financial reporting, segregation of duties, and the retention of supporting documentation for certain revenue transactions. Additionally, as discussed in Note 1 to the unaudited condensed consolidated financial statements, management identified errors in the allocation of revenue between product and service revenue, in the roll-forward supporting the disclosure of revenue recognized from deferred revenue, and in the cash flow classification of the related-party inventory financing arrangement, which resulted in the revision of certain previously reported amounts. The circumstances giving rise to these revisions further demonstrated that the Company’s disclosure controls and procedures were not operating effectively to prevent or detect material misstatements on a timely basis.

 

Notwithstanding the existence of these material weaknesses, we believe that the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present in accordance with GAAP, in all material respects, our financial condition, results of operations and cash flows for the periods presented in this report.

 

56


Table of Contents

 

Remediation Plans for Material Weaknesses in Internal Control Over Financial Reporting

 

The Company, under oversight by the Audit Committee of the Company’s Board of Directors, is in the process of remediating the above noted material weaknesses. The Company’s remediation plans include, among other things, the following:

 

 

•

The Company has added and will continue to add finance and accounting personnel as required to the organization to strengthen our finance and accounting teams. The additional personnel are expected to provide oversight, structure, reporting lines, and additional review over the Company’s disclosures.

 

 

•

The Company will continue to develop new written accounting policies and procedures over accounting transaction processing and period end financial close and reporting.

 

 

•

The Company has increased and will continue to increase training for all relevant personnel designed to uphold our internal controls standards.

 

The identified material weaknesses will not be considered remediated until the remediation plans have been fully implemented, the applicable controls operate for a sufficient period of time, and the Company has concluded that newly implemented controls are operating effectively.

 

Limitations on Effectiveness of Controls.

 

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all controls systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving its objectives.

 

 

a.

Changes in internal controls over financial reporting.

 

Other than the remediation activities described above, there were no changes made in the internal controls over financial reporting for the quarter ended September 30, 2026 that have materially affected our internal control over financial reporting.

 

57


Table of Contents

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

While we are not currently involved in any material legal proceedings, from time-to-time we are, and we anticipate that we will be, involved in legal proceedings, claims, and litigation arising in the ordinary course of our business and otherwise. The ultimate costs to resolve any such matters could have a material adverse effect on our financial statements. The Company’s management believes, based on current information, matters currently pending or threatened are not expected to have a material adverse effect on the Company’s consolidated financial position or results of operations.

 

ITEM 1A. RISK FACTORS

 

For information regarding other risk factors pertinent to the Company’s business please refer to Part I Item 1A of the Company’s 2025 Annual Report on Form 10-K, which was filed with the SEC on April 15, 2026 and is incorporated by reference herein, as further updated and supplemented by the risk factors set forth below.

 

We may not be able to maintain a listing of our Class A common stock on Nasdaq Capital Market, or Nasdaq

 

We are subject to Nasdaq continued listing requirements, including the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). On July 1, 2026, the Company received a determination letter from the Listing Qualifications Staff of The Nasdaq that it is not in compliance with the $2.5 million stockholders’ equity requirement for continued listing on Nasdaq under the Nasdaq Listing Rule. The Company requested a hearing before the Nasdaq Hearings Panel (the “Panel”), which was held on August 13, 2026. On September 2, 2026, the Panel notified the Company that it has regained compliance with the Nasdaq Listing Rule, which requires listed companies to maintain a minimum of $2.5 million in stockholders’ equity (the “Equity Rule”), and granted the Company’s request for continued listing on Nasdaq. As of September 30, 2026, the Company had stockholders’ equity of approximately $1.9 million, which is below the $2.5 million minimum required. Accordingly, based on the Company’s reported stockholders’ equity as of September 30, 2026, the Company does not satisfy the Equity Rule. If Nasdaq Staff determines during the Monitoring Period that the Company is again not in compliance with the Equity Rule or another applicable continued-listing requirement, the Company will not be eligible to submit a compliance plan to Nasdaq Staff, Nasdaq Staff will not be permitted to provide additional time to regain compliance, and the Company will not be afforded an otherwise applicable cure or compliance period. Instead, Nasdaq Staff would issue a Staff Delisting Determination. As of the filing date of this Quarterly Report, the Company has not received written notice from Nasdaq regarding the Company’s compliance with the Equity Rule based on its September 30, 2026 stockholders’ equity. If the Company receives a Staff Delisting Determination, the Company intends to timely request a hearing before the Nasdaq Hearings Panel. A timely request is expected to stay any suspension or delisting action pending completion of the hearings process and the expiration of any additional extension period granted by the Panel, if any. There can be no assurance that the Panel would grant continued listing, that the Company would regain compliance, or that the Company’s Class A common stock would continue to be listed on Nasdaq.

 

A delisting of our Class A common stock from Nasdaq may materially impair our stockholders’ ability to buy and sell our Class A common stock and could have an adverse effect on the market price of, and the efficiency of the trading market for, our Class A common stock. In the event our stock is delisted from Nasdaq, whether by choice or otherwise, the delisting of our Class A common stock could significantly impair our ability to raise capital and stockholder value.

 

58


Table of Contents

 

A new Nasdaq listing requirement based on market value could result in the immediate suspension and delisting of our common stock.

 

On July 22, 2026, the SEC approved a new Nasdaq listing rule that requires companies listed on the Nasdaq Capital Market to maintain a Market Value of Listed Securities ("MVLS") of at least $5 million. Under the new rule, if a company's MVLS remains below $5 million for 30 consecutive business days, Nasdaq may suspend trading in, and commence delisting proceedings with respect to, the company's securities. Based on approximately 844,556 shares of Class A common stock outstanding as of September 30, 2026 and a market price of approximately $4.75 per share, the Company's MVLS was approximately $4.0 million, which was below the required $5.0 million threshold.

 

On July 30, 2026, the SEC stayed implementation of the rule pending further action by the Commission. As of the date of this Quarterly Report, the stay remains in effect and the 30-consecutive-business-day measurement period has been suspended. There can be no assurance that the stay will remain in effect or that the rule will not become effective in the future. If the rule becomes effective and we are unable to maintain the required MVLS threshold, our Class A common stock could become subject to suspension and delisting proceedings.

 

Any delisting of our Class A common stock from Nasdaq could materially and adversely affect the liquidity and market price of our Class A common stock, limit the availability of market quotations for our securities and impair our ability to raise additional capital or pursue strategic transactions.

 

We have not complied with certain covenants, minimum liquidity and borrowing base requirements under the Credit Agreement and this could cause us to be unable to continue to operate as a going concern.  

 

As of September 30, 2026 we owed approximately $30.0 million to the lender under our Credit Agreement. During 2025 and 2026, we did not comply with certain financial covenants, minimum liquidity requirements, and borrowing base requirements under the Credit Agreement. Although we have obtained waivers and amendments from the lender with respect to these instances of noncompliance, there can be no assurance that we will be able to maintain compliance with the Credit Agreement in the future or that additional waivers or amendments will be available on acceptable terms or at all.

 

On December 18, 2025, the Company entered into the Eleventh Amendment to the Credit Agreement, which eliminated the Senior Leverage Ratio covenant and replaced it with a Minimum Consolidated Adjusted EBITDA covenant, commencing with the period ending March 31, 2026. We have not complied with the borrowing base or Minimum Consolidated Adjusted EBITDA covenants for any measurement period since the covenant took effect. Pursuant to the May 2026 Forbearance Agreement, the Lenders granted a limited waiver of the borrowing base and Minimum Consolidated Adjusted EBITDA defaults for the periods ended March 31, 2026 and April 30, 2026. Pursuant to the August 2026 Forbearance Agreement, the Lenders granted a limited waiver of such defaults for the periods ended May 31, 2026, June 30, 2026 and July 31, 2026, and the mandatory quarterly amortization payments on the initial term loan remain suspended through September 30, 2026, with the first payment due on December 31, 2026. In addition, the August 2026 Forbearance Agreement amended the Credit Agreement’s mandatory prepayment provisions to require that 50% (or 100% if an Event of Default exists) of net cash proceeds from subordinated indebtedness in addition to equity issuances be applied to prepay the Credit Agreement loan, with any retained proceeds restricted from being used to make payments on equity interests, redeemable preferred stock, or subordinated indebtedness. On November 10, 2026, pursuant to the November 2026 Waiver, the Lenders waived our over advances in excess of the Permitted Over Advance and our failure to make the related mandatory prepayments for the months ended August 31, 2026, September 30, 2026 and October 31, 2026, as well as our non-compliance with the financial covenants in Sections 7.03(a) and 7.03(b) of the Credit Agreement. The waiver is limited to the specified defaults and is conditioned on our compliance with its terms; if we fail to comply, the failure will constitute an immediate event of default, and the waiver will become null and void. Interest at the Post-Default Rate continues to accrue on our outstanding loans until we regain compliance with the borrowing base and other requirements of the Credit Agreement, and we have confirmed that the Lenders’ right to the Post-Default Rate has continued since December 18, 2025. The loans mature on April 1, 2027.

 

In August 2026, the Company completed an equity raise, the proceeds of which were required to be applied to repay a portion of the outstanding Whitehawk Credit Agreement loan, resulting in a principal repayment of approximately $2.25 million and a prepayment penalty of $0.14 million.

 

59


Table of Contents

 

On September 30, 2026, the Company entered into a Securities Purchase Agreement pursuant to which it sold 106,250 shares of Series E Convertible Preferred Stock at a purchase price of $8.00 per share, each having a stated value of $10.00, for gross proceeds of $850,000. Pursuant to the Credit Agreement, approximately $425 thousand of the net proceeds received from the Series E sale was applied in October 2026 to prepay the Whitehawk Credit Agreement loan.

 

These conditions, together with our historical operating losses and liquidity constraints, raise substantial doubt about our ability to continue as a going concern for a period of one year following the issuance of these financial statements.

 

Our ability to continue as a going concern is dependent upon our ability to generate sufficient cash flows from operations, obtain additional waivers or other relief under the Credit Agreement for any future covenant or borrowing base noncompliance, or refinance our indebtedness with the existing lender or a new lender. If the lender were to refuse to grant future waivers or declare an event of default, the lender could accelerate the maturity of our obligations under the Credit Agreement.

 

In the event of an acceleration, we would be required to refinance our indebtedness or obtain additional capital, which we may not be able to do on acceptable terms, on a timely basis, or at all. Our ability to refinance existing debt or raise additional capital is dependent on market conditions and other factors beyond our control.

 

If we were required to pursue refinancing or capital raising in response to an imminent or declared default, we could be forced to do so on an expedited basis, which could further limit available options and adversely affect the terms of any such transaction. If we are unable to successfully execute one or more of the foregoing plans, our business, financial condition, and results of operations could be materially adversely affected, and we may be required to significantly curtail or cease operations.

 

In view of these matters, continuation as a going concern is dependent upon our ability to continue to achieve positive cash flow from operations, obtain waivers or other relief under the Credit Agreement for any future non-compliance with the Minimum Consolidated Adjusted EBITDA, borrowing base requirements, or any other covenants or requirements under the Credit Agreement, or refinance our Credit Agreement with a different lender. Furthermore, in the event the Lender refuses to grant waivers to avoid a future default, the Lender might accelerate our obligations under the Credit Agreement. In order to satisfy such obligations, we would similarly have to refinance our obligations or seek additional capital, which we might not be able to do on acceptable terms or on a timely basis, or at all. Our ability to refinance our existing debt is based upon credit markets and economic forces that are outside of our control. There can be no assurance that we will be successful in refinancing our debt or raising additional capital, whether on acceptable terms, or on a timely basis, or at all. Furthermore, if we were attempting to refinance our obligations or raise capital in response to an imminent or declared acceleration and default, we might have to do so on an expedited basis, which might further jeopardize our ability to successfully refinance or obtain capital. In the event we fail in any of the efforts described in the preceding sentences, our business may materially suffer or even cease operations.

 

Additionally, as we have previously disclosed, there is substantial doubt about our ability to continue as a going concern.

 

The variable-price conversion features of our Series D and Series E Preferred Stock and our other equity-linked obligations may result in substantial dilution, and the removal of the Nasdaq exchange caps increases this risk.

 

The conversion prices of our Series D and Series E Preferred Stock are based on a discount to recent trading prices, subject to floor prices that can only be reset downward, and amounts owed under our inventory finance agreement with J.J. Astor are convertible at 90% of a trailing volume weighted average price. Conversion in full of the 937,500 issued and issuable shares of Series D Preferred Stock at the current Adjusted Floor Price of $0.6160 would result in the issuance of approximately 15.2 million shares of Class A common stock, compared to 844,556 shares outstanding. Following the stockholder approvals obtained on November 10, 2026, the 19.99% exchange caps no longer limit these issuances. The stated value of the Series D and Series E Preferred Stock automatically increases by 20% upon an Event of Default and may increase further through the 20% per annum default dividend. We have not met the registration and special meeting deadlines under the Series D transaction documents and have not obtained written waivers. Sales of conversion shares, ELOC shares, Commitment Shares and shares issued to J.J. Astor, or the expectation of such sales, could depress the market price of our Class A common stock, lower conversion prices, trigger further floor price resets and result in additional dilution.

 

60


Table of Contents

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASE OF EQUITY SECURITIES

 

Except as set forth below, or as previously reported in our Current Reports on Form 8-K, during the three months ended September 30, 2026, we did not sell any equity securities that were not registered under the Securities Act of 1933, as amended (the “Securities Act”).


Series D Convertible Preferred Stock

 

On August 5, 2026, we entered into a securities purchase agreement (the “Series D Securities Purchase Agreement”) with certain accredited investors (the “Series D Purchasers”), pursuant to which we agreed to issue and sell an aggregate of 937,500 shares of our newly designated Series D Convertible Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”), at a purchase price of $8.00 per share (each share having a stated value of $10.00, reflecting a 20% original issue discount), for aggregate gross proceeds of $7,500,000. The offering was structured in two tranches: (i) Tranche One, consisting of 687,500 shares for aggregate gross proceeds of $5,500,000, which was funded at the initial closing on August 6, 2026 and resulted in net proceeds of approximately $4.7 million, and (ii) Tranche Two, consisting of 250,000 shares for aggregate gross proceeds of $2,000,000, which is payable upon, and subject to, the effectiveness of the resale registration statement covering the shares of Class A common stock issuable upon conversion of the Series D Preferred Stock and the other conditions set forth in the Series D Securities Purchase Agreement, and which had not been funded as of September 30, 2026. As of the date of this report, Tranche Two has not been funded. Each share of Series D Preferred Stock is convertible into a number of shares of Class A common stock determined by dividing the stated value by the conversion price then in effect, which equals the greater of (x) the Adjusted Floor Price (as defined in the Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (the “Series D Certificate of Designation”)) and (y) 80% of the lowest closing price of our Class A common stock during the five consecutive trading days ending immediately prior to the applicable conversion date. The initial floor price is $0.6160 per share and is subject to reset on each six-month anniversary of the initial issuance date and, in certain circumstances, upon issuances of Class A common stock or Class A common stock equivalents below the then-effective floor price. Conversions are subject to a 4.99% beneficial ownership limitation, which may not be waived, and were subject to a 19.99% exchange cap under Nasdaq Listing Rule 5635(d) until the Series D Required Stockholder Approvals (as defined in the Series D Securities Purchase Agreement) were obtained at our special meeting of stockholders held on November 10, 2026. On September 30, 2026, we entered into the First Amendment to the Series D Securities Purchase Agreement and filed a Certificate of Amendment to the Series D Certificate of Designation with the Secretary of State of the State of Nevada, which limits the $10.00 per-share liquidation preference to a voluntary or involuntary liquidation, dissolution or winding up and adds a protective provision requiring the consent of the holders of Series D Preferred Stock before we consummate, or enter into an agreement to consummate, specified fundamental transactions. RBW Capital Partners LLC and Dawson James Securities, Inc. acted as co-placement agents for the offering on a “best efforts” basis and are entitled to a cash fee equal to 7.0% of the aggregate gross proceeds received in the Series D Preferred Stock financing (or $385,000 with respect to Tranche One), reimbursement of accountable expenses of up to $100,000, and a cash fee equal to 2.0% of the gross proceeds received under the Equity Purchase Agreement described below as amounts are drawn down. The Series D Preferred Stock was offered and sold in a private placement in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. The Series D Purchasers represented that they were accredited investors as defined in Rule 501(a) of Regulation D, and the offering was conducted without general solicitation or advertising. During the three months ended September 30, 2026, holders converted an aggregate of 25,752 shares of Series D Preferred Stock (aggregate stated value of $257,520) into an aggregate of 109,861 shares of Class A common stock, and 661,748 shares of Series D Preferred Stock remained outstanding as of September 30, 2026. The offer of the shares of Class A common stock issuable upon conversion was made at the time of the original private placement of the Series D Preferred Stock in reliance upon Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D. The issuance of such shares upon conversion was exempt from registration under Section 3(a)(9) of the Securities Act, as the shares were issued exclusively in exchange for outstanding shares of Series D Preferred Stock and no commission or other remuneration was paid or given for soliciting the exchange. 

 

Additional information regarding the Series D Preferred Stock financing was previously reported in our Current Reports on Form 8-K filed with the SEC on August 11, 2026, and October 6, 2026.

 

61


Table of Contents


Equity Purchase Agreement Commitment Shares

 

Concurrently with the Series D Preferred Stock financing, on August 5, 2026, we entered into an Equity Purchase Agreement (the “Equity Purchase Agreement”) with Secure Net Capital LLC (the “Investor”), pursuant to which we have the right, but not the obligation, to sell to the Investor up to $15,000,000, Concurrently with the Series D Preferred Stock financing, on August 5, 2026, we entered into an equity purchase agreement (the “Equity Purchase Agreement”) with Secure Net Capital LLC (the “Investor”), pursuant to which we have the right, but not the obligation, to sell to the Investor up to $15,000,000 in aggregate value of shares of our Class A common stock over a 36-month commitment period. As consideration for the Investor’s commitment, we agreed to pay a commitment fee of $150,000, payable in 48,702 shares of Class A common stock (the “Commitment Shares”) or, at the Investor’s election, pre-funded warrants exercisable at $0.0001 per share. As of September 30, 2026, and as of the date of this report, no Commitment Shares or pre-funded warrants had been issued. Additional true-up commitment shares may become issuable upon the earlier of the date the resale registration statement is declared effective and the date the Commitment Shares become eligible for resale under Rule 144. The Commitment Shares (or pre-funded warrants) will be issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder, and the Investor represented that it was an accredited investor as defined in Rule 501(a) of Regulation D. No underwriting discounts or commissions were paid in connection with the issuance of the Commitment Shares. No shares of Class A common stock were sold to the Investor pursuant to put notices under the Equity Purchase Agreement during the three months ended September 30, 2026.


Series E Convertible Preferred Stock

 

On September 30, 2026, we entered into a Securities Purchase Agreement (the “Series E Securities Purchase Agreement”) with J.J. Astor & Co. (“J.J. Astor”), an accredited investor, pursuant to which we issued and sold to J.J. Astor 106,250 shares of our newly designated Series E Convertible Preferred Stock, par value $0.0001 per share (the “Series E Preferred Stock”), at a purchase price of $8.00 per share (each share having a stated value of $10.00, reflecting a 20% original issue discount), for aggregate gross proceeds of $850,000. Michael Pope, our Executive Chairman, is the Chief Executive Officer of J.J. Astor, and J.J. Astor is beneficially owned, directly or indirectly, by a private investment fund affiliated with Mr. Pope. Mr. Pope disclosed his conflict of interest, recused himself from all discussions and deliberations regarding the transaction and did not vote on its approval, and the transaction was approved by the disinterested members of our Board of Directors. The Series E Preferred Stock is convertible into shares of Class A common stock at a conversion price equal to the greater of (x) the Adjusted Floor Price (as defined in the Certificate of Designation of Series E Convertible Preferred Stock), which is initially $0.95 per share and is subject to six-month resets and specified full-ratchet resets, and (y) 80% of the lowest closing price of our Class A common stock during the five trading days before conversion, subject to a 19.99% beneficial ownership limitation. Conversions were also subject to a 19.99% exchange cap until the Series E Required Stockholder Approvals (as defined in the Series E Securities Purchase Agreement) were obtained at our special meeting of stockholders held on November 10, 2026. Under a Consent, Waiver and Ratification executed on October 9, 2026 and effective as of September 30, 2026, among us, the holders of a majority of the outstanding Series D Preferred Stock and J.J. Astor, the Series E Preferred Stock may not be converted, and the resale of the shares of Class A common stock issuable upon its conversion may not be registered, until the earlier of (i) such time as no shares of Series D Preferred Stock remain outstanding and (ii) the date on which a registration statement covering the resale of all shares of Class A common stock issuable upon conversion of the Series D Preferred Stock has been declared effective and the Series D Required Stockholder Approvals have been obtained. No placement agent, broker or finder fees were payable in connection with the Series E financing under the transaction documents. The Series E Preferred Stock was issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder, as the securities were sold in a private placement, without general solicitation, to an accredited investor.

 

Additional information regarding the Series E Preferred Stock financing was previously reported in our Current Report on Form 8-K filed with the SEC on October 6, 2026, as amended by our Current Report on Form 8-K/A filed with the SEC on October 13, 2026.


Conversion of Inventory Financing Obligations

 

On August 17, 2026, $75,608.38 of outstanding obligations under our inventory finance agreement with J.J. Astor was converted into 30,290 shares of our Class A common stock at a conversion price of $2.49615 per share. On August 19, 2026, an additional $92,357.55 of outstanding obligations under the inventory finance agreement was converted into 37,000 shares of our Class A common stock at a conversion price of $2.49615 per share. Each issuance was exempt from registration under Section 4(a)(2) of the Securities Act, as the transactions did not involve a public offering and J.J. Astor represented that it was an accredited investor as defined in Rule 501(a) of Regulation D.

 

62


Table of Contents


Registration Rights

 

Pursuant to a Registration Rights Agreement, dated August 5, 2026, with the Series D Purchasers, we agreed to register the resale of shares of Class A common stock issuable upon conversion of the Series D Preferred Stock and issued or issuable under the Equity Purchase Agreement. On September 22, 2026, we filed a registration statement on Form S-1 (File No. 333-299084), which was amended on October 23, 2026 and November 10, 2026, which also covers the resale of shares of Class A common stock issued or issuable to J.J. Astor under the inventory finance agreement and which has not yet been declared effective. Pursuant to a separate Registration Rights Agreement, dated September 30, 2026, with J.J. Astor, we agreed to register the resale of the shares of Class A common stock issuable upon conversion of the Series E Preferred Stock, subject to the restrictions described above. The shares of Class A common stock issuable upon conversion of the Series D Preferred Stock and the Series E Preferred Stock will be issued in reliance upon the exemption from registration provided by Section 3(a)(9) of the Securities Act.


Use of Proceeds

 

Pursuant to the mandatory prepayment provisions of our Credit Agreement, as amended, we applied approximately $2.25 million of the net proceeds of the Series D Preferred Stock financing to prepay a portion of the outstanding loans under the Credit Agreement in August 2026, together with a prepayment premium of approximately $0.14 million, and approximately $425 thousand of the net proceeds of the Series E Preferred Stock financing to prepay a portion of such loans in October 2026, together with a prepayment premium of approximately $26 thousand. We have used, and intend to use, the remaining net proceeds for working capital and general corporate purposes, including support of the commercialization of our Symphony product line.


Issuer Purchases of Equity Securities. 

 

None.  

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

As described in Note 8, Debt, and Note 17, Subsequent Events, to our unaudited condensed consolidated financial statements, we were in default under the Credit Agreement, under which approximately $30.0 million in aggregate principal amount was outstanding as of September 30, 2026 and approximately $29.6 million as of the date of this report. For each of the months ended August 31, 2026 and September 30, 2026 (and, as anticipated, the month ending October 31, 2026), we were in an over advance in excess of the Permitted Over Advance and did not make the mandatory prepayment required under Section 2.05(c)(vii) of the Credit Agreement, and we were not in compliance with the financial covenants in Sections 7.03(a) and 7.03(b) of the Credit Agreement.. On November 10, 2026, the Lenders waived these defaults pursuant to the November 2026 Waiver, subject to the conditions described in Note 8. As of September 30, 2026, accumulated and unpaid dividends on the Series B Preferred Stock totaled approximately $2.2 million.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

Securities Trading Plans of Directors and Executive Officers

 

During the three months ended  September 30, 2026, none of our directors or officers (as defined in Rule 16a-1 under the Exchange Act) adopted or terminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K).

 

Disclosure in Lieu of Current Report on Form 8-K

 

The information regarding the November 2026 Waiver and the First Amendment to Amended and Restated Inventory Finance Agreement with J.J. Astor & Co., each entered into on November 10, 2026, set forth in Note 8, Debt, Note 13, Related Party Transactions, and Note 17, Subsequent Events, to our unaudited condensed consolidated financial statements and in Part II, Item 3 of this Quarterly Report, is incorporated by reference into this Item 5 and is provided in lieu of disclosure under Items 1.01, 2.03 and 2.04 of Form 8-K. The foregoing descriptions are qualified in their entirety by reference to the agreements, which are filed as Exhibits 10.19 and 10.20 to this Quarterly Report.

 

63


Table of Contents

 

ITEM 6. EXHIBITS 

 

The following exhibits are filed or furnished with this report:

 

Exhibit No.

 

Description of Exhibit

3.1*

 

Eleventh Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.5 to the Registration Statement on Form S-1 (File No. 333-204811) filed on December 15, 2016) as amended through September 30, 2026.

3.2

 

Amended and Restated Bylaws, adopted as of April 14, 2026 (incorporated by reference to Exhibit 3.2 to the Annual Report on Form 10-K filed on April 15, 2026).

3.3*

 

Certificate of Amendment to the Articles of Incorporation of Boxlight Corporation, increasing authorized Class A Common Stock to 500,000,000 shares filed with the Nevada Secretary of State on November 13, 2026.

3.4

 

Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on August 11, 2026).

3.5

 

Certificate of Amendment to the Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock, filed with the Secretary of State of the State of Nevada on September 30, 2026 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on October 6, 2026).

3.6

 

Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock, filed with the Nevada Secretary of State on September 30, 2026 (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed on October 6, 2026).

4.1

 

Form of Pre-Funded Warrants to Purchase Class A Common Stock (incorporated by reference to Exhibit 10.7 to the Current Report on Form 8-K filed on August 11, 2026)

10.1

 

Forbearance Agreement and Waiver to Credit Agreement, dated August 10, 2026, between Boxlight Corporation, its subsidiaries, Whitehawk Capital Partners, LP and Whitehawk Finance LLC. (incorporated by reference to Exhibit 10.4 to the Quarterly Report on Form 10-Q filed on August 14, 2026)

10.2

 

Securities Purchase Agreement, dated August 5, 2026, by and among Boxlight Corporation and the Purchasers party thereto (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on August 11, 2026).

10.3

 

Registration Rights Agreement, dated August 5, 2026, by and among Boxlight Corporation and the Purchasers party thereto (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on August 11, 2026).

10.4

 

Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed on August 11, 2026).

10.5

 

Form of Irrevocable Transfer Agent Instructions (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed on August 11, 2026).

10.6

 

Equity Purchase Agreement, dated August 5, 2026, by and between Boxlight Corporation and Secure Net Capital LLC (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K filed on August 11, 2026).

 

 

64


Table of Contents

 

10.7

 

Placement Agent Agreement, dated August 5, 2026, by and among Boxlight Corporation, RBW Capital Partners LLC, and Dawson James Securities, Inc. (incorporated by reference to Exhibit 10.8 to the Current Report on Form 8-K filed on August 11, 2026).

10.8#

 

Interim Chief Financial Officer Appointment Agreement, dated August 3, 2026, by and between Boxlight Corporation and Jennifer Grabow (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed August 4, 2026).

10.9

 

First Amendment to Securities Purchase Agreement, dated September 30, 2026, by and among Boxlight Corporation and the Purchasers party thereto (relating to the Series D Convertible Preferred Stock) (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on October 6, 2026).

10.10

 

Securities Purchase Agreement, dated September 30, 2026, by and between Boxlight Corporation and J.J. Astor & Co. (relating to the Series E Convertible Preferred Stock) (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on October 6, 2026).

10.11

 

Registration Rights Agreement, dated September 30, 2026, by and between Boxlight Corporation and J.J. Astor & Co. (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on October 6, 2026).

10.12

 

Second Amendment to Amended and Restated Inventory Finance Agreement, dated August 17, 2026, by and between Boxlight Corporation and J.J. Astor & Co. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on August 25, 2026).

10.13

 

Third Amendment to Amended and Restated Inventory Finance Agreement, dated August 19, 2026, by and between Boxlight Corporation and J.J. Astor & Co. (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on August 25, 2026).

10.14

 

Consent, Waiver and Ratification, dated October 6, 2026 and amended on October 9, 2026 (effective as of September 30, 2026), by and between the holders of Series D Preferred Stock, acknowledged by the Company and J.J. Astor (incorporated by reference to Exhibit 10.4 to the Amendment No. 1 to the Current Report on Form 8-K/A filed on October 13, 2026).

10.15*

 

First Amendment to Amended and Restated Inventory Finance Agreement, dated November 10, 2026, by and between Boxlight Corporation and J.J. Astor & Co.

10.16*

 

Forbearance Agreement and Waiver, dated November 10, 2026, by and among Boxlight Corporation, certain of its subsidiaries, the lenders party thereto and Whitehawk Capital Partners LP, as administrative agent.

31.1*

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

 

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

 

Inline XBRL Instance Document

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

*

Filed herewith.

 

**

Furnished herewith.

 

#

Indicates a management contract or compensatory plan or arrangement.

 

65


Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

BOXLIGHT CORPORATION

 

 

 

 

 

 

November 16, 2026

By:

/s/ Michael R. Pope

 

 

Michael R. Pope

 

 

Executive Chairman

 

 

Principal Executive Officer

 

 

November 16, 2026

By:

/s/ Jennifer Grabow

 

 

Jennifer Grabow

 

 

Interim Chief Financial Officer

 

 

(Principal financial and accounting officer)

 

 

66

Keep reading